var title_f5_44_5824="SDRIFE";
var content_f5_44_5824=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Symmetrical drug-related intertriginous and flexural exanthem (SDRIFE)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 271px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sharply demarcated erythema in the gluteal/perianal area in a patient with SDRIFE. Note the involvement of the popliteal folds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5824=[""].join("\n");
var outline_f5_44_5824=null;
var title_f5_44_5825="Isoniazid and thiacetazone: International drug information";
var content_f5_44_5825=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"24\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Isoniazid and thiacetazone: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F2226003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Thiacetazone and Isoniazid",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F2226004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antitubercular Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F2226005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     Treatment of pulmonary and extrapulmonary tuberculosis",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F2226007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     Adults: Oral: 1 capsule (containing isoniazid 300 mg and thiacetazone 150 mg) daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2226008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule: Isoniazid 300 mg and thiacetazone 150 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10465 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-2.133.93.82-D9A3241E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5825=[""].join("\n");
var outline_f5_44_5825=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2226003\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2226004\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2226005\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2226007\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821242\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2226008\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10465\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10465|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_44_5826="GAP flap breast reconstruction";
var content_f5_44_5826=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F75614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F75614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    GAP flap breast reconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 538px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    For patients who do not have sufficient lower abdominal fat for reconstructive flaps, but who prefer the use of autologous tissue, a more viable donor site may be the buttock area. For this free flap, perforating vessels from either the superior gluteal artery (SGAP flap) or the inferior gluteal artery (IGAP flap) can be used as the vascular supply for the transferred tissue. For the SGAP flap, upper buttock tissue is used, resulting in a donor site scar that is concealable under most swimwear. If an IGAP flap is performed, the donor site scar lies within the lower buttock crease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5826=[""].join("\n");
var outline_f5_44_5826=null;
var title_f5_44_5827="Laryngeal inlet";
var content_f5_44_5827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F67789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F67789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laryngeal inlet",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joshua Nagler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5827=[""].join("\n");
var outline_f5_44_5827=null;
var title_f5_44_5828="Clotrimazole (oral): Patient drug information";
var content_f5_44_5828=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clotrimazole (oral): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/60/35780?source=see_link\">",
"     see \"Clotrimazole (oral): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/6/15460?source=see_link\">",
"     see \"Clotrimazole (oral): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692183",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat yeast infections in the mouth.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701845",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clotrimazole or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698702",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the yeast infection keeps coming back.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695691",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Suck oral lozenge. Do not chew, break, or crush it. Do not swallow it whole.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11607 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-01FC61200C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5828=[""].join("\n");
var outline_f5_44_5828=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026907\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026906\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026911\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026912\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026914\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026909\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026910\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026915\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026916\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/60/35780?source=related_link\">",
"      Clotrimazole (oral): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/6/15460?source=related_link\">",
"      Clotrimazole (oral): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/61/29652?source=related_link\">",
"      Clotrimazole (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/37/41556?source=related_link\">",
"      Clotrimazole (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/28/13763?source=related_link\">",
"      Clotrimazole (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_44_5829="Skin excoriations in chronic methamphetamine abuse";
var content_f5_44_5829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86746&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Skin excoriations in chronic methamphetamine abuse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Many chronic methamphetamine abusers suffer multiple small skin excoriations from unremitting picking, as seen in the photograph above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5829=[""].join("\n");
var outline_f5_44_5829=null;
var title_f5_44_5830="Desflurane: Drug information";
var content_f5_44_5830=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Desflurane: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?7/62/8164?source=see_link\">",
"    see \"Desflurane: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F157562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Suprane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F157563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Suprane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F157589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      General Anesthetic, Inhalation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F157567\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The minimum alveolar concentration (MAC), the concentration at which 50% of patients do not respond to surgical incision, varies by age. In adults, the concentration at which amnesia and loss of awareness occur (MAC - awake) is 2.4%. Surgical levels of anesthesia are achieved between 2.5% to 8.5%.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <col align=\"center\" width=\"150\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         Patient Age and Minimum Alveolar Concentration (MAC)",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"top\">",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:-2em;margin-left:2em;\">",
"         <b>",
"          Note:",
"         </b>",
"         Concurrent use with benzodiazepines, nitrous oxide, or opioids decreases desflurane dose. Because of the higher vapor pressure of desflurane, its vaporizer is heated in order to deliver a constant concentration.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          Age",
"         </b>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          MAC with 100% Oxygen",
"         </b>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          MAC with 60% N",
"          <sub>",
"           2",
"          </sub>",
"          O/40% Oxygen",
"         </b>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         9 mo",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         7.5%",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         3 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         8.9%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         6.4%",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         25 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         7.3%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4%",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         45 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         6%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         2.8%",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         70 y",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5.2%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1.7%",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F157578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F157568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15796016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15796017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F157549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, for inhalation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suprane&reg;: 100% (240 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F157539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F157551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Via desflurane-specific calibrated heated vaporizer",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F157550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Induction and/or maintenance of general anesthesia in adults; maintenance of anesthesia in intubated children;",
"     <b>",
"      Note:",
"     </b>",
"     Use of desflurane for induction of general anesthesia is not recommended due to its irritant properties and unpleasant odor which causes coughing, breath holding, laryngospasm, oxygen desaturation, increased secretions, hypertension, and tachycardia.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F7677466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intraoperative cardio- and neuroprotection (ischemic preconditioning)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F157595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Desflurane may be confused with Desferal&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F157587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Potential safety issues exist for occupational exposure to inhaled anesthetic gases (primarily nitrous oxide). Although there are no documented adverse effects of chronic occupational exposure to halogenated anesthetic vapors, like desflurane, some epidemiological studies suggest a link between these anesthetics and increased health problems (particularly spontaneous abortion). No conclusive relationship has been determined, but the National Institute for Occupational Safety and Health Administration (NIOSH) recommends no worker be exposed to &gt;2 ppm (ceiling concentrations) over a period of 1 hour. Precautions (eg, adequate ventilation, scavenging-systems, minimizing leaks/spills) can help to lessen any potential risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (27%), vomiting (16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Cough (3% to 34%), breath-holding (&gt;1% to 30%), apnea (3% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, hypertension, nodal arrhythmia, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Emergence delirium, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Salivation increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctivitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Secretions increased (3% to 10%), laryngospasm (3% to 10%), oxyhemoglobin desaturation (3% to 10%), pharyngitis (&gt;1% to 10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Shivering",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Agitation, ALT increased, ammonia increased, arrhythmia, AST increased, asthma, bigeminy, bronchospasm, cardiac arrest, cholestasis, coagulopathy, CPK increased, cytolytic hepatitis, dizziness, dyspnea, ECG changes,  hemoptysis, hemorrhage, hepatic failure, hepatic necrosis, hepatitis, hyperglycemia, hyper-/hypokalemia, hypotension, hypoxia, jaundice, malignant hypertension, malignant hyperthermia, metabolic acidosis, MI, myocardial ischemia, myalgia, ocular icterus, pancreatitis (acute), respiratory arrest, respiratory distress, respiratory failure, rhabdomyolysis, seizure, shock, torsade de pointes, vasodilation, ventricular failure, ventricular hypokinesia, WBC increased, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adverse reactions with accidental occupational exposure: Blindness (transient), dizziness, encephalopathy, eye burns, eye irritation, eye pain, fatigue, migraine, ocular hyperemia, palpitations, skin burning sensation, tachyarrhythmia, ulcerative keratitis, visual acuity reduced",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F157554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to desflurane, other halogenated anesthetic agents, or any component of the formulation; known or suspected susceptibility to malignant hyperthermia",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F157542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Decreased blood flow: May cause decrease in hepatic and/or renal blood flow.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatitis: May cause sensitivity hepatitis in patients who have been sensitized by previous exposure to halogenated anesthetics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperkalemia: Use of other inhaled anesthetics has been associated with rare cases of perioperative hyperkalemia; concomitant use of succinylcholine was associated with many of the reported cases, but not all. Risk of hyperkalemia is increased in pediatric patients with underlying neuromuscular disease (eg, Duchenne muscular dystrophy). Other abnormalities may include elevation in CK and myoglobinuria. Monitor closely for arrhythmias. Aggressively identify and treat hyperkalemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intracranial pressure: May dilate the cerebral vasculature and may, in certain conditions, increase intracranial pressure. In patients with intracranial space-occupying lesions, administer at &le;0.8 MAC in conjunction with a barbiturate induction and hyperventilation in the period before cranial decompression; maintain cerebral perfusion pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Malignant hyperthermia: May trigger malignant hyperthermia (MH); contraindicated in patients susceptible to MH.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory depression: Causes dose-dependent respiratory depression and blunted ventilatory response to hypoxia and hypercapnia. Hypoxic pulmonary vasoconstriction is blunted which may lead to increased pulmonary shunt. May produce elevated carbon monoxide levels in the presence of a dry carbon dioxide absorbent within the circle breathing system of an anesthetic machine; maintain fresh absorbent as per manufacturer guidelines regardless of state of colorimetric indicator.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Do not use as a single agent to induce anesthesia in patients with CAD or in whom an increase in heart rate or blood pressure should be avoided. Abrupt increases in inspired concentrations &gt;1 MAC can produce a transient increase in blood pressure and heart rate due to increased plasma catecholamine levels. Hypotensive effect due to peripheral vasodilation is dose dependent and increases as anesthesia is deepened.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Due to higher incidences of airway irritation (eg, laryngospasm, coughing, breath-holding, increased secretions) in pediatric patients; do not use to induce and/or maintain anesthesia in nonintubated pediatric patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F157545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOPamine: Inhalational Anesthetics may enhance the arrhythmogenic effect of DOPamine.  Management: Avoid use of dopamine in patients receiving halogenated hydrocarbon anesthetics.  If concomitant treatment cannot be avoided, monitor for arrhythmia.  Dopamine induced ventricular arrhythmia may be reversible with propranolol based on animal data.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     EPHEDrine (Systemic): May enhance the arrhythmogenic effect of Inhalational Anesthetics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     EPINEPHrine (Nasal): Inhalational Anesthetics may enhance the arrhythmogenic effect of EPINEPHrine (Nasal).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     EPINEPHrine (Systemic, Oral Inhalation): Inhalational Anesthetics may enhance the arrhythmogenic effect of EPINEPHrine (Systemic, Oral Inhalation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Formoterol: Inhalational Anesthetics may enhance the arrhythmogenic effect of Formoterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoproterenol: Inhalational Anesthetics may enhance the arrhythmogenic effect of Isoproterenol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May enhance the hypertensive effect of Inhalational Anesthetics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Inhalational Anesthetics may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Norepinephrine: Inhalational Anesthetics may enhance the arrhythmogenic effect of Norepinephrine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F157546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F4323389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adverse events observed in animal studies. There are no adequate and well-controlled studies in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F4323390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F4323391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to rapid washout, desflurane levels in milk most likely have no clinical importance 24 hours after anesthesia.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F157547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate and rhythm, temperature, oxygen saturation, end-tidal CO",
"     <sub>",
"      2",
"     </sub>",
"     and end-tidal desflurane concentrations should be monitored prior to and throughout anesthesia",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F157556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Sulorane (IL);",
"     </li>",
"     <li>",
"      Suprane (AR, AT, AU, BE, CH, CL, CZ, DE, DK, EC, EE, ES, FI, GB, GR, HK, HN, ID, IT, KP, LU, MY, NL, NO, NZ, PE, PH, PL, SE, SG, TH, VE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F8002849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Although not completely defined, it is thought that desflurane enhances inhibitory postsynaptic channel activity and inhibits excitatory synaptic activity resulting in general anesthesia.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F157553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 1-2 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Emergence time: Depends on blood concentration when desflurane is discontinued",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     The rate of change of anesthetic concentration in the lung is more rapid with desflurane because of its low blood/gas solubility (0.42), which is similar to nitrous oxide.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (0.02%) to triflouroacetate (negligible) and inorganic fluoride",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Exhaled gases",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Campagna JA, Miller KW, and Forman SA, &ldquo;Mechanisms of Actions of Inhaled Anesthetics,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2003, 348(21):2110-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/12761368/pubmed\" id=\"12761368\" target=\"_blank\">",
"        12761368",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      De Hert SG, Turani F, Mathur S, et al, &ldquo;Cardioprotection With Volatile Anesthetics: Mechanisms and Clinical Implications,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2005, 100(6):1584-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/15920178/pubmed\" id=\"15920178\" target=\"_blank\">",
"        15920178",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ebert TJ and Muzi M, &ldquo;Sympathetic Hyperactivity During Desflurane Anesthesia in Healthy Volunteers. A Comparison With Isoflurane,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1993, 79(3):444-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/8363068/pubmed\" id=\"8363068\" target=\"_blank\">",
"        8363068",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guarracino F, Landoni G, Tritapepe L, et al, &ldquo;Myocardial Damage Prevented by Volatile Anesthetics: A Multicenter Randomized Controlled Study,&rdquo;",
"      <i>",
"       J Cardiothorac Vasc Anesth",
"      </i>",
"      , 2006, 20(4):477-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/16884976/pubmed\" id=\"16884976\" target=\"_blank\">",
"        16884976",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Meco M, Cirri S, Gallazzi C, et al, &ldquo;Desflurane Preconditioning in Coronary Artery Bypass Graft Surgery: A Double-Blinded, Randomised and Placebo-Controlled Study,&rdquo;",
"      <i>",
"       Eur J Cardiothorac Surg",
"      </i>",
"      , 2007, 32(2):319-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/17574858/pubmed\" id=\"17574858\" target=\"_blank\">",
"        17574858",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sakai EM, Connolly LA, and Klauck J, &ldquo;Inhalation Anesthesiology and Volatile Liquid Anesthetics: Focus on Isoflurane, Desflurane, and Sevoflurane,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2005, 25(12):1773-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/16305297/pubmed\" id=\"16305297\" target=\"_blank\">",
"        16305297",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tritapepe L, Landoni G, Guarracino F, et al, &ldquo;Cardiac Protection by Volatile Anaesthetics: A Multicentre Randomized Controlled Study in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass,&rdquo;",
"      <i>",
"       Eur J Anaesthesiol",
"      </i>",
"      , 2007, 24(4):323-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/17156509/pubmed\" id=\"17156509\" target=\"_blank\">",
"        17156509",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wang L, Traystman RJ, and Murphy SJ, &ldquo;Inhalational Anesthetics as Preconditioning Agents in Ischemic Brain,&rdquo;",
"      <i>",
"       Curr Opin Pharmacol",
"      </i>",
"      , 2008, 8(1):104-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/17962069/pubmed\" id=\"17962069\" target=\"_blank\">",
"        17962069",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weiskopf RB, Eger EI 2nd, Noorani M, et al, &ldquo;Fentanyl, Esmolol, and Clonidine Blunt the Transient Cardiovascular Stimulation Induced by Desflurane in Humans,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1994, 81(6):1350-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/7992902/pubmed\" id=\"7992902\" target=\"_blank\">",
"        7992902",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weiskopf RB, Moore MA, Eger EI 2nd, et al, &ldquo;Rapid Increase in Desflurane Concentration Is Associated With Greater Transient Cardiovascular Stimulation Than With Rapid Increase in Isoflurane Concentration in Humans,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1994, 80(5):1035-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/8017643/pubmed\" id=\"8017643\" target=\"_blank\">",
"        8017643",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yasuda N, Lockhart SH, Eger EI 2nd, et al, &ldquo;Kinetics of Desflurane, Isoflurane, and Halothane in Humans,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1991, 74(3):489-98.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/44/5830/abstract-text/2001028/pubmed\" id=\"2001028\" target=\"_blank\">",
"        2001028",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8891 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-71A5527948-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5830=[""].join("\n");
var outline_f5_44_5830=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157562\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157563\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157589\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157567\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157578\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157568\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15796016\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15796017\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157549\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157539\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157551\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157550\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7677466\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157595\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157587\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157554\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157542\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299135\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157545\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157546\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4323389\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4323390\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4323391\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157547\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157556\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8002849\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157553\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8891\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8891|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?7/62/8164?source=related_link\">",
"      Desflurane: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_44_5831="Overview of the neuropsychiatric aspects of HIV infection and AIDS";
var content_f5_44_5831=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the neuropsychiatric aspects of HIV infection and AIDS",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5831/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5831/contributors\">",
"     Andrew A Pieper, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5831/contributors\">",
"     Glenn J Treisman, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5831/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5831/contributors\">",
"     Jonathan M Silver, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5831/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5831/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/44/5831/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 29, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The high prevalence of neuropsychiatric disorders in individuals infected with the human immunodeficiency virus (HIV), is related to a wide variety of factors including: direct effects of the virus, preexisting psychiatric conditions, personality vulnerabilities, affective disorders, addictions, and personal responses to the social isolation and disenfranchisement associated with the diagnosis of HIV. Furthermore, many HIV-infected persons experience difficulty with treatment adherence due to their behavior patterns as well as acquisition of specific neuropsychiatric disorders associated with HIV disease progression. Studies have shown that patients with neuropsychiatric conditions have poorer outcomes and less benefit from antiretroviral therapy; however, psychiatric treatment improves HIV-related outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuropsychiatric care in HIV disease ranges from supportive psychotherapy for grief and loss issues to treatment of specific HIV-associated neuropsychiatric conditions (eg, HIV-associated dementia, minor cognitive-motor disorder, acquired immune deficiency syndrome [AIDS]-mania), as well as managment of unique clinical presentations of other psychiatric disorders such as depression and schizophrenia. The availability of effective psychiatric care to HIV-infected patients is critical for their treatment and also for controlling the HIV epidemic.",
"   </p>",
"   <p>",
"    The most prevalent comorbid axis-I conditions associated with HIV disease are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delirium",
"     </li>",
"     <li>",
"      Minor cognitive-motor disorder (MCMD)",
"     </li>",
"     <li>",
"      HIV-associated dementia",
"     </li>",
"     <li>",
"      Major depression",
"     </li>",
"     <li>",
"      Bipolar disorder (including AIDS mania)",
"     </li>",
"     <li>",
"      Schizophrenia",
"     </li>",
"     <li>",
"      Substance abuse or dependence",
"     </li>",
"     <li>",
"      Posttraumatic stress disorder (PTSD)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the range of neuropsychiatric conditions associated with HIV infection will be presented here. More detailed reviews of these specific conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"     \"Dementia and delirium in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2551?source=see_link\">",
"     \"Substance abuse and addiction in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DELIRIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delirium, a state of global derangement of cerebral function, occurs frequently in medically ill, brain injured, or metabolically unstable patients. This disorder is characterized by inattention, disorganized thinking, confusion, emotional liability, and fluctuations in level of consciousness. Hallucinations and delusions are also common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"     \"Dementia and delirium in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Due to the complexity and number of comorbid disorders, delirium is highly prevalent in HIV disease. The differential diagnosis of delirium in HIV-infected patients includes HIV-associated dementia, AIDS mania, minor cognitive-motor disorder, major depression, bipolar disorder, panic disorder, and schizophrenia. Delirium can usually be distinguished by its rapid onset, fluctuating level of consciousness, and link to a medical etiology. Common etiologies include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Toxic (eg, poisoning or medication toxicity, especially medications with potent anticholinergic activity)",
"     </li>",
"     <li>",
"      Metabolic",
"     </li>",
"     <li>",
"      Infectious, especially central nervous system (CNS) infection",
"     </li>",
"     <li>",
"      Endocrine (eg, thyroid and adrenal axes)",
"     </li>",
"     <li>",
"      CNS neoplasm",
"     </li>",
"     <li>",
"      Cardiovascular (eg, myocardial infarction or arrhythmia)",
"     </li>",
"     <li>",
"      Neurologic (eg, seizure or stroke)",
"     </li>",
"     <li>",
"      Pulmonary (eg, hypoxia or hypercapnea)",
"     </li>",
"     <li>",
"      Traumatic (eg, head injury or burns)",
"     </li>",
"     <li>",
"      Withdrawal from alcohol or medications",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEMENTIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-associated dementia (also called AIDS dementia complex) is a major cause of neurocognitive disturbance in HIV patients, with other common etiologies including cytomegalovirus (CMV) encephalitis, progressive multifocal leukoencephalopathy (PML), cerebral toxoplasmosis, cryptococcal meningitis, and CNS lymphoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41128?source=see_link\">",
"     \"Approach to HIV-infected patients with central nervous system lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33129?source=see_link\">",
"     \"Toxoplasmosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40919?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20042?source=see_link\">",
"     \"AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV-associated dementia usually occurs in patients with a CD4 count nadir &lt;200",
"    <span class=\"nowrap\">",
"     cells/microL.",
"    </span>",
"    Risks factors for HIV-associated dementia include high serum or cerebrospinal fluid (CSF) HIV viral load [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/2\">",
"     2",
"    </a>",
"    ], low educational level, advanced age (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/44/26313?source=see_link\">",
"     \"HIV and the older patient\"",
"    </a>",
"    ), anemia, illicit drug use, and female sex. Since the introduction of highly active antiretroviral therapy (HAART), the incidence of HIV-associated dementia has declined, although not as much as some of the opportunistic infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"     \"Dementia and delirium in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MINOR COGNITIVE MOTOR IMPAIRMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;MCMD, cognitive impairment that approaches but does not meet diagnostic criteria for dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/3\">",
"     3",
"    </a>",
"    ], is less severe than HIV-associated dementia and emerges earlier in HIV disease. Symptoms of MCMD are subtle and often overlooked. It is not known whether MCMD predisposes to HIV-associated dementia. Some patients continue to have only minor problems while others progress to full dementia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MAJOR DEPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbid depression is common with HIV disease, both in those with HIV dementia and others, and depression hinders effective treatment of HIV-infected individuals, such that these patients are at significantly increased risk for HIV-disease progression and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. Furthermore, depressive symptoms in patients with HIV worsen ART adherence, while adherence to antidepressant therapy in HIV-positive individuals with depression reverses this trend [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. HIV also increases the risk of developing depression through direct damage to subcortical brain areas, chronic stress, worsening social isolation and intense demoralization. Indeed, patients with symptomatic HIV disease are significantly more likely to undergo a major depressive episode than patients with asymptomatic HIV disease, or HIV-negative control study subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/11\">",
"     11",
"    </a>",
"    ]. Unfortunately, depression is underdiagnosed and undertreated in most medical clinics and has thus emerged as one of the most significant factors in the",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    epidemic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV-associated dementia and other HIV-related CNS conditions can produce a flat, apathetic state often misdiagnosed as depression. The differential diagnosis in HIV patients reporting depressive symptoms includes major depression, dysthymia, dementia, delirium, demoralization, intoxication, withdrawal, CNS injury, CNS infection, and acute medical illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MANIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mania, which occurs in HIV-infected patients both as a component of bipolar illness and as a the unique entity of AIDS mania, is associated with impulsivity, impaired judgment, and risk taking, all of which can lead to behavior that accelerates HIV-disease progression. Bipolar illness is broad in spectrum, ranging from a severely crippling and chronic mental illness to a mild disorder with alternating experiences of elevated or depressed mood. It is thus difficult to accurately measure the prevalence and incidence of bipolar disorder and it has also been difficult historically to distinguish severe bipolar illness from schizophrenia. Investigators looking at the relationship between HIV and mental illness have thus often simply employed the term \"chronically mentally ill\" for patients with severe disability from either schizophrenia or bipolar disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    AIDS mania is uniquely associated with late stage HIV infection. AIDS mania is characterized by typical mania and additional cognitive impairment in the setting of a lack of previous personal or family history of bipolar illness. AIDS mania has less euphoria and more irritability than the mania associated with illness, and is also far more chronic. In contrast to bipolar mania, AIDS mania usually does not remit if left untreated. The prevalence of AIDS mania has dropped significantly since the onset of HAART.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SCHIZOPHRENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe and chronic mental illness, historically encompassing schizophrenia and bipolar I disorder, is estimated at prevalence rates from four to 19 percent in HIV patients. No evidence suggests that HIV causes schizophrenia, but data does suggest that schizophrenia contributes to high-risk behavior associated with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link\">",
"     \"Depression, mania, and schizophrenia in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUBSTANCE ABUSE AND ADDICTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substance abuse adds a complex dimension to HIV-infected patients since addiction can serve as a primary vector for the spread of the virus but also greatly complicate treatment of HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Extensive psychiatric, psychological and medical comorbidities are associated with substance abuse and addiction in HIV disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2551?source=see_link\">",
"     \"Substance abuse and addiction in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     POSTTRAUMATIC STRESS DISORDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between PTSD and HIV infection is also complex. PTSD exacerbates HIV risk behaviors and worsens health outcomes. HIV risk behaviors, such as prostitution and drug abuse, may increase exposure to trauma associated with increased likelihood of developing PTSD, and likewise, PTSD from early trauma predisposes individuals to engage in sex or drug behaviors that increase the risk of HIV infection. For example, PTSD often coexists with depression and",
"    <span class=\"nowrap\">",
"     cocaine/opioid",
"    </span>",
"    abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/14\">",
"     14",
"    </a>",
"    ], both of which are risk factors for HIV. Substance abuse may be either a relief strategy in response to traumatic experience, or a lifestyle that increases exposure to traumatic events like robbery or assault [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ISSUES OF PERSONALITY IN HIV DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Personality disorders are more prevalent among HIV-infected (19 to 36 percent) and HIV at-risk (15 to 20 percent) individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/16-18\">",
"     16-18",
"    </a>",
"    ] than the general population (10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/19\">",
"     19",
"    </a>",
"    ]. Antisocial personality disorder (ASPD) is the most common personality disorder among HIV infected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/20\">",
"     20",
"    </a>",
"    ], and has been shown to significantly increase risk of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dimensional nature of personality",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Johns Hopkins AIDS Service (JHAS) patients are characterized along the dimensions of extroversion-introversion and emotional stability-instability [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/22,23\">",
"     22,23",
"    </a>",
"    ] rather than the discrete categories provided by Axis II of the DSM-IV [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/24\">",
"     24",
"    </a>",
"    ]. This approach emphasizes the assets as well as the vulnerabilities of extremes of personality and helps in understanding the behavior exhibited by patients. It also suggests intervention strategies and is less stigmatizing. Furthermore, a classification system based on a continuum approach is a better predictor of HIV risk behavior than DSM-IV Axis II categories [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The extroversion-introversion dimension refers to the individual's tendency to respond to stimuli with either excitation or inhibition. Extroverted individuals are present-oriented, feeling-directed and reward-seeking. Feelings dominate thoughts. Their primary motivation is reward-seeking or relief from discomfort and their chief focus is the immediate emotional experience [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5831/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. By contrast, introverted individuals are future and past oriented, cognition-directed and consequence-avoidant. Logic and function predominate over feelings in their decisions. Introverts are motivated by appraisal of past experience and avoidance of future adverse consequences.",
"   </p>",
"   <p>",
"    The second dimension of personality, stability-instability, describes the degree of emotional lability. Stable individuals respond to emotional stimuli slowly and require intense stimuli for significant emotional arousal. They also have predictable emotional responses and will usually respond the same way to the same stimulus over time. By contrast, unstable individuals experience intense mercurial emotions that are easily aroused, require only modest provocation for intense reactions, and are unpredictable, in that the same stimulus may produce very different responses when encountered at different times. The juxtaposition of these two personality dimensions allows classification of individuals into four personality types: unstable extroversion, stable extroversion, unstable introversion and stable introversion.",
"   </p>",
"   <p>",
"    Although this classification scheme is not the method used in the DSM-IV, various forms have been used extensively in research and we have found it to be more useful in the description and treatment of HIV-infected individuals.",
"   </p>",
"   <p>",
"    For example, extreme extroverts, which comprise the most highly represented personality disorder in patients seen at the JHAS, are vulnerable when it is important for them to avoid consequences and focus on the future, like adhering to a complex daily HAART regimen. As most healthcare professionals tend to be on the introverted side (ie, consequence-avoidant), they are often puzzled by the extrovert's insensitivity to consequence and thus may face significant difficulty in communicating with these patients as they stress the long-term negatives while patients are focused on their immediate goals. We have found the following approaches to be particularly useful in aligning with unstable extrovert patients to optimize their treatment:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Describe behaviors in terms of rewards. Reframe consequence avoidance to describe the benefits likely to be garnered from a particular course of action as opposed to describing the negative results that will ensue. For example, reframing \"If you don't stop shooting drugs, you'll get sicker\" as \"If you get off drugs you'll feel better\" places the emphasis on getting the patient to choose the desired behavior directly linked to the reward.",
"     </li>",
"     <li>",
"      Appeal to the patient's cognitive side, whenever possible, to help patients learn to recognize their vulnerabilities (ie, impulsiveness, short temper). Instruct them to remove themselves from potentially problematic situations or to have a planned response that does not rely on these feelings.",
"     </li>",
"     <li>",
"      Describe the treatment plan clearly and with firm limits. This provides all clinicians with a unified set of goals and expectations, and increases the likelihood of persuading a patient to adhere to the clinician's treatment goals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ultimately, these approaches can help unstable extroverted patients with HIV to change how they respond to problems by redefining their goals towards health and function, and thus gradually changing their lives in a fundamental way.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/12/35009?source=see_link\">",
"       \"Patient information: Dementia with HIV (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?10/57/11155?source=see_link\">",
"       \"Patient information: Delirium (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95741367\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most prevalent psychiatric disorders associated with HIV disease are delirium, minor cognitive-motor disorder (MCMD), HIV-associated dementia, major depression, bipolar disorder (including AIDS mania), schizophrenia, substance abuse or dependence, posttraumatic stress disorder (PTSD), and personality disorders and traits. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Delirium is characterized by inattention, disorganized thinking, confusion, emotional liability, and fluctuations in level of consciousness. The differential diagnosis of delirium in HIV-infected patients includes HIV-associated dementia, AIDS mania, minor cognitive-motor disorder, major depression, bipolar disorder, panic disorder, and schizophrenia. Delirium can usually be distinguished by its rapid onset, fluctuating level of consciousness, and link to a medical etiology. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Delirium'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HIV-associated dementia usually occurs in patients with a CD4 count nadir &lt;200",
"      <span class=\"nowrap\">",
"       cells/microL.",
"      </span>",
"      Risks factors for HIV-associated dementia include high serum or cerebrospinal fluid HIV viral load, low educational level, advanced age, anemia, illicit drug use, and female sex. Since the introduction of highly active antiretroviral therapy (HAART), the incidence of HIV-associated dementia has declined. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"       \"Dementia and delirium in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      MCMD is cognitive impairment that approaches but does not meet diagnostic criteria for dementia. MCDM is less severe than HIV-associated dementia and emerges earlier in HIV disease. It is not known whether MCMD predisposes to HIV-associated dementia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=see_link\">",
"       \"Dementia and delirium in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Comorbid major depression (",
"      <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"       table 1",
"      </a>",
"      ) is common with HIV disease and hinders effective treatment of HIV-infected individuals, such that these patients are at significantly increased risk for HIV-disease progression and mortality. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Major Depression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link&amp;anchor=H2#H2\">",
"       \"Depression, mania, and schizophrenia in HIV-infected patients\", section on 'Major depression'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mania (",
"      <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"       table 2",
"      </a>",
"      ) occurs in HIV-infected patients either as a component of bipolar illness, or as the unique entity of AIDS mania associated with late stage HIV infection. AIDS mania is characterized by typical mania and additional cognitive impairment in the setting of a lack of previous personal or family history of bipolar illness. The prevalence of AIDS mania has dropped significantly since the onset of HAART. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Mania'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link&amp;anchor=H13#H13\">",
"       \"Depression, mania, and schizophrenia in HIV-infected patients\", section on 'Mania'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      No evidence suggests that HIV causes schizophrenia, but data indicate that schizophrenia contributes to high-risk behavior associated with HIV infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=see_link&amp;anchor=H21#H21\">",
"       \"Depression, mania, and schizophrenia in HIV-infected patients\", section on 'Schizophrenia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Substance dependence can serve as a primary vector for the spread of HIV and complicate HIV treatment. Numerous comorbidities are associated with substance use disorders in HIV disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2551?source=see_link\">",
"       \"Substance abuse and addiction in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      PTSD exacerbates HIV risk behaviors and worsens health outcomes. HIV risk behaviors (sex and drug use) may increase exposure to trauma associated with increased likelihood of developing PTSD. Likewise, PTSD from early trauma predisposes individuals to engage in behaviors that increase the risk of HIV infection. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Posttraumatic stress disorder'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Personality in patients infected with HIV can be classified according to personality disorders as well as the dimensional constructs of extroversion-introversion (tendency to respond to stimuli with either excitation or inhibition) and emotional stability-instability (degree of emotional lability). Antisocial personality disorder is the most common personality disorder among HIV infected individuals. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Issues of personality in HIV disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/1\">",
"      Himelhoch S, Moore RD, Treisman G, Gebo KA. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004; 37:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/2\">",
"      McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/3\">",
"      Janssen RS, Cornblath DR, Epstein LG, et al. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology 1989; 39:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/4\">",
"      van Servellen G, Chang B, Garcia L, Lombardi E. Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDS 2002; 16:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/5\">",
"      Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001; 285:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/6\">",
"      Berger-Greenstein JA, Cuevas CA, Brady SM, et al. Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care STDS 2007; 21:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/7\">",
"      Colibazzi T, Hsu TT, Gilmer WS. Human immunodeficiency virus and depression in primary care: a clinical review. Prim Care Companion J Clin Psychiatry 2006; 8:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/8\">",
"      Villes V, Spire B, Lewden C, et al. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther 2007; 12:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/9\">",
"      Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 2008; 47:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/10\">",
"      Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008; 79:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/11\">",
"      Atkinson JH, Heaton RK, Patterson TL, et al. Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord 2008; 108:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/12\">",
"      Cournos F, Guido JR, Coomaraswamy S, et al. Sexual activity and risk of HIV infection among patients with schizophrenia. Am J Psychiatry 1994; 151:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/13\">",
"      McKinnon K, Cournos F, Sugden R, et al. The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among people with severe mental illness. J Clin Psychiatry 1996; 57:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/14\">",
"      Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/15\">",
"      Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. A research review. Am J Addict 1997; 6:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/16\">",
"      Sher KJ, Trull TJ. Substance use disorder and personality disorder. Curr Psychiatry Rep 2002; 4:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/17\">",
"      Mulder RT. Alcoholism and personality. Aust N Z J Psychiatry 2002; 36:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/18\">",
"      Jacobsberg L, Frances A, Perry S. Axis II diagnoses among volunteers for HIV testing and counseling. Am J Psychiatry 1995; 152:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/19\">",
"      Johnson JG, Williams JB, Rabkin JG, et al. Axis I psychiatric symptoms associated with HIV infection and personality disorder. Am J Psychiatry 1995; 152:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/20\">",
"      Perkins DO, Davidson EJ, Leserman J, et al. Personality disorder in patients infected with HIV: a controlled study with implications for clinical care. Am J Psychiatry 1993; 150:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/21\">",
"      Weissman, MM. The epidemiology of personality disorders: a 1990 update. J Personal Disord 1993; 7 (suppl):44.",
"     </a>",
"    </li>",
"    <li>",
"     Jung, C. Psychological Types, Harcourt Brace, New York 1923.",
"    </li>",
"    <li>",
"     Costa, PT Jr, Widiger, TA (Eds). Personality Disorders and the Five-Factor Model of Personality. American Psychological Association, Washington DC 1994.",
"    </li>",
"    <li>",
"     American Psychiatric Association: The Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Press, Washington DC 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/25\">",
"      Tourian K, Alterman A, Metzger D, et al. Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients. Drug Alcohol Depend 1997; 47:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/26\">",
"      Eysenck, HJ. Genetic and environmental contributions to individual differences: the three major dimensions of personality. J Personality 1990; 58:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5831/abstract/27\">",
"      Lucas RE, Diener E, Grob A, et al. Cross-cultural evidence for the fundamental features of extraversion. J Pers Soc Psychol 2000; 79:452.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4860 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-4E972C53F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5831=[""].join("\n");
var outline_f5_44_5831=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H95741367\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DELIRIUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEMENTIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MINOR COGNITIVE MOTOR IMPAIRMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MAJOR DEPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MANIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SCHIZOPHRENIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUBSTANCE ABUSE AND ADDICTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POSTTRAUMATIC STRESS DISORDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ISSUES OF PERSONALITY IN HIV DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dimensional nature of personality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95741367\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/4860\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/4860|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17756\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/53/3932\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for mania",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20042?source=related_link\">",
"      AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41128?source=related_link\">",
"      Approach to HIV-infected patients with central nervous system lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12249?source=related_link\">",
"      Dementia and delirium in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12504?source=related_link\">",
"      Depression, mania, and schizophrenia in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/61/40919?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/44/26313?source=related_link\">",
"      HIV and the older patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?10/57/11155?source=related_link\">",
"      Patient information: Delirium (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/12/35009?source=related_link\">",
"      Patient information: Dementia with HIV (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2551?source=related_link\">",
"      Substance abuse and addiction in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33129?source=related_link\">",
"      Toxoplasmosis in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_44_5832="Anatomy and localization of spinal cord disorders";
var content_f5_44_5832=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anatomy and localization of spinal cord disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5832/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5832/contributors\">",
"     Andrew Eisen, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5832/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5832/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5832/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5832/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/44/5832/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because it is the primary pathway of communication between the brain and peripheral nervous system, diseases that affect the spinal cord are clinically eloquent. Many of these disease processes have a predilection for targeting specific areas or tracts within the spinal cord. As a result, knowledge of spinal cord anatomy and recognition of typical common spinal cord syndromes are useful in the evaluation of a patient with a myelopathy and can allow for a more directed diagnostic evaluation.",
"   </p>",
"   <p>",
"    The anatomy of the spinal cord and its vascular supply and clinical features of common spinal cord syndromes will be reviewed here. Diseases that affect the spinal cord are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPINAL CORD ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are 31 spinal cord segments, each with a pair of ventral (anterior) and dorsal (posterior) spinal nerve roots, which mediate motor and sensory function, respectively. The ventral and dorsal nerve roots combine on each side to form the spinal nerves as they exit from the vertebral column through the neuroforamina (",
"    <a class=\"graphic graphic_figure graphicRef65024 \" href=\"UTD.htm?21/60/22465\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Longitudinal organization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinal cord is divided longitudinally into four regions: the cervical, thoracic, lumbar, and sacral cord. The spinal cord extends from the base of the skull and terminates near the lower margin of the first lumbar vertebral body (L1). Below that level, the spinal canal contains the lumbar, sacral, and coccygeal spinal nerve roots that comprise the cauda equina.",
"   </p>",
"   <p>",
"    Because the spinal cord is shorter than the vertebral column, vertebral and spinal cord segmental levels are not necessarily the same. The C1 through C8 spinal cord segments lie between the C1 through C7 vertebral levels. The T1 through T12 cord segments lie between T1 through T8. The five lumbar cord segments are situated at the T9 through T11 vertebral levels, and the S1 through S5 segments lie between T12 to L1. The C1 through C7 nerve roots emerge above their respective vertebrae; the C8 nerve root emerges between the C7 and T1 vertebral bodies. The remaining nerve roots emerge below their respective vertebrae (",
"    <a class=\"graphic graphic_figure graphicRef50257 \" href=\"UTD.htm?39/43/40629\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Cervical cord",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first cervical vertebra (the atlas) and the second cervical vertebra (the axis), upon which the atlas pivots, support the head at the atlanto-occiput junction. The interface between the first and second vertebra is called the atlanto-axis junction.",
"   </p>",
"   <p>",
"    Cervical spinal segments innervate the skin and musculature of the upper extremity and diaphragm (",
"    <a class=\"graphic graphic_figure graphicRef58656 \" href=\"UTD.htm?10/47/10995\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53006 \" href=\"UTD.htm?21/8/21634\">",
"     figure 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      C3 through C5 innervate the diaphragm, the chief muscle of inspiration, via the phrenic nerve",
"     </li>",
"     <li>",
"      C4 through C7 innervate the shoulder and arm musculature",
"     </li>",
"     <li>",
"      C6 through C8 innervate the forearm extensors and flexors",
"     </li>",
"     <li>",
"      C8 through T1 innervate the hand musculature",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Thoracic cord",
"    </span>",
"    &nbsp;&mdash;&nbsp;The thoracic vertebral segments are defined by those that have an attached rib. The spinal roots form the intercostal nerves that run along the inferior rib margin and innervate the associated dermatomes, as well as the intercostal abdominal wall musculature. These muscles are the main muscles of expiration. The thoracic cord also contains the sympathetic nerves that innervate the heart and abdominal organs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Lumbosacral cord",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lumbosacral spinal cord contains the segments that innervate the muscles and dermatomes of the lower extremity, as well as the buttocks and anal regions (",
"    <a class=\"graphic graphic_figure graphicRef64884 \" href=\"UTD.htm?30/36/31297\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef50419 \" href=\"UTD.htm?10/36/10822\">",
"     figure 6",
"    </a>",
"    ). Sacral nerve roots S3 through S5 originate in the narrow terminal part of the cord, called the conus medullaris.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      L2 and L3 mediate hip flexion",
"     </li>",
"     <li>",
"      L3 and L4 mediate knee extension",
"     </li>",
"     <li>",
"      L4 and L5 mediate ankle dorsiflexion and hip extension",
"     </li>",
"     <li>",
"      L5 and S1 mediate knee flexion",
"     </li>",
"     <li>",
"      S1 and S2 mediate ankle plantar flexion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Sacral nerve roots also provide parasympathetic innervation of pelvic and abdominal organs, while lumbar nerve roots L1 and L2 contain sympathetic innervation of some pelvic and abdominal organs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Cauda equina",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults, the spinal cord ends at the level of the first or second lumbar vertebral bodies. The filum terminale, a thin connective tissue filament that descends from the conus medullaris with the spinal nerve roots, is connected to the third, fourth, and fifth sacral vertebrae; its terminal part is fused to the periosteum at the base of the coccygeal bone.",
"   </p>",
"   <p>",
"    Pathology at the T12 and L1 vertebral level affects the lumbar cord. Injuries to L2 frequently damage the conus medullaris. Injuries below L2 usually involve the cauda equina and represent injuries to spinal roots rather than to the spinal cord (",
"    <a class=\"graphic graphic_figure graphicRef50257 \" href=\"UTD.htm?39/43/40629\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cross-sectional anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinal cord contains the gray matter, the butterfly-shaped central region, and the surrounding white matter tracts. The spinal cord gray matter, which contains the neuronal cell bodies, is made up of the dorsal and ventral horns, each divided into several laminae [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Dorsal horn",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dorsal horn is the entry point of sensory information into the central nervous system. It is divided into six layers or laminae that process sensory information. More than a relay station for the transmission of sensory information, the dorsal horn also modulates pain transmission through spinal and supraspinal regulatory circuits. Three major categories of sensory input that are important to the clinical examination of spinal cord pathology include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Afferents from muscle spindles that participate in spinal cord reflexes.",
"     </li>",
"     <li>",
"      Axons, mostly small and unmyelinated, mediating sensory modalities of pain and temperature. These can travel up and down a few segments before synapsing with the second order neurons, which then cross the midline of the cord in the anterior commissure, just anterior to the central canal, and then enter the contralateral anterior or lateral spinothalamic tract.",
"     </li>",
"     <li>",
"      Axons mediating the sensory modalities of proprioception, vibration, and touch discrimination. These large myelinated fibers pass through the dorsal horn to enter the ipsilateral dorsal column.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The anatomy of the sensory system is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31879?source=see_link\">",
"     \"Approach to the patient with sensory loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Ventral horn",
"    </span>",
"    &nbsp;&mdash;&nbsp;The motor nuclei of the spinal cord are contained within the ventral horn, which also contains interneurons mediating information from other descending tracts of the pyramidal and extrapyramidal motor systems. These ultimately synapse on the alpha and gamma motor neurons, which subsequently leave the ventral horn via the ventral nerve root to terminate at the neuromuscular junction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     White matter tracts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major white matter tracts of clinical importance in the assessment of spinal cord disease include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The dorsal or posterior columns, the fasciculus gracilis, and the fasciculus cuneatus. These contain sensory information regarding joint position and vibration. They are organized anatomically such that cervical sections lie most laterally and sacral segments most medially (",
"      <a class=\"graphic graphic_figure graphicRef74602 \" href=\"UTD.htm?27/10/27810\">",
"       figure 7",
"      </a>",
"      ). These pathways will cross in the medulla; hence, in the spinal cord, these tracts contain ipsilateral sensory representation.",
"     </li>",
"     <li>",
"      The anterior and lateral spinothalamic tracts contain sensory information regarding pain, temperature, and touch. These axons have crossed in the ventral commissure and therefore contain contralateral sensory representation. This tract is somatotopically organized with cervical inputs located most medially and sacral inputs most laterally (",
"      <a class=\"graphic graphic_figure graphicRef74602 \" href=\"UTD.htm?27/10/27810\">",
"       figure 7",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The corticospinal tracts contain the upper motor neurons that originate in M1 of the primary motor cortex. These axons synapse either directly or indirectly on the anterior horn cells, and as such have distinct sites of anatomic origin within M1 [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/3\">",
"       3",
"      </a>",
"      ]. A single corticomotoneuronal axon synapses with many anterior horn cells of its own motor neuron pool and also with those of agonists and antagonists, allowing for coordination of highly skilled movements.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lateral corticospinal tract contains the majority (80 to 85 percent) of these fibers, which have previously decussated (crossed) at the cervicomedullary junction and therefore provide input to the ipsilateral musculature. Fibers are somatotopically organized within the tract such that fibers destined for upper extremity motor control lie most medially, while fibers controlling the lower extremity lie more laterally (",
"    <a class=\"graphic graphic_figure graphicRef74602 \" href=\"UTD.htm?27/10/27810\">",
"     figure 7",
"    </a>",
"    ). The anterior corticospinal tract contains undecussated fibers, some of which will subsequently cross at the spinal level through the anterior commissure.",
"   </p>",
"   <p>",
"    Other descending tracts include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The tectospinal tract originates in the superior colliculus and mediates reflex postural movements of the head in response to visual",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      acoustic input",
"     </li>",
"     <li>",
"      The rubrospinal tract originates in the red nucleus and controls tone of ipsilateral flexor muscle groups",
"     </li>",
"     <li>",
"      The vestibulospinal tracts arise from the vestibular nuclei and facilitate spinal cord reflexes and muscle tone to maintain posture",
"     </li>",
"     <li>",
"      The reticulospinal tracts originate in the brainstem and provide facilitatory input to muscle groups as well as input to spinal autonomic fibers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other ascending tracts include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The dorsal and ventral spinocerebellar tracts carry inputs mediating unconscious proprioception directly to the cerebellum",
"     </li>",
"     <li>",
"      The spinoreticular tract carries deep pain input to the reticular formation of the brainstem",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Autonomic fibers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autonomic fibers of hypothalamic and brainstem origin descend in the lateral aspect of the spinal cord but not in a well-defined tract. These synapse with cell bodies in the intermediolateral columns of the central gray matter of the spinal cord. Sympathetic fibers exit between T1 and L2, and parasympathetic fibers exit between S2 and S4.",
"   </p>",
"   <p>",
"    The sympathetic neurons lie in the lateral horn of the central gray matter at spinal levels T1-L3. The preganglionic fibers exit via the ventral root, spinal nerve, and ventral ramus to reach the paravertebral ganglion. Many will synapse at the paravertebral ganglion, others pass through it to terminate on postganglionic neurons (eg, coeliac, superior mesenteric, and inferior mesenteric ganglia) more proximate to their end organ.",
"   </p>",
"   <p>",
"    Parasympathetic neurons originate in the sacral spinal cord and exit the spinal cord with other efferents to the ventral ramus. After leaving the ventral ramus, they may subsequently join with sympathetic nerves to reach the viscera. These preganglionic fibers then synapse with a diffuse network of terminal ganglion cells that affect organs in the pelvis.",
"   </p>",
"   <p>",
"    Autonomic dysfunction is an important determinant of site, extent, and severity of spinal cord pathology. Many autonomic functions can be affected by spinal cord pathology, but for clinical evaluation, the most useful symptoms relate to bladder control.",
"   </p>",
"   <p>",
"    Autonomic bladder control is primarily parasympathetic, and is unaffected by isolated injury to the sympathetic fibers. Voluntary bladder control is under somatomotor control, mediated by motor fibers originating from the anterior horn cells at levels S2-S4. A spinal cord lesion that interrupts descending motor and autonomic tracts above the S2 level produces an \"automatic bladder\" that cannot be emptied voluntarily, but empties reflexly when expanded to a certain degree, the so-called neurogenic bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. Loss of descending inhibition of segmental reflex control leads to urinary urgency and incontinence. Injury to S2-S4 spinal levels interrupts the bladder reflex circuit; the bladder becomes flaccid, and fills beyond capacity with overflow incontinence.",
"   </p>",
"   <p>",
"    Other autonomic functions are disturbed by spinal cord pathology. The effects of spinal cord injury on the colon and rectum are similar to those on the bladder. Spinal cord transections interrupt voluntary control of the external sphincter and produce constipation. Sacral lesions cause a loss of the anal reflex and rectal incontinence. Impotence can result from spinal cord lesions at any level. Spinal cord injuries can also affect cardiovascular function, most dramatically with lesions above T6 which can produce a phenomenon of autonomic dysreflexia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37642?source=see_link&amp;anchor=H4#H4\">",
"     \"Chronic complications of spinal cord injury\", section on 'Autonomic dysreflexia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Blood supply",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single anterior and two posterior spinal arteries supply the spinal cord (",
"    <a class=\"graphic graphic_figure graphicRef72176 \" href=\"UTD.htm?28/9/28817\">",
"     figure 8",
"    </a>",
"    ). The anterior spinal artery supplies the anterior two-thirds of the cord [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/8-12\">",
"     8-12",
"    </a>",
"    ]. The posterior spinal arteries primarily supply the dorsal columns. The anterior and posterior spinal arteries arise from the vertebral arteries in the neck and descend from the base of the skull. Various radicular arteries branch off the thoracic and abdominal aorta to provide additional blood supply to the spinal arteries. The largest and most consistently present of these radicular branches is the great ventral radicular artery or the artery of Adamkiewicz, which supplies the anterior spinal artery [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/13\">",
"     13",
"    </a>",
"    ]. This artery enters the spinal cord anywhere between T5 and L1 (usually between T9 and T12).",
"   </p>",
"   <p>",
"    In most people, the anterior spinal artery passes uninterrupted along the entire length of the spinal cord; in others, it is discontinuous, usually in its midthoracic segment, making these individuals more susceptible to vascular injury. The primary watershed area of the spinal cord in most people is in the midthoracic region.",
"   </p>",
"   <p>",
"    The vascular anatomy of the spinal cord is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/43/40631?source=see_link&amp;anchor=H3#H3\">",
"     \"Spinal cord infarction: Vascular anatomy and etiologies\", section on 'Vascular anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CLINICAL LOCALIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spinal cord lesion may be suspected when there are bilateral motor and sensory signs or symptoms that do not involve the head or face. Motor deficits are manifest by weakness and long tract signs (spasticity, increased reflexes, Babinski sign) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/5,14-16\">",
"     5,14-16",
"    </a>",
"    ]. When the pathology is localized or segmental, these findings will be present in muscle groups innervated below that level and will be normal above. A sensory level, with normal sensation above and reduced or absent below, can also often be defined and should be specifically sought. Other so-called segmental signs include lower motor neuron findings (atrophy, flaccid weakness, loss of reflexes) in a myotomal distribution at the specific level of involvement; however, these are usually not elicitable in thoracic lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link&amp;anchor=H45#H45\">",
"     \"The detailed neurologic examination in adults\", section on 'Motor examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link&amp;anchor=H64#H64\">",
"     \"The detailed neurologic examination in adults\", section on 'Reflex examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link&amp;anchor=H72#H72\">",
"     \"The detailed neurologic examination in adults\", section on 'Sensory examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As well as longitudinal localization within the spinal cord, it can also be helpful to distinguish specific areas of functional loss with a spinal cord level (or across spinal cord levels for nonsegmental pathologies). Some disorders affecting the spinal cord preferentially affect different structures, and therefore careful testing of all spinal cord functions, including motor, reflex, and all sensory modalities, and sphincter function is important for clinical localization.",
"   </p>",
"   <p>",
"    Several distinct spinal cord syndromes are recognized. These are useful in the clinical evaluation, as they often correspond to distinct pathologies. These are summarized in the table and are discussed below (",
"    <a class=\"graphic graphic_table graphicRef62066 \" href=\"UTD.htm?13/40/13964\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Segmental syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologies that affect all functions of the spinal cord at one or more levels produce a segmental syndrome. Loss of function may be total or incomplete. A total cord transection syndrome results from the cessation of function in all ascending and descending spinal cord pathways and results in the loss of all types of sensation and loss of movement below the level of the lesion. Less profound injuries produce a similar pattern of deficits, which are less severe: ie, weakness rather than paralysis and decreased sensation rather than anesthesia.",
"   </p>",
"   <p>",
"    Acute transection can cause spinal shock, with a flaccid paralysis, urinary retention, and diminished tendon reflexes. This is usually temporary, and increased tone, spasticity, and hyperreflexia will usually supervene in days or weeks after the event.",
"   </p>",
"   <p>",
"    Transverse injuries above C3 involve cessation of respiration and are often fatal if acute. Cervical cord lesions that spare the phrenic nerve but impair intercostal nerve function can produce respiratory insufficiency. Lesions above the L2 cord level will cause impotence and spastic paralysis of bladder. There is loss of voluntary control of the bladder, which will empty automatically by reflex action.",
"   </p>",
"   <p>",
"    Causes of a cord segmental syndrome include acute myelopathies, such as traumatic injury and spinal cord hemorrhage. Epidural or intramedullary abscess, tumors, and transverse myelitis may have a more subacute presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Dorsal (posterior) cord syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dorsal cord syndrome results from the bilateral involvement of the dorsal columns, the corticospinal tracts, and descending central autonomic tracts to bladder control centers in the sacral cord (",
"    <a class=\"graphic graphic_figure graphicRef63862 \" href=\"UTD.htm?16/39/17009\">",
"     figure 9",
"    </a>",
"    ). Dorsal column symptoms include gait ataxia and paresthesias. Corticospinal tract dysfunction produces weakness that, if acute, is accompanied by muscle flaccidity and hyporeflexia and, if chronic, by muscle hypertonia and hyperreflexia. Extensor plantar responses and urinary incontinence may be present.",
"   </p>",
"   <p>",
"    Causes of a dorsal cord syndrome include multiple sclerosis (more typically the primary progressive form), tabes dorsalis, Friedreich ataxia, subacute combined degeneration, vascular malformations, epidural and intradural extramedullary tumors, cervical spondylotic myelopathy, and atlantoaxial subluxation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27944?source=see_link\">",
"     \"Cervical spondylotic myelopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Ventral (anterior) cord syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventral cord or anterior spinal artery syndrome usually includes tracts in the anterior two-thirds of the spinal cord, which include the corticospinal tracts, the spinothalamic tracts, and descending autonomic tracts to the sacral centers for bladder control (",
"    <a class=\"graphic graphic_figure graphicRef63739 \" href=\"UTD.htm?19/60/20417\">",
"     figure 10",
"    </a>",
"    ). Corticospinal tract involvements produce weakness and reflex changes. A spinothalamic tract deficit produces the bilateral loss of pain and temperature sensation. Tactile, position, and vibratory sensation are normal. Urinary incontinence is usually present.",
"   </p>",
"   <p>",
"    The causes of a ventral cord syndrome include spinal cord infarction, intervertebral disc herniation, and radiation myelopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Brown-Sequard (hemi-cord) syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lateral hemisection syndrome, also known as the Brown&ndash;Sequard syndrome, involves the dorsal column, corticospinal tract, and spinothalamic tract unilaterally (",
"    <a class=\"graphic graphic_figure graphicRef58103 \" href=\"UTD.htm?10/22/10593\">",
"     figure 11",
"    </a>",
"    ). This produces weakness, loss of vibration, and proprioception ipsilateral to the lesion and loss of pain and temperature on the opposite side. The unilateral involvement of descending autonomic fibers does not produce bladder symptoms. While there are many causes of this syndrome, knife or bullet injuries and demyelination are the most common. Rarer causes include spinal cord tumors, disc herniation, infarction, and infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Central cord syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The central cord syndrome is characterized by loss of pain and temperature sensation in the distribution of one or several adjacent dermatomes at the site of the spinal cord lesion caused by the disruption of crossing spinothalamic fibers in the ventral commissure (",
"    <a class=\"graphic graphic_figure graphicRef60859 \" href=\"UTD.htm?30/33/31249\">",
"     figure 12",
"    </a>",
"    ). Dermatomes above and below the level of the lesion have normal pain and temperature sensation, creating the so-called \"suspended sensory level.\" Vibration and proprioception are often spared.",
"   </p>",
"   <p>",
"    As a central lesion enlarges, it may encroach on the medial aspect or the corticospinal tracts or on the anterior horn gray matter, producing weakness in the analgesic areas. Fibers mediating the deep tendon reflexes are interrupted as they pass from the dorsal to the ventral horn, thus causing tendon reflex loss in the analgesic areas. There are usually no bladder symptoms.",
"   </p>",
"   <p>",
"    The classic causes of a central cord syndrome are slow-growing lesions such as syringomyelia or intramedullary tumor. However, central cord syndrome is most frequently the result of a hyperextension injury in individuals with long-standing cervical spondylosis. This form of central cord syndrome is characterized by disproportionately greater motor impairment in upper compared with lower extremities, bladder dysfunction, and a variable degree of sensory loss below the level of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27944?source=see_link\">",
"     \"Cervical spondylotic myelopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pure motor syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pure motor syndrome produces weakness without sensory loss or bladder involvement. This may involve only the upper motor neurons, producing hyperreflexia and extensor plantar responses, or only the lower motor neuron bilaterally, producing muscle atrophy and fasciculations. Other disorders involve both the upper and lower motor neurons and produce mixed signs.",
"   </p>",
"   <p>",
"    The causes of a pure motor syndrome include chronic myelopathies such as HTLV-I myelopathy, hereditary spastic paraplegia, primary lateral sclerosis, amyotrophic lateral sclerosis, progressive muscular atrophy, post-polio syndrome, and electric shock-induced myelopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Conus medullaris syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lesions at vertebral level L2 often affect the conus medullaris. There is early and prominent sphincter dysfunction with flaccid paralysis of the bladder and rectum, impotence, and saddle (S3-S5) anesthesia. Leg muscle weakness may be mild if the lesion is very restricted and spares both the lumbar cord and the adjacent spinal and lumbar nerve roots.",
"   </p>",
"   <p>",
"    Causes include disc herniation, spinal fracture, and tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/4,20\">",
"     4,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cauda equina syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Though not a spinal cord syndrome, cauda equina syndrome is considered here because its location within the spinal canal subjects it to many of the same disease processes that cause myelopathy. The syndrome is caused by the loss of functions of two or more of the 18 nerve roots constituting the cauda equina. Deficits usually affect both legs but are often asymmetric. Symptoms include [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low back pain accompanied by pain radiating into one or both legs. Radicular pain reflects involvement of dorsal nerve roots and may have localizing value [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Weakness of plantar flexion of the feet with loss of ankle jerks occurs with mid cauda equina lesions, involving S1, S2 roots. Involvement of progressively higher levels leads to corresponding weakness in other muscles (",
"      <a class=\"graphic graphic_figure graphicRef64884 \" href=\"UTD.htm?30/36/31297\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Bladder and rectal sphincter paralysis usually reflect involvement of S3-S5 nerve roots [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/21,22\">",
"       21,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sensory loss of all sensory modalities occurs in the dermatomal distribution of the affected nerve roots (",
"      <a class=\"graphic graphic_figure graphicRef50419 \" href=\"UTD.htm?10/36/10822\">",
"       figure 6",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many etiologies can cause a cauda equina syndrome, including intervertebral disc herniation, epidural abscess, epidural tumor, intradural extramedullary tumor, lumbar spine spondylosis, and a number of inflammatory conditions including spinal arachnoiditis, chronic inflammatory demyelinating polyneuropathy, and sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/20,24-29\">",
"     20,24-29",
"    </a>",
"    ]. The cauda equina can also be the primary site of involvement in carcinomatous meningitis and a number of infections (eg, cytomegalovirus, herpes simplex virus, herpes zoster virus, Epstein Barr virus, Lyme disease, mycoplasma, and tuberculosis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1480?source=see_link\">",
"     \"Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=see_link\">",
"     \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lhermitte's sign",
"    </span>",
"    &nbsp;&mdash;&nbsp;This well-described sign describes a sensation of electric shock-like sensations that run down the back",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    limbs during flexion of the neck. This generally occurs with pathologies involving the cervical spinal cord, but is not specific to etiology, occurring in patients with cervical spondylotic myelopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/30\">",
"     30",
"    </a>",
"    ], multiple sclerosis, radiation myelopathy, and vitamin B12 deficiency, among others. It can also occur with cervical nerve root pathology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of myelopathy is wide, but can be significantly narrowed by the clinical syndrome (",
"    <a class=\"graphic graphic_table graphicRef62066 \" href=\"UTD.htm?13/40/13964\">",
"     table 1",
"    </a>",
"    ). Other features in the examination and history also limit the differential diagnosis and tailor the diagnostic work-up. Clinical features of some of the more common causes of myelopathy are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef50336 \" href=\"UTD.htm?6/0/6157\">",
"     table 2",
"    </a>",
"    ). These are discussed in detail separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For patients with a clinical syndrome that suggests a localized process within the spinal cord (eg, transection syndrome, central cord syndrome, ventral cord syndrome, etc), an imaging study, usually magnetic resonance imaging (MRI), of the relevant section of the spinal cord is usually required [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5832/abstract/16,31\">",
"     16,31",
"    </a>",
"    ]. Administration of gadolinium contrast is often helpful. When an infectious or inflammatory disorder is suspected, cerebrospinal fluid examination may be helpful.",
"   </p>",
"   <p>",
"    In general, the pace at which spinal cord deficits appear dictate the urgency of the neurologic evaluation. Even when the deficits are not severe, acute myelopathic signs need to be evaluated urgently because neurologic deterioration can occur abruptly, and the clinical deficit at the time of intervention often dictates the chances of recovery. This is true particularly for compressive etiologies such as spinal cord metastases and epidural spinal abscess.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/18/43297?source=see_link\">",
"       \"Patient information: Central spinal cord syndrome (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11522?source=see_link\">",
"       \"Patient information: Cauda equina syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders that affect the spinal cord often target specific structural and functional anatomic regions, producing distinct clinical syndromes. The spinal cord syndromes are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef62066 \" href=\"UTD.htm?13/40/13964\">",
"     table 1",
"    </a>",
"    ). The clinical syndrome along with other features in the examination and history usually significantly limits the differential diagnosis and tailors the diagnostic work-up (",
"    <a class=\"graphic graphic_table graphicRef50336 \" href=\"UTD.htm?6/0/6157\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link\">",
"     \"Disorders affecting the spinal cord\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/1\">",
"      REXED B. SOME ASPECTS OF THE CYTOARCHITECTONICS AND SYNAPTOLOGY OF THE SPINAL CORD. Prog Brain Res 1964; 11:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/2\">",
"      REXED B. A cytoarchitectonic atlas of the spinal cord in the cat. J Comp Neurol 1954; 100:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/3\">",
"      Rathelot JA, Strick PL. Subdivisions of primary motor cortex based on cortico-motoneuronal cells. Proc Natl Acad Sci U S A 2009; 106:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/4\">",
"      Wagner R, Jagoda A. Spinal cord syndromes. Emerg Med Clin North Am 1997; 15:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/5\">",
"      BAKER AB. SPINAL CORD LOCALIZATION. J Lancet 1965; 85:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/6\">",
"      Abdel-Azim M, Sullivan M, Yalla SV. Disorders of bladder function in spinal cord disease. Neurol Clin 1991; 9:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/7\">",
"      Seftel AD, Oates RD, Krane RJ. Disturbed sexual function in patients with spinal cord disease. Neurol Clin 1991; 9:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/8\">",
"      Biglioli P, Roberto M, Cannata A, et al. Upper and lower spinal cord blood supply: the continuity of the anterior spinal artery and the relevance of the lumbar arteries. J Thorac Cardiovasc Surg 2004; 127:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/9\">",
"      GILLILAN LA. The arterial blood supply of the human spinal cord. J Comp Neurol 1958; 110:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/10\">",
"      Kawaharada N, Morishita K, Hyodoh H, et al. Magnetic resonance angiographic localization of the artery of Adamkiewicz for spinal cord blood supply. Ann Thorac Surg 2004; 78:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/11\">",
"      Lasjaunias P, Vallee B, Person H, et al. The lateral spinal artery of the upper cervical spinal cord. Anatomy, normal variations, and angiographic aspects. J Neurosurg 1985; 63:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/12\">",
"      McCormick PC, Stein BM. Functional anatomy of the spinal cord and related structures. Neurosurg Clin N Am 1990; 1:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/13\">",
"      Skalski JH, Zembala M. Albert Wojciech Adamkiewicz: the discoverer of the variable vascularity of the spinal cord. Ann Thorac Surg 2005; 80:1971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/14\">",
"      HADDEN SB. Diagnosis of spinal cord disease. Med Clin North Am 1951; 35:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/15\">",
"      Miller DH, McDonald WI, Blumhardt LD, et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol 1987; 22:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/16\">",
"      Offenbacher H. The diagnostic impact of magnetic resonance imaging on the evaluation of suspected spinal cord disease. Wien Klin Wochenschr 1992; 104:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/17\">",
"      Morse SD. Acute central cervical spinal cord syndrome. Ann Emerg Med 1982; 11:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/18\">",
"      Dickman CA, Hadley MN, Pappas CT, et al. Cruciate paralysis: a clinical and radiographic analysis of injuries to the cervicomedullary junction. J Neurosurg 1990; 73:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/19\">",
"      Harrop JS, Sharan A, Ratliff J. Central cord injury: pathophysiology, management, and outcomes. Spine J 2006; 6:198S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/20\">",
"      Podnar S. Epidemiology of cauda equina and conus medullaris lesions. Muscle Nerve 2007; 35:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/21\">",
"      Orend&aacute;cov&aacute; J, C&iacute;zkov&aacute; D, Kafka J, et al. Cauda equina syndrome. Prog Neurobiol 2001; 64:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/22\">",
"      Valen B, Rolfsen LC. [The cauda equina syndrome]. Tidsskr Nor Laegeforen 2003; 123:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/23\">",
"      Fraser S, Roberts L, Murphy E. Cauda equina syndrome: a literature review of its definition and clinical presentation. Arch Phys Med Rehabil 2009; 90:1964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/24\">",
"      Belinch&oacute;n JM, Campos J, Merino J, et al. [Chronic spontaneous lumbar epidural hematoma]. Neurocirugia (Astur) 2005; 16:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/25\">",
"      Cohen DB. Infectious origins of cauda equina syndrome. Neurosurg Focus 2004; 16:e2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/26\">",
"      Johnsson KE, Sass M. Cauda equina syndrome in lumbar spinal stenosis: case report and incidence in Jutland, Denmark. J Spinal Disord Tech 2004; 17:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/27\">",
"      Kebaish KM, Awad JN. Spinal epidural hematoma causing acute cauda equina syndrome. Neurosurg Focus 2004; 16:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/28\">",
"      Lenehan B, Sullivan P, Street J, Dudeney S. Epidural abscess causing cauda equina syndrome. Ir J Med Sci 2005; 174:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/29\">",
"      Wright MH, Denney LC. A comprehensive review of spinal arachnoiditis. Orthop Nurs 2003; 22:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/30\">",
"      Baron EM, Young WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 2007; 60:S35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5832/abstract/31\">",
"      Do-Dai DD, Brooks MK, Goldkamp A, et al. Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review. Curr Probl Diagn Radiol 2010; 39:160.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5110 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-1E1E8CC54B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5832=[""].join("\n");
var outline_f5_44_5832=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPINAL CORD ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Longitudinal organization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Cervical cord",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Thoracic cord",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Lumbosacral cord",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Cauda equina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cross-sectional anatomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Dorsal horn",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Ventral horn",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - White matter tracts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Autonomic fibers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Blood supply",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CLINICAL LOCALIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Segmental syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Dorsal (posterior) cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Ventral (anterior) cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Brown-Sequard (hemi-cord) syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Central cord syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pure motor syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Conus medullaris syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lhermitte's sign",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5110\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5110|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/60/22465\" title=\"figure 1\">",
"      Spinal cord cross-section",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/43/40629\" title=\"figure 2\">",
"      Vertebral and spinal column",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/47/10995\" title=\"figure 3\">",
"      Upper extremity nerve roots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/8/21634\" title=\"figure 4\">",
"      Cervical dermatomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/36/31297\" title=\"figure 5\">",
"      Lower extremity nerve roots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/36/10822\" title=\"figure 6\">",
"      Lumbosacral dermatomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/10/27810\" title=\"figure 7\">",
"      Spinal cord white matter tracts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/9/28817\" title=\"figure 8\">",
"      Spinal cord blood supply",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/39/17009\" title=\"figure 9\">",
"      Dorsal cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/60/20417\" title=\"figure 10\">",
"      Ventral cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/22/10593\" title=\"figure 11\">",
"      Brown Sequard syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/33/31249\" title=\"figure 12\">",
"      Central cord syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5110|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/40/13964\" title=\"table 1\">",
"      Spinal cord syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/0/6157\" title=\"table 2\">",
"      Spinal cord disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31879?source=related_link\">",
"      Approach to the patient with sensory loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27944?source=related_link\">",
"      Cervical spondylotic myelopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37642?source=related_link\">",
"      Chronic complications of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=related_link\">",
"      Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1480?source=related_link\">",
"      Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11522?source=related_link\">",
"      Patient information: Cauda equina syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/18/43297?source=related_link\">",
"      Patient information: Central spinal cord syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/43/40631?source=related_link\">",
"      Spinal cord infarction: Vascular anatomy and etiologies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=related_link\">",
"      The detailed neurologic examination in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_44_5833="Long-term management of patients with anaphylaxis";
var content_f5_44_5833=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Long-term management of patients with anaphylaxis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5833/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5833/contributors\">",
"     F Estelle R Simons, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5833/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5833/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/44/5833/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/44/5833/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/44/5833/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H7657148\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical management of anaphylaxis has traditionally focused on recognition and treatment of the acute event. Equally important, however, is the long-term care of a patient who has experienced anaphylaxis, and the implementation of measures to prevent and treat recurrences in community settings [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term risk reduction includes the following elements [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ongoing education about recognition and prompt treatment of future anaphylactic episodes",
"     </li>",
"     <li>",
"      Optimal management of relevant comorbidities (eg, asthma or cardiovascular disease) and assessment or reassessment of the benefits and risks of concurrent medications, eg, beta-blockers or ACE inhibitors",
"     </li>",
"     <li>",
"      Strict avoidance of specific relevant triggers",
"     </li>",
"     <li>",
"      Specific interventions to reduce or prevent anaphylaxis recurrences from some triggers (examples include venom immunotherapy for those with anaphylaxis from stinging insects such as bees, yellow jackets, wasps, and hornets, and desensitization for those with anaphylaxis from some medications)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will discuss the proactive, long-term management of patients after diagnosis and treatment of their acute anaphylactic episode and confirmation of the trigger(s) suggested by the history of the episode. The diagnosis and treatment of an acute anaphylactic episode, and an approach to identifying triggers for anaphylaxis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=see_link\">",
"     \"Anaphylaxis: Confirming the diagnosis and determining the trigger(s)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657155\">",
"    <span class=\"h1\">",
"     ONGOING EDUCATION OF PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients (and for children, their families and caregivers) must be able to recognize the signs and symptoms of an anaphylaxis recurrence in the community and initiate treatment in a prompt and effective manner. Education about the recognition and management of anaphylaxis is an ongoing, long-term process that should be continued at each follow-up visit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657162\">",
"    <span class=\"h2\">",
"     Important teaching points",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important teaching points, which should be reviewed on a regular basis, include the following (",
"    <a class=\"graphic graphic_table graphicRef51175 \" href=\"UTD.htm?43/1/44059\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       Epinephrine (adrenaline)",
"      </a>",
"      is the first and best treatment for anaphylaxis and should be injected as soon as possible after the reaction begins [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2-7\">",
"       2-7",
"      </a>",
"      ]. If a patient at risk for anaphylaxis had an",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      autoinjector prescribed, but either did not fill the prescription, did not have the autoinjector available at the time of the episode, or had it available but failed to use it, these issues should be discussed in depth during the follow-up visit [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      H1-antihistamines and asthma inhalers (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"       albuterol",
"      </a>",
"      ) alone are NOT adequate treatment for anaphylaxis. H1-antihistamines relieve itch and hives, and asthma inhalers relieve wheezing and coughing, but these medicines do not prevent or relieve upper airway obstruction, hypotension, or shock and are therefore not life-saving [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/1-6,8\">",
"       1-6,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The severity of previous anaphylactic episodes does not reliably predict the severity of future episodes, which may be more severe, less severe, or similar to previous episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/1,9\">",
"       1,9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anaphylaxis is under-recognized and under-treated, even by healthcare professionals [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Some patients do not have ready access to emergency medical services, and some emergency medical services teams are still not equipped with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      or permitted to inject it. Therefore, people at risk for anaphylaxis (and for children, their families or caregivers) must have an epinephrine autoinjector available at all times, so that effective treatment can be initiated without delay.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657169\">",
"    <span class=\"h1\">",
"     PREPARING THE PATIENT TO TREAT POSSIBLE RECURRENCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have experienced anaphylaxis should be equipped to treat possible recurrences in the community by carrying self-injectable",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    , having an anaphylaxis emergency action plan, and wearing medical identification.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657176\">",
"    <span class=\"h2\">",
"     Self-injectable epinephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any patient who has experienced anaphylaxis should be supplied with one or more",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    autoinjectors and trained in why, when, and how to inject epinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/1-7,12\">",
"     1-7,12",
"    </a>",
"    ]. For children who have experienced anaphylaxis, families and caregivers should be trained. Issues with regard to prescribing epinephrine autoinjectors correctly are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=see_link\">",
"     \"Prescribing epinephrine for anaphylaxis self-treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patient educational materials include autoinjector trainers and printed handouts. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"     \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"    </a>",
"    .) Most autoinjector manufacturers provide training DVDs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    website videos.",
"   </p>",
"   <p>",
"    Important issues with regard to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    injection include need for prompt administration [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/13\">",
"     13",
"    </a>",
"    ], need for a second dose [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/14\">",
"     14",
"    </a>",
"    ], inability of children to access their epinephrine autoinjectors in school [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/15\">",
"     15",
"    </a>",
"    ], lack of availability",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    high cost of autoinjectors in some countries [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/16\">",
"     16",
"    </a>",
"    ], and need for training and regular coaching in correct and safe use of autoinjectors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prescriptions for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    autoinjectors should be renewed annually. In order to ensure that renewal is not overlooked, consideration should be given to linking this with a birthday or the start of the calendar year or the school year.",
"   </p>",
"   <p>",
"    There are some important reasons why a patient (or for children, their families and caregivers) may fail to administer",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    when it is appropriate to do so. One study surveyed a unique population of 1885 survivors of anaphylaxis in the community and asked about administration of epinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/18\">",
"     18",
"    </a>",
"    ]. Users of epinephrine autoinjectors were defined as those who self-injected epinephrine or injected it into a person for whom they were responsible (eg, a child) during anaphylaxis. Users reported problems in deciding whether to use the epinephrine autoinjector, whether to go to the emergency department after using it, holding it in place, choosing the correct site on the thigh for the injection, deciding whether to repeat the dose, and disposing of the autoinjector(s) after use. Non-users were defined as those who did not self-inject epinephrine or failed to inject it into a person for whom they were responsible, eg, a child, during anaphylaxis. Non-users reported a variety of reasons for not injecting epinephrine, such as using an H1-antihistamine or an asthma inhaler instead, never receiving a prescription for an epinephrine autoinjector,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    not having the epinephrine autoinjector available when the medical emergency occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657183\">",
"    <span class=\"h2\">",
"     Anaphylaxis emergency action plan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any individual who has experienced anaphylaxis should have a written, personalized, and regularly updated anaphylaxis emergency action plan, developed with the assistance of their healthcare professional. In order to help patients recognize anaphylaxis, this form should list typical symptoms and signs that might develop suddenly during an episode. In addition, it should provide instructions for prompt",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    injection followed by transportation to the nearest hospital emergency department. A sample action plan is available (",
"    <a class=\"graphic graphic_form graphicRef60439 \" href=\"UTD.htm?2/42/2722\">",
"     form 1",
"    </a>",
"    ) and online through the American Academy of Asthma, Allergy and Immunology (",
"    <a class=\"external\" href=\"file://www.aaaai.org/\">",
"     www.aaaai.org",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2\">",
"     2",
"    </a>",
"    ]. Formal evaluation of the clinical efficacy and cost-effectiveness of anaphylaxis emergency action plans is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple copies of the completed form should be available at home, work, or school, and when discussing the information with anyone who may be responsible for administering",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    to the patient at risk of anaphylaxis recurrence. In addition, the written personalized anaphylaxis emergency action plan should be reviewed and updated periodically at follow-up visits. This process often reveals areas in which the patient needs further instruction and also stimulates discussion of more complex and patient-specific issues [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657190\">",
"    <span class=\"h2\">",
"     Medical identification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should also be advised to wear medical identification jewelry listing their anaphylaxis trigger(s) and their relevant comorbidities and concurrent medications. Options include medical identification bracelets and medallions; bracelets are deemed safest for children to wear. Anaphylaxis wallet cards (",
"    <a class=\"graphic graphic_form graphicRef54466 \" href=\"UTD.htm?22/62/23524\">",
"     form 2",
"    </a>",
"    ) are also available (",
"    <a class=\"external\" href=\"file://www.aaaai.org/\">",
"     www.aaaai.org",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Detailed information about allergen trigger(s) for anaphylaxis should be accurately documented in an individual's electronic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    paper medical records and updated as needed [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657197\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF COMORBIDITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent asthma, especially if symptoms are poorly-controlled, is an important risk factor for severe or fatal anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/20\">",
"     20",
"    </a>",
"    ]. Optimal asthma management is therefore critically important in those patients with asthma who are also at risk of anaphylaxis. Cardiovascular disease and chronic obstructive pulmonary disease are important risk factors for deaths from anaphylaxis in middle-aged and older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/21,22\">",
"     21,22",
"    </a>",
"    ], and these risks need to be discussed with the patient as needed with the other healthcare professionals involved in the patient's care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/13/1241?source=see_link\">",
"     \"Fatal anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657204\">",
"    <span class=\"h2\">",
"     Medications for other disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term management of patients with anaphylaxis also involves discussion of medications taken concomitantly for other disorders. The following classes of medications potentially present problems for patients at risk for recurrence of anaphylactic episodes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beta-adrenergic blockers, administered orally or topically (eg, eye drops) may be associated with severe anaphylaxis and may also potentially make anaphylaxis more difficult to treat by causing unopposed alpha-adrenergic effects and hypertension and reduced bronchodilator response to the beta-adrenergic effects of endogenous or exogenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H29#H29\">",
"       \"Anaphylaxis: Rapid recognition and treatment\", section on 'Glucagon for patients taking beta-blockers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Alpha-adrenergic blockers may decrease the effects of endogenous or exogenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      at alpha-adrenergic receptors, rendering patients less responsive to the alpha-adrenergic effects of epinephrine.",
"     </li>",
"     <li>",
"      Angiotensin-converting enzyme inhibitors may interfere with endogenous compensatory mechanisms, resulting in more severe or prolonged symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/23\">",
"       23",
"      </a>",
"      ]. Angiotensin II receptor blockers might be less likely to have this effect, although this has not been conclusively documented [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Central nervous system-active medications such as psychotropics, anxiolytics, and insomnia remedies may impair cognitive function and patients' ability to recognize anaphylaxis triggers and symptoms. CNS-active medications include impairing, sedating first-generation H1-antihistamines, for example,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      , that are widely used for the treatment of insomnia and allergic diseases [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/2,4,6,8\">",
"       2,4,6,8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The relevant risks and benefits of medications in the above classes should be discussed with these patients and with other healthcare professionals involved in their care. The discussions should be documented in the patient's medical record. Substitution of medications may be necessary in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657211\">",
"    <span class=\"h1\">",
"     EFFECTIVE AVOIDANCE OF SPECIFIC RELEVANT TRIGGERS AND CO-TRIGGERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete avoidance of a trigger requires ongoing education about the allergen and where it is likely to be encountered. Printed information on avoidance of relevant, specific triggers should be provided and reviewed at regular intervals with those at risk and their families and caregivers [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The most common triggers are mentioned here; however, the list of implicated substances continues to lengthen (",
"    <a class=\"graphic graphic_table graphicRef70667 \" href=\"UTD.htm?29/0/29708\">",
"     table 2",
"    </a>",
"    ). Determining what triggered a patient&rsquo;s anaphylaxis is reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=see_link&amp;anchor=H4433858#H4433858\">",
"     \"Anaphylaxis: Confirming the diagnosis and determining the trigger(s)\", section on 'Testing for allergen trigger(s)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Food",
"      </strong>",
"      - Patients with a history of food-triggered anaphylaxis should avoid the foods that cause the reaction [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. This is easier said than done [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/27\">",
"       27",
"      </a>",
"      ]. Difficulties arise because of hidden, substituted and cross-reacting foods, and foods that are contaminated because of cross-contact with the relevant food allergen. In addition to avoiding the actual food in question, patients need to avoid foods labeled with &ldquo;may contain&hellip;&rdquo; or similar less precise warnings, which greatly increases the number of products that must be avoided. In a supermarket survey, 17 percent of manufactured (processed) foods were found to carry advisory or warning labels about allergens such as \"may contain\", or \"made on shared equipment\", or \"made in a shared facility\" [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/28\">",
"       28",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In another study focusing on milk as the allergenic food, milligram amounts of milk were measured in 61 percent of foods labeled \"may contain milk\", 33 percent of foods labeled \"made on shared equipment\" and 29 percent of foods labeled \"made in shared facility\" [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/29\">",
"       29",
"      </a>",
"      ]. Some of these foods contained clinically relevant amounts of milk that could trigger anaphylaxis in highly sensitized patients. Issues surrounding food allergen avoidance are reviewed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"       \"Management of food allergy: Avoidance\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Vigilant food avoidance measures potentially decrease quality of life for those at risk of anaphylaxis to food and their families, and for children, their caregivers, teachers, childcare workers, and classmates [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. Adolescents and young adults at risk for food-induced anaphylaxis are particularly prone to risk-taking behaviors [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42759?source=see_link\">",
"       \"Food allergy: Impact on health-related quality of life\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Insect stings",
"      </strong>",
"      - Ideally, patients with a history of insect sting-triggered anaphylaxis should avoid subsequent exposure to insects; however, this may be impossible for beekeepers, park rangers, gardeners, and others with occupational exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/3,33-36\">",
"       3,33-36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/22/6502?source=see_link\">",
"       \"Bees, yellow jackets, hornets, and wasps: Avoidance\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Medications",
"      </strong>",
"      - Patients with a history of anaphylaxis to a medication or biological agent should not be given that specific medication. A safe and effective non-cross-reacting drug, preferably from a different pharmacologic class, should be substituted if available. A written list containing the name of the medication that triggered the anaphylaxis and the names of related and cross-reacting drugs should be provided [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/3,37-40\">",
"       3,37-40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Exercise",
"      </strong>",
"      - Prevention strategies for anaphylaxis triggered by exercise depend upon the avoidance of co-triggers, including foods, ethanol, or specific medications (eg, NSAIDs). Food co-triggers should be avoided for approximately four hours before exercise. If no specific co-trigger for exercise-induced anaphylaxis has been identified, it might be prudent for the individual to avoid ingesting anything at all within four to six hours of exercise. Factors amplifying exercise-induced anaphylaxis might include airborne pollen or mold allergens, high humidity, extreme heat or extreme cold. Based on a detailed history of the patient's previous episodes, avoidance of one or more of these factors might be relevant. People with exercise-induced anaphylaxis need to be advised that they should discontinue exercise at the earliest hint of symptom development and should not exercise alone [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/3,41\">",
"       3,41",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42709?source=see_link\">",
"       \"Exercise-induced anaphylaxis: Management and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Natural rubber latex (NRL)",
"      </strong>",
"      - Patients at risk for anaphylaxis from NRL should avoid exposure to NRL, which can be found in disposable gloves, condoms, infant pacifiers, toys, balloons, sports equipment, and other items. They should inform all their healthcare professionals about their NRL allergy, particularly when being evaluated for potential surgery or dental work. In some of these patients, foods that cross-react with NRL, for example, kiwi, banana, peach, fig, chestnut, avocado, bell pepper, tomato, and white potato should also be avoided (",
"      <a class=\"graphic graphic_figure graphicRef60713 \" href=\"UTD.htm?0/50/801\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40070?source=see_link&amp;anchor=H4#H4\">",
"       \"Latex allergy: Management\", section on 'Individual avoidance'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=see_link&amp;anchor=H22#H22\">",
"       \"Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)\", section on 'Latex-fruit syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657218\">",
"    <span class=\"h1\">",
"     INTERVENTIONS TO REDUCE SENSITIVITY TO SPECIFIC ALLERGENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific interventions to reduce the risk of recurrent reactions are available for certain anaphylaxis triggers [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/33-43\">",
"     33-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Food",
"      </strong>",
"      - Oral immunotherapy for food-induced anaphylaxis is not currently recommended [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/25,42\">",
"       25,42",
"      </a>",
"      ]. Clinical trials of food-specific oral immunotherapy have been completed or are ongoing in carefully-selected, highly-motivated, closely-monitored patients who have experienced anaphylaxis from peanut, milk, or egg. Desensitization can be achieved and in some studies, immunologic tolerance has been documented; however, with current protocols, treatment-related allergic reactions are common, especially on the initial dose escalation day and on subsequent dose build-up days. Such treatment is therefore not yet ready for clinical use [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/25,26,42\">",
"       25,26,42",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44057?source=see_link\">",
"       \"Future therapies for food allergy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Insect stings",
"      </strong>",
"      - Anaphylaxis triggered by venom from insects in the order Hymenoptera (eg, honeybees, yellow jackets, yellow hornets, white-faced hornets, paper wasps, and fire ants) can be almost entirely prevented by use of allergen-specific immunotherapy, as demonstrated in randomized placebo-controlled trials. This therapy is initiated by an",
"      <span class=\"nowrap\">",
"       allergy/immunology",
"      </span>",
"      specialist and administered over a period of three to five years. Protection is long-lasting [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/33-36\">",
"       33-36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=see_link&amp;anchor=H7#H7\">",
"       \"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action\", section on 'Indications and patient selection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=see_link&amp;anchor=H26#H26\">",
"       \"Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment\", section on 'Venom immunotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Medications needed daily",
"      </strong>",
"      - Anaphylaxis may be triggered by a medication that is essential for the patient and is needed on a daily basis and for which there is no effective and safe substitute available (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      for the patient with atherosclerotic heart disease). Successful desensitization should be followed by regular daily administration [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31672?source=see_link\">",
"       \"NSAIDs (including aspirin): Allergic and pseudoallergic reactions\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26006?source=see_link\">",
"       \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18281?source=see_link\">",
"       \"Aspirin exacerbated respiratory disease: NSAID challenge and desensitization\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Medications needed temporarily",
"      </strong>",
"      - Desensitization can be performed successfully to prevent anaphylaxis triggered by a drug that is needed temporarily as a single dose or an uninterrupted course of multiple doses, and for which there is no effective and safe substitute available. Examples include antimicrobials, especially beta-lactam antibiotics, anti-fungals, anti-virals, NSAIDs, chemotherapeutics, and biologics (eg, platinum salts and taxanes) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/37,39,40\">",
"       37,39,40",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29672?source=see_link\">",
"       \"Rapid drug desensitization for immediate hypersensitivity reactions\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=see_link\">",
"       \"Allergy to penicillins\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/57/43930?source=see_link\">",
"       \"Infusion reactions to systemic chemotherapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Human seminal fluid",
"      </strong>",
"      - Uncommonly, seminal fluid can trigger anaphylaxis in women; symptoms typically begin during or shortly after their first sexual intercourse and worsen gradually over time. Reactions to seminal fluid can be prevented by use of condoms. Desensitization strategies have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/3,43\">",
"       3,43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Idiopathic anaphylaxis",
"      </strong>",
"      - Idiopathic anaphylaxis is a diagnosis of exclusion that is made when no trigger for the anaphylactic episode can be identified. Hidden or previously unrecognized triggers have been found in such patients [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/44\">",
"       44",
"      </a>",
"      ]. Some people with this disorder have mastocytosis or a clonal mast cell disorder; therefore, in addition to a meticulous history and physical examination for urticaria pigmentosa and other skin lesions of cutaneous mastocytosis, an elevated baseline serum tryptase level (&gt;11.4",
"      <span class=\"nowrap\">",
"       ng/mL)",
"      </span>",
"      may help to identify such patients [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/23,45-48\">",
"       23,45-48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34071?source=see_link\">",
"       \"Idiopathic anaphylaxis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20937?source=see_link\">",
"       \"Mast cell activation disorders\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657225\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term monitoring of a patient with a history of anaphylaxis due to a known trigger includes following the status of the individual's sensitization to the trigger over time.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Food allergy",
"      </strong>",
"      - For patients with food-induced anaphylaxis, monitoring usually involves obtaining detailed historical information about inadvertent exposures and reactions, as well as measurements of food-specific IgE levels in serum or, less commonly, food-specific skin tests, at intervals. Recommendations for monitoring food allergy in children have been revised and are reviewed separately. As an example, up to 80 percent of children with clinical reactions to milk or egg eventually lose this reactivity; however, in some patients, this does not occur until mid- or late-adolescence [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=see_link\">",
"       \"The natural history of childhood food allergy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Drug allergies",
"      </strong>",
"      - For patients with drug-induced anaphylaxis, monitoring of sensitization status is also important, as sensitization may resolve with sufficient time. As an example, only a small proportion of penicillin-allergic individuals remain allergic after decades of avoidance [",
"      <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/38\">",
"       38",
"      </a>",
"      ]; however, in contrast to food allergy, serial skin testing is avoided because repeated skin tests have the potential to resensitize the patient. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=see_link\">",
"       \"Allergy to penicillins\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657232\">",
"    <span class=\"h1\">",
"     FUTURE LABORATORY TESTS TO PREDICT RISK OF ANAPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present, no laboratory tests are available for quantifying an individual's risk of a future anaphylactic episode [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]; however, such tests are in development [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Allergen-component resolved systems might help to identify patients sensitized to foods, venom, or latex who are at increased risk of anaphylaxis after exposure to these allergens versus those who are sensitized to the allergens but clinically tolerant, that is, remain asymptomatic after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/51\">",
"     51",
"    </a>",
"    ]. For example, patients with elevated specific IgE levels to food allergen components such as casein (Bos d 8), ovomucoid (Gal d 1), or Ara h 2 are unlikely to tolerate milk, egg, or peanut, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10585?source=see_link\">",
"     \"Future diagnostic tools for food allergy\"",
"    </a>",
"    .) Such tests might also be helpful for predicting potential resolution of clinical reactivity; currently, this is predicted on the basis of the history, and skin testing or measurement of the IgE level to the food [",
"    <a class=\"abstract\" href=\"UTD.htm?5/44/5833/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657239\">",
"    <span class=\"h2\">",
"     Internet resources",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several Internet resources available for patients that consistently provide accurate information, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Food Allergy and Anaphylaxis Network (",
"      <a class=\"external\" href=\"file://www.foodallergy.org/\">",
"       www.foodallergy.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      American Latex Allergy Association (",
"      <a class=\"external\" href=\"file://www.latexallergyresources.org/\">",
"       www.latexallergyresources.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      American Academy of Allergy, Asthma and Immunology (",
"      <a class=\"external\" href=\"file://www.aaaai.org/\">",
"       www.aaaai.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      American College of Allergy, Asthma and Immunology (",
"      <a class=\"external\" href=\"file://www.acaai.org/\">",
"       www.acaai.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      National Institute of Allergy and Infectious Diseases (",
"      <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"       www.niaid.nih.gov",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/30/33250?source=see_link\">",
"       \"Patient information: Anaphylaxis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/57/29586?source=see_link\">",
"       \"Patient information: Epinephrine auto-injectors (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=see_link\">",
"       \"Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=see_link\">",
"       \"Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"       \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7657253\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients (and for children, their families and caregivers) should be taught to recognize the early symptoms of anaphylaxis and to initiate treatment promptly. They should be counseled regularly that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      injection is the first and best treatment for anaphylaxis. For patients with confirmed anaphylaxis triggers, education about specific allergen avoidance is also important. This is an ongoing, long-term process that should be continued at each follow-up visit. (See",
"      <a class=\"local\" href=\"#H7657155\">",
"       'Ongoing education of patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients should be supplied with at least one, and preferably two doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      in an autoinjector formulation, and trained in when and how to use the autoinjector. (See",
"      <a class=\"local\" href=\"#H7657169\">",
"       'Preparing the patient to treat possible recurrences'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A personalized anaphylaxis emergency action plan is a written one page document that lists the signs and symptoms of anaphylaxis and outlines treatment appropriate for that individual (",
"      <a class=\"graphic graphic_form graphicRef60439 \" href=\"UTD.htm?2/42/2722\">",
"       form 1",
"      </a>",
"      ). It can be used to convey information between clinician and patient, as well as between patient and family, caregivers, teachers, or other people who may be involved in emergency treatment of recurrent episodes. (See",
"      <a class=\"local\" href=\"#H7657183\">",
"       'Anaphylaxis emergency action plan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All prescription and non-prescription medications taken by the patient for any reason should be monitored. Certain medications may interfere with early recognition of symptoms, increase the severity of symptoms, or impact the treatment of anaphylaxis. In some clinical situations, it is possible to substitute medications with a more favorable",
"      <span class=\"nowrap\">",
"       benefit/risk",
"      </span>",
"      ratio. (See",
"      <a class=\"local\" href=\"#H7657204\">",
"       'Medications for other disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Avoidance of anaphylaxis triggers is easier said than done and is difficult to maintain over years or decades. However, it is of fundamental importance in prevention of recurrent anaphylactic episodes in the community. (See",
"      <a class=\"local\" href=\"#H7657211\">",
"       'Effective avoidance of specific relevant triggers and co-triggers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific immunomodulation is available for patients with anaphylaxis caused by certain triggers, such as stinging insect venoms and some medications. (See",
"      <a class=\"local\" href=\"#H7657218\">",
"       'Interventions to reduce sensitivity to specific allergens'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/1\">",
"      Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010; 125:S161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/2\">",
"      Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 2006; 117:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/3\">",
"      Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/4\">",
"      Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reactions--guidelines for healthcare providers. Resuscitation 2008; 77:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/5\">",
"      Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust 2006; 185:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/6\">",
"      Simons FE, Ardusso LR, Bil&ograve; MB, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/7\">",
"      Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 2010; 10:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/8\">",
"      Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/9\">",
"      Sampson HA, Mu&ntilde;oz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/10\">",
"      Simons FE, Sampson HA. Anaphylaxis epidemic: fact or fiction? J Allergy Clin Immunol 2008; 122:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/11\">",
"      Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 2007; 98:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/12\">",
"      Sampson HA, Mu&ntilde;oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/13\">",
"      Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/14\">",
"      Manivannan V, Campbell RL, Bellolio MF, et al. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol 2009; 103:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/15\">",
"      Ben-Shoshan M, Kagan R, Primeau MN, et al. Availability of the epinephrine autoinjector at school in children with peanut allergy. Ann Allergy Asthma Immunol 2008; 100:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/16\">",
"      Simons FE, World Allergy Organization. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community. Ann Allergy Asthma Immunol 2009; 102:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/17\">",
"      Simons FE, Edwards ES, Read EJ Jr, et al. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol 2010; 125:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/18\">",
"      Simons FE, Clark S, Camargo CA Jr. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009; 124:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/19\">",
"      Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol 2008; 122:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/20\">",
"      Gonz&aacute;lez-P&eacute;rez A, Aponte Z, Vidaurre CF, Rodr&iacute;guez LA. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010; 125:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/21\">",
"      Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/22\">",
"      Triggiani M, Patella V, Staiano RI, et al. Allergy and the cardiovascular system. Clin Exp Immunol 2008; 153 Suppl 1:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/23\">",
"      Ru&euml;ff F, Przybilla B, Bil&oacute; MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/24\">",
"      Caviglia AG, Passalacqua G, Senna G. Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: Are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors? J Allergy Clin Immunol 2010; 125:1171; author reply 1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/25\">",
"      Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010; 125:S116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/26\">",
"      NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/27\">",
"      Boyano-Mart&iacute;nez T, Garc&iacute;a-Ara C, Pedrosa M, et al. Accidental allergic reactions in children allergic to cow's milk proteins. J Allergy Clin Immunol 2009; 123:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/28\">",
"      Pieretti MM, Chung D, Pacenza R, et al. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol 2009; 124:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/29\">",
"      Crotty MP, Taylor SL. Risks associated with foods having advisory milk labeling. J Allergy Clin Immunol 2010; 125:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/30\">",
"      Lebovidge JS, Strauch H, Kalish LA, Schneider LC. Assessment of psychological distress among children and adolescents with food allergy. J Allergy Clin Immunol 2009; 124:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/31\">",
"      King RM, Knibb RC, Hourihane JO. Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy 2009; 64:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/32\">",
"      Greenhawt MJ, Singer AM, Baptist AP. Food allergy and food allergy attitudes among college students. J Allergy Clin Immunol 2009; 124:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/33\">",
"      Golden DB, Moffitt J, Nicklas RA, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011; 127:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/34\">",
"      Bil&ograve; MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy 2009; 39:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/35\">",
"      Bil&ograve; BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008; 8:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/36\">",
"      Tankersley MS. The stinging impact of the imported fire ant. Curr Opin Allergy Clin Immunol 2008; 8:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/37\">",
"      Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol 2010; 125:S126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/38\">",
"      Liu A, Fanning L, Chong H, et al. Desensitization regimens for drug allergy: state of the art in the 21st century. Clin Exp Allergy 2011; 41:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/39\">",
"      Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/40\">",
"      Brennan PJ, Rodriguez Bouza T, Hsu FI, et al. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009; 124:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/41\">",
"      Du Toit G. Food-dependent exercise-induced anaphylaxis in childhood. Pediatr Allergy Immunol 2007; 18:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/42\">",
"      Nowak-W��grzyn A, Sampson HA. Future therapies for food allergies. J Allergy Clin Immunol 2011; 127:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/43\">",
"      Basaga&ntilde;a M, Bartolom&eacute; B, Pastor C, et al. Allergy to human seminal fluid: cross-reactivity with dog dander. J Allergy Clin Immunol 2008; 121:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/44\">",
"      Commins SP, Satinover SM, Hosen J, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2009; 123:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/45\">",
"      Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/46\">",
"      Bonadonna P, Perbellini O, Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/47\">",
"      M&uuml;ller UR. Elevated baseline serum tryptase, mastocytosis and anaphylaxis. Clin Exp Allergy 2009; 39:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/48\">",
"      Metcalfe DD, Schwartz LB. Assessing anaphylactic risk? Consider mast cell clonality. J Allergy Clin Immunol 2009; 123:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/49\">",
"      Skripak JM, Matsui EC, Mudd K, Wood RA. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2007; 120:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/50\">",
"      Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol 2007; 120:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/51\">",
"      Shreffler WG. Microarrayed recombinant allergens for diagnostic testing. J Allergy Clin Immunol 2011; 127:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/52\">",
"      Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediatr Allergy Immunol 2011; 22:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/44/5833/abstract/53\">",
"      Kim JS, Nowak-W��grzyn A, Sicherer SH, et al. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 2011; 128:125.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15817 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-806F72AFFC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5833=[""].join("\n");
var outline_f5_44_5833=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7657253\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657148\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657155\">",
"      ONGOING EDUCATION OF PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7657162\">",
"      Important teaching points",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657169\">",
"      PREPARING THE PATIENT TO TREAT POSSIBLE RECURRENCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7657176\">",
"      Self-injectable epinephrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7657183\">",
"      Anaphylaxis emergency action plan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7657190\">",
"      Medical identification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657197\">",
"      MANAGEMENT OF COMORBIDITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7657204\">",
"      Medications for other disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657211\">",
"      EFFECTIVE AVOIDANCE OF SPECIFIC RELEVANT TRIGGERS AND CO-TRIGGERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657218\">",
"      INTERVENTIONS TO REDUCE SENSITIVITY TO SPECIFIC ALLERGENS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657225\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657232\">",
"      FUTURE LABORATORY TESTS TO PREDICT RISK OF ANAPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7657239\">",
"      Internet resources",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7657253\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/15817\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/15817|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/50/801\" title=\"figure 1\">",
"      Latex food cross rxn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/15817|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?2/42/2722\" title=\"form 1\">",
"      Anaphylaxis action plan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?22/62/23524\" title=\"form 2\">",
"      Anaphylaxis wallet card",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/15817|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/1/44059\" title=\"table 1\">",
"      Anaphylaxis key msgs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/0/29708\" title=\"table 2\">",
"      Anaphylaxis triggers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/46/23274?source=related_link\">",
"      Allergy to penicillins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9401?source=related_link\">",
"      Anaphylaxis: Confirming the diagnosis and determining the trigger(s)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18281?source=related_link\">",
"      Aspirin exacerbated respiratory disease: NSAID challenge and desensitization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/22/6502?source=related_link\">",
"      Bees, yellow jackets, hornets, and wasps: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26006?source=related_link\">",
"      Diagnostic challenge and desensitization protocols for NSAID reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42709?source=related_link\">",
"      Exercise-induced anaphylaxis: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/13/1241?source=related_link\">",
"      Fatal anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42759?source=related_link\">",
"      Food allergy: Impact on health-related quality of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10585?source=related_link\">",
"      Future diagnostic tools for food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44057?source=related_link\">",
"      Future therapies for food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=related_link\">",
"      Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34071?source=related_link\">",
"      Idiopathic anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/57/43930?source=related_link\">",
"      Infusion reactions to systemic chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40070?source=related_link\">",
"      Latex allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20937?source=related_link\">",
"      Mast cell activation disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31672?source=related_link\">",
"      NSAIDs (including aspirin): Allergic and pseudoallergic reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/41/5785?source=related_link\">",
"      Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/30/33250?source=related_link\">",
"      Patient information: Anaphylaxis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=related_link\">",
"      Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=related_link\">",
"      Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/57/29586?source=related_link\">",
"      Patient information: Epinephrine auto-injectors (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=related_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=related_link\">",
"      Prescribing epinephrine for anaphylaxis self-treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29672?source=related_link\">",
"      Rapid drug desensitization for immediate hypersensitivity reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=related_link\">",
"      Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/28/12746?source=related_link\">",
"      The natural history of childhood food allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_44_5834="Extramammary Pagets disease";
var content_f5_44_5834=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62814%7EOBGYN%2F77680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62814%7EOBGYN%2F77680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extramammary Paget disease of the vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 300px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEsAZADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pozXBap44milSOws1kf+PcWOwe+BxWdZeONYvZp4oItP82EbmQ7un51nzM3+rztc9ONJXmcHi3xDdWr3CDSYY4mYNH5vz8fXpViDWvEEscctvJaxRsMg3TKY29sp0NKQewl1t956JmlzXl2p+IZrl7eTULeWG5tycTWZJAPtng0h1G6vpFkGsX8eVOwNBx+IT+tNOQnRa3PUc1E9zAjlXmjVgMkFgCK8wlurC1hjl1GNLpwMAx3h49coACKS0gtbrUGupJ4dOhcY/c+ZJLL+J/wpKT6miw11e/8AX5nf3fiPSLO+is7jUIEuZV3pHnJI9eKkXXLBtwjm3EdsFc/TOK5C0udF0ycxaRardXyJlpronzD9N3J/CtlPEJjtkkvbmxtmx88JDIU/4G3A/KruS6PKrtGh/bqPA0kNrcMQfuPtRv8AvknP6VkXniu78qRrXT5DHtK+ZtYmJvV1IHFYXiH4gaNbajHELxHkQZ3wuZCfYYG2s4fEvwnPPMl1KLaVRgTOjOw+gXpTtO17GkKUVq1c6/SPEN3Dp0Z1V7S6nzy1u+GI7HZit+21exuMCKdGcjPlj74/4D1/SvI5viXoFvGTY3kV5eynaHkiY8erLjA/A11Oi+JrTxCkcdtFFMVGZ1ihAkX3U55oamtWv6+4uWHjJXSsd8lxC77FljL/AN0Nz+VSKwZQQeDXHNqWkaYyIbyeRJZNpWWXDRNjuDjg0q396tlPcJezIUJ2Kyo8bAdhn584o16mLw7fw/idjRXms/xPhsdch025t/OLqGMiKY9o/vbTnIrpLHxHLqiLNZ232ezxua5uASh9lxx+OcVVmTLDVI6taHTUVj3Oo38DRKLATGQ4UxucD6nb6Ul3rE1o0QnsWPmttTy5AfzBAIpEqjN7fmjZorGOsXKTBJdNdQ3RhPGcD354qzZ6vZ3U3kpIUmHBjcY59AehP0JoE6M0r2/U0KKCcDJ6VFDL5wJVWC9AWGM+49qDMlooqlf3pgaOKCMzXEh2qo7e59hQOMXJ2RdoJwMmvNfG/wAS7Pw7bagjCQTWR2PLKyqhfbnAAOXPI4H4mvm/XfivrWtM4gS3kiXIwN4eX/bJ3fp0qoxcjaFBvV6H2Jf+IdLsSRPeR5X72w7tn1x0pLTxDp15KI7ScTuTjCYNfHVt8WfGlvYfY4ZFFsVCbWiTFc5f+M9cnleSQGL2t2K49yAf51fsmt0bLDwtqz77WVWIGdrHorcGieVIIXllbbGgLMfQCviPQvirrECQNPfT3UcDZRJZT+7+hzwfwrph8dtTkuIvtU8jxA4KLggj3GOan2b2E8IlrzaH1paXMN3bR3FtIssMg3K6nIIqavnTwz8ebW1smt7mKO4bd8i7zAQCf93aPpmvZfB3i6w8T2SzafcW87D/AFiRyAvH/vL/AIVLi1uY1KTi21sdNRRRSMQooooAKp6f9pxKLsAEMQpB6j1q5Ufnxed5Xmp5vXZuGfypO3UalZNElFFMmVmidUbaxGAfShiIG1CzDKpuoNzLuA3jketM07UrfUPONt5mIm2kvGVBPtmqes39votgqxeSkx4ijK9fwFY9yuoAo2p3lo6nO8M5hjU9gPU1nKdjWMItanXo6ugZGDKeQQcg06uVstatlt03apZ2wQ7RAu0g/wBcVq6Xr2nakrfZ7mPerbCpYZz7eoq1K5MoOJq0VFPPFbxl55UjQfxO2BTPtSvbJPADNEwyCnUj2p3SJSbLFFc3P4rtbBiurQ3NoN21ZGhbY3OK2bLUbO9UNaXMMoIz8rAnH0pXuVKnKOrR8IN4x1fUGk8hojHIf9Wp2DP+yBWefEd3pepkySNDcHrl+lYlvH5yoImjZQPmaIY2VcGiC4icyANIe7ybq6lhpL7dj0/rN17sNTdi8barHdf6PfozueT2rbsPiFqlm/kzWkYaU5kVvnST3AI4NeWmKCwvNzoVTO1hnIrW0e8haIwzEEH7rMfu1yVpVKErS1R0Yf2eJXZnu/hfxwl1aw6YxdX3B0nM5jCnOQHHP0rvm8aQ3Ylt9Vt7ZFhOPNbaZB+oH4j8q+Xbe5mtJUdF+eM8SA/My+m7vW5qGqXeqW8R0qJhPLLly0gCSfyx9K0Xs6uqMZ0PZ6z0PaLXUdKk8QTRsb0wzfKgt8ZlOOcj0rV8Rapb6Vp8c17cmCBeYYLgZmf24PFeHJearbILrdDbXCDAgikEhHbf3A/Oub1nXvOnjubp1+0x5+ZiTn8+v8qqahGzv/mEU5y916Hqer/EC4lj+22P+jrDxvRhEPoB1auA8Q+I576dLqa4nlU8+TI5WP8AxNc1NrFxdXEbq0kpHHynbj/ZrQbRZL64BlL78c5J2IP/AGaqpc8/gVl3KlGEX73vP8PvFm1yS5ACTx25248qIlB/Ouish4Wl8KT3N1rF4mvRj5YnjWSJsdBkdKzW0CxW1gjjyJz829l4k/wqhqdhbQ28bxxBHSPEoPf6etU8HKas5O/3FKvy2aSt94ltLcXcYe3uYHKnhSRkfnXQaLq98mqQW2o3j6YuOZdhIX3AB/lXCz6LC2fImWOQjepBxU+mX00kaRTzmXyeNrHOPpXNUpVsN70Xdeh00q1LEvkqRtLvfQ9b0XxattrPl3s8dzGjYNyik+YPUbuv0Ne12PjbT9TgtBLa2925cpFLHJ5Z3YP3h/AcfXOa+TJ3kt3fCvGxAJ2cp7Vp6F4k1DTlZbYbjnJcod4/EHn8aI4mFRe/oya+AldKOp6j4guNR1/xKYLzSrq2w/lBrYByRnkH1/xr2bw7r88X2bTlsXt40h2wpIMhUTC5dh0P59a+WdQ8c6kbt7karew7lCs8P7tmH5mqGoeMLe8/eSanqc1wowpmuPM/DAGP51pGz039DnxFLmVmrW7s+sfEvxB0TRbuO2ut8zyvseaPc6QN7nHy/hWffeMdAcxQw+I0lnLAeQyFUb/fZ+PxNfIcev6xdGS2tobhoSxcI8pA9+OmaI47xrkS3NoPLbqrnqPTI5rb2astH+ByQp/yyX9fI+0bS5t9QtJl0nULV23iIrPLvlhkJAwMcY/Oty+twNPuYlVZHWH9+q4UE9QcdiMHpXxp4W8W3+h3EclreXUCEGLaZScD0z+A4NfTngPxpHrWmq8sgupplAFyqhXUjojgdcHP1HrUygrXiwlGorN9Dl/FGuTSeJ9L0/XppJrFwYittJtJLDAYt7Zr0O98WXdnavN/Z9q0KsUHlXDORgdxsFQ+MrC2tLePxCtray31q6P5gfgjpwp4z6e9HiDxNaW+neTDPDBdz/N5UJEkjAjgEY5c+gzWcYNu5dWrSq8rUf6+Rna54ovrS8sbi5nUafgyyGI7AMrwDwT/APrrgPEXxmjs9PkvPD0Swx4MIuJoy5J6nk/yrlPjH4wtbuM22p3b3F35vzWa/LtGBwcdOnT8/byuW4vfE19p9tNJFDaK4itrZRtihBPXHrW9OlzvRfPp/wAF/gL3VHVfL+ugy/1C+8W6yZtSd2iLEoJDgyOTkk+5NdTYaFaJor3EmI2tW/fIRjcM46jpWjqFrp+irZLJbeYiMQjqOXOcA0umrqVtf3umvGjWU+wyyv1UckqfXrXZGKUbrQqMei1uVbmxs4rSJ4FJ+QGbnIibOBx+NYtxbQtcO43AY5ZTgD61sT77fVGkS282wUEHLHBJ6AfQ4rT0fw8LiS2KwXD3WomRoYlGQQOMn0HWq0Wt9xt6O/Q5i30SGQxiQIglcDftAUZ78Vu3ekaNbWkBd0Vlys2Dkl+1dYY4LnRdPtruy8mZrgRsbdc7EA4ZvYmsTUPDt8niC5QaRE8kpX7Mc4MnPX06Cs3y3tLQEtLxX4HCyabp1wsgYSFAHMTLwSR07Vm6dqmpeFL+G8geaLZytxA22RfY4r2w/C26GjRzS3LQOke543wQJOuSfTnFcDeeG7gRuWQXKZwdnTf3GKn93U1i9ibNKx7v8M/jNpWtQW1rq+oRLcsoAuXHlqzejY+7+PHvXrUupQ28aSXAZYn6SIC6/mK/PvULJtOM09nEYDG2HUcV1nhP4m+JtCSGHS9TljgzxEyiRG/4Cf6VxVoKm9dPyIWF9rrHftt9x9xrLG0QlDDYRnNQWt2091dRGB0jiK7JSeJQVzkfQ8V89+G/jtc29wqa5HZ+Rsw3k7lwfXaen0H5V10fx68L7iZLa/DcAssfy49s4P6VLhLS2pySpSTasewnoa+VvGGoeItC+NESCeQ20sgOF9K9NuPjZpDyxJb21zCPMBZ7iPKvH3wVJwfrXj3xV8cR6j4pgv0VofLHyKgw7D8elKDlCqrrRpoznRk1qj6en8VaVaabHc3N7b5PylElUncPvDr2rh/EHxZhsy4thZRKCQvnTb5JPpGnI/4FivkzxF4mn1C6M5Kkbi6rGTwT1JPGT70miwQTrNLqi3EkjRny9jdH9zRSoylFHVGjGOk3dntmu/HLULKOQ2z6cly38boZJD+RwPpXjOp+NfEWq6n9uurme7YHd/pDfKPonYVY8OaBbvfRC6spbmFWEksgfkL3rYmsbe5u3/svTZlsriQrEFHJH05NdEKCi9TSy+yrGA2s+Irm4S4j8mHyzvUQny/yPUUS+IdXhmjvJZX2RkFm8wl1Prk8muim0e8tNNDGLNwhxJAfvRpnrWTHDIkl3FIkZ24QnORnFa+yT+FlJ8rR6/4W8b3HiTwmdOs7+Jb1CCsFw+NxHP7s/wBK77wB46urQ2+keINMltvm2fal5jUn7u70zXys2lyWsIezKxOrlyF/i9qu6N421O0vI7XVZJo1QgxtMxIX0/CuWVBxdzblp1I8j0v/AF6fkfd91BBeW5huFSSKQdD3+lcvbeAdLtYZ1hacSSFiJN+CuegGPSvE7zxDf63pEcWgajf2uoQDzERJCy4PDFCOcc9q9d8NeIdas9Itxq2nT6iqRgNeWkiPuIGTlOGB9jXNUjFX5tPwObkq0Leze58a2vhjUrHVZbOzSOdhGs2Gfa7Lu+7T9fhuLO9ktpYozO8aMgJ2svp/wKui1Ow1iXXHktWtmv7ubhlbPlqvof8Ax2sfxHo13DraC/mWS/8ALWVkd/utu/h/hNe0rNrXUy1irJaHD6/HKfndQDnkjvUOkXVusuLjCgjH410Wo6aro7Kfm+667vu1zmmWso1FGt0WZojv2noa569BVtCoVJUKqlE6mxsZLmNZbKbzUHQJ1qrdahbW8v76G3jlUfPGFK5/3l/vUyOHVI7+aTTD9i83khRtGf8AZqtDoc4uibty7yH5yfm+tcsMuak7vToehVzByilGOvW+3yHJrdxeMbewhQDouV6U+DTriaKUXLqIyfmP3ctXQ2lha2YC+X5XYMBnNaYKAsLVVYgK7o4yFX1rtpYVQ16nJJyqfG9OxneHtGaJPNZsSvy7E7jiuvkisVtHgEkn2naBydgOewNV/wCzr9YPOGnSquMiTace1TWGmzTaRLO9srshcRyE8qfx71sop6otP2eiM24ukdDNGU8uIcxqckGs3UlSWxkPPHbFTsjxyNFCXjhjjBIlQZJye9JczpLEVjVh5o6hfu1fLyvQ0TU46nGS38sN7GnynZuTZjtSO9r9oWQRkzNu4HykGrNxAbeQTQxEqxOcjkU+202W7ijdpJRg7mRhXNVpzqVFf4UTTkoQaWsmTaWl1FMIpC8VyeJN3cH9Kv2+mIsktyLjzpWOC2TgH8Kv2FqgQpbxAsOQZO1dP4d0lZ4p5maI/ZojK8bHAc5AA/Wt3GO9iYQaWrMLS/AUesXESLJiZiAEByT3J+laY8FW2lTINQil+e3Etsm3O5s/cPpXSXU0mi29lq/mpaXO4+SkbZ49CPXGKoz6nqupX/2uaIG5j3go4AAwOOlSoNvsh+6tTDt9PlsJY82obccOYxvwDx9M1avoZ1s5JmtJUggAVlKHP410914hjIsIo447e7hURzTAj99nJJAHcUr28x0S6vZBdh5YdqOx3LJHjk9OvUe1OTSV5af8OKEm37qPL9Y0eR7F7i3glQZ5IX+dZmk+J73w/dMLa7urYH5CAf3cqehHY17uJNOi+GxS4hhWR0w3mfuyOMB0zySOK8u1bRbdrERKNzMB5vydHxyKxlHnbtpqN+8tPuG2XxGeGBxfNJNGxzDlQdp+pzn61kT+Ndb1G8kOnzNDM2VMxGCBjoCOneqNt4egSR8KwxkEHjHpW7pOjTWR2y2kqx92IPy57mrVJv43ciKlJ7W/EyNF8Pfar8Pd3HmXLnlpOg967nUfCVva3+lw6bdSyyv/AK1oCNgYe/r04qbwZp1hca9YJeRT3Es3AypGwHo/0r0jUvDmjaMdMbTrqKWZW2lEPzMe7jv1Iq5e40o6P8C4xWz269zz5tMhtLm5lvWB8lcRwsCc5PatXVI4rKR2tpbdophH9oBbGAfQ89ga6fX4GtRDcC2iuZlwWi2jnJH8qydO8Ovqmp2unmHyrCV2yYVzhRzjn69a5HilVaT+fyPQeEeGjKXTp8zz2fY4le1mUwtORCH69e1ex6hdaNcfD+FYLxrG5ghERZMlto68Z78/nWF468LaToukyIsgi/chLZEXJEm7hz+dc14RmnhiaG6TfLtMdtwC27B3Aj0reUo1IKXY83W/KjZ1rUGkGkLockIMgh3BBvMikc59K6fxpCNSOmyxXMdtdRFygzgSAAcD8zWL4a02HTGtluVjimudkUa4AMeRz+NS695tt4suoYzEdLjkR7fcoAMeP3mSevauaVVTqLkduXr3/r/M9CFGUKfLNXcunZf8Eg1PU7i2ZftLT3NzdHaFScCJ8HgY9q5ae1uLO1iuLi1li0oT8zo29ickk4H410qsYozdac9raW0rf60QeYQScd+/sBWH41/tfR9MttIu5YpILj97/o8fz9c8g9M10025NX0+/wDrT/hziq8sLqBymoW8ckMkUTxvbs+UcjlgT0PpXIt4cmjmb7G6Iyn7suevtXcxRMh81bV/JtwMeVCSGTPIP41NrVwlxNG5s4bWR8+Su0AH8qqpHm0tciKS1Z51ceH7tGMtxcu7nqFbFS6Xb6ppN39o0uQxNjYGlw4/+sfeuruHuhp9uhiRYXPAYcZz61A1tfzRXBitWUo+1mxkAVHsoWtZEW1vdmbJJ4pIuJJNWKiYgsYpTnNY9zpV46efJPNPI38RaurJREDR42ICJPM6xPjgYqBJiEjPmpIqhSwxjOfapVFLVLX0G+VnP6DoUtuiyTp87nJ3D7tbqRLtKsI44lJ5PIH1xV1NRgS3nuZFjJD+QgYEbW7fqaW305heRNeEeQ5cGI9OeR9a0TsveJjBX5aZp+HbdYZon1C8QKIvNC45IzgjANdLpUMsB+0GSWSQsEhSMYwM8H6cinaZawDUbaV4oX3wrCoVcbpMdvxFdL4U1WDSLKWw1Swm06fzdrAoW81CDwp/3sVx160mvcV38vw6nXSpqGtTr+BjWc5eWeys4JdSvJozI/mcAYOMH0rN8RaahNtBo9pDFfThzIs3Eav/AFNdVYTRaNZXtlHZbILhUkE74Msgxyp49fSuJ1e+sZ40t57a6W5QgEwgh29wPT6VFD2lSpe36mtbkhC33HNyWtzBdGGaJYcAOwzncTWdrOkm5j27AFzuIDkB8Vr3UoS9eKOOdBERHECvRPf61fmsEsUiE1wsdxKdwDNwB716kjjUVKLucBu1fQZhNptxcQqh8yFEl5jz2Fdr4a+N+uWcjm5kQyONsmRgPx3HQn3qWAxiF5WRJ85ABOF6+9UNc8OWht2LQohaLzAFXOK461DR6Fxim1Z/ebEsb+ZZgLLJFNHskim4MRzwQRjrVG+tbye8kl1GB2dfnAX+ALzVzw5aPFDcz3cgs1nfck00bSRlh6L2IGcVXv719Rv5Zo7qRoOI18kfOTnnj35NdaW9tkct+nU51443tRtj8hnT5DIaf4VsLa0jnju7ZZJWHGPuN69K0ruOFfs6NFJcr94OAPl+tVbs+TZvPcRFYfMw/wA2zCD2HNVbmNXHl1fQuT28Jg2Rx+U6H5UYdAazVZI1dYvkzhMyJ/6DWnpWlza2bl7R1+wQhZJJZCfl9APf2rtLnwdp0Vta26O8k8kbNl2IOQOMDp6damVSMNBuz1Z51LYETETP5nnRCTyuvVvXt/u16V4a0u6srFIHgiktLmEeaFVWZuePwxXG674avNJ0E6rC06oGEVzbMd2DzyD6H/Cu68D302oaLvtFj83IAaQ4O3+7Sq+9DR6ERkk7G2dZubXT/wCz7izCQxgKXbhiOoxn1FctfGJYpf7OzHaP+8mjn7SDIPI6dq6a80+682GxilW6hnmWDa75MB7Z/Ssb4nafF4bsJ7C0lR5Xk3Mx6EnG4Vg5Rg1GO8n/AEzahT523LZJnmF/Mbq4ukaGQIEEkZMn3+en6Zp1rEvnOZJMAjGP7tOc2l5CsdpaPHAH4blSj981JvjWWMuNqSD73Ymu1roOkkt2U2sMTjI3Rn3rQgtoQcxIXOcYB6VHcS2kTRNIx2RHqBxXQeHNGvtVjW7t7aOK1hnDb3fAOPUVMnpeWhfuwbSOw+GPgRdavI5LhQjKPNkZv4R/dIqv460v+yNVktbCZXJJ8xoouD9AO3Fdeuv2I8H+c9rLbXk0nlGCA7TL77h/AKoal/Z8HjLwqGdGR0YSeW/JCnIWueLmpc0vP8NTNyd32OZ8R+Fr0Q2VrfTF4co7STfwc5KjAz2FbOhy6PpcP2jVraUToHAlU7gf/r1f1jVpruK9kupfslitwY4oTkMwHX5u/sa5LSIJPEstuBEHtllkbB5MYOBzn0HOTR70ornenX8w5kk+Vamvq2iaOZYtdsrCCSBURngZidwP+z2bkcfWuV1S5vtOiZYY5rGwMvmiIkEoh6/JXqE/2eKzu4be2EdtFMsUIHSf/bGOn/16851xpJNbvTLFMJLePEcTjHzE8Ajv2rKMubSRCbTvEdaeLNN8NaVLaXNvJe6nOMW880YdYUPdfc1z0t4Lq+mmUItvOfvD7zyDj860bjw3E+kpBqWqFJmXzQjJ0fpgPn+VYcmmNowtDM7TJC5w23AV+MbPpWsVC+m7/EUOZa9PyJTpb2DWt7JF58Zbc2TgnB9K7RtXtrnwpMFeL+1Z28ufz+D5WeAOxfFY2uX8FzoCb7ArLJL8smDuz/sexwOPaqscM9q0WwiUqRJtAzu5z/Kri1NLm7mrg18jufA+r6NpWi3H2q2MmoMxjypCNsOOmeuM9qh8MWCaVqsWqRm5uNPj3RMkjeZv3cg89MHvVN4NC1nUIL2O3vYZUYebphQycuD+8TH8FbGqWz6JoO3Tvs3mSjKqVYKcZJH1wKyrPli0tHLQ1w8FUlzT2RTtdRsleeRZI7gqTAZ5ZcBcn7gz3/wrR8Lrczm4niuY43tPNVApyzA88/if0rmdR07SdXSS4SyNlLaoJmbJEUjEDI9zk5+lbAs7i1mhn0WURXEUYTyyf3cwA6H/ABrz7xo1Fd2b01PVqRni6D5Unaz0Okh1GL+woYNYijnmH75hJyQAT0/SuE8WRaXfa3avYReVHkzzqeOvp+NbenpNa6Q39o2sMUoJCYlMnB554rmIdNuoLor5kj2xk3jK5464H41pKvDmapvX8DloYCokqlVe6bmkXdvqekPf30wWaQk29uxAMZGRnI7HioYro6vq1mLiWJ7S3A8xIm6Zz19veqmsaLPrp+y2xSxmWAs7O2AigZwSPX+tV/hFqmj2RvLS7aM386hIYpc/MAPu5P1Jq6VK6c0ttl2v1/rqRiMSov2ae+77nY6b4Ye1u/sthPFdhkeW3MkipGp9MYz75zWZ8SvDdho2gQ31zJOl/cMu9BIZFLdSc9RWL4rk1TRNftpxYMmnr/pBgguMMPfp0qnq+u2viHRNT1CW8S2kUIiWhfeXPYnsOtdkYyfLNS9f6R50mk2vuNDTfDGryWdhfJLuxEZAokwWRuox9DWLdeHNQg1S5sbq5VRb2/mqXPRecYPrn+VbfhX+252054kRTFb+TGHyDjpkU/V/DF2sdzdS6ibi6Z8PlMfJnOMelZTrKMuVyX3G0MNOScoxOZOgajdwWzlI/wCy9uZLsxl+eAT+narvh3VrbQ/EE0F3LLJplxEXibbkOcdx2PtXaW1xcJpenR2eJ7UWu07TgKwOCMVg69Eka2erPbWsRt2d5AoILg4wSO7cGhzvpPYyVOT+AreIPCB1XVBJYmHy7gCXEYxkdifftXF2ujC38YQaTqjsnLxySQkjA7Zrv9W8VaWk9hLpf7ic8s1ug25IAwR0rINpFBLNqTx/bZLh2BfOCpzkEfn+VFJz5bPYVWMU7Lcr6b4YsH1640mC4W78mBpoZF5GeePc1TbTzemLyY5TN5oSXC48ojocVLqvh+5T7FcSSPa3NxgSJG3zA5+9x0FXtb1az0ixurM+bvz5Ek5U/Me5z19qmpJxtyu7f9M1w9O93KySNK00ttOiXzGnmkt2BH2fkwnrn6nmrFz4outTnvJJGmeK3QLIJlwUGMdOMVg+FJtR1BLuZj5tvG4j+zLuAYf3xjvjua0PEup21tpslxZ3wN0k/wBnlgnUoVXH3PccZzWSw7btLV/kXLFq6aSXmc5d6tY3SyMo1BZ4l8uAI+Fcf3/fH611PhmWysbk3Or3SGWNQVBI+dcZx7Vx9rp17q00lzEkazk5CvzhOn4VLH4c1GXUm0+VDBcwx/aCTnLqehX1ru5YcvLexy3d+Z63NrXJbvV72TUUgSDTXIWNFzuIHIz9RWDpwa+jkubpI5CW8uMsOUPofxNdTN4deHToILi5MkH2jEalSCzbByfYZIq14d0y2m0+3tTaNPcvcG4zCuFBHH+fpUzrQoxujpo0J1na9jL8MOpuQL7Sy0J3BYtmBnjH65q5qPh25t0d7MFIinmNFuyFznPX61tOuo291cS2jRi3iiZvJk2gtgdfpmsPV9YvJoXsdWNtHbyxPICH5xsyAB3/AArCVSc03FJaa/cXKFOGnM2/+CY95Jrum2cGk6pbywW8J89ZdokKj8O3JrJ1DULWGbz47l7zodhB/A8du9euWe86ebk3sFz5eYpJJI8lRjGP515j4z0QaXqPlod1nKBvYLwMjoD+tdVKScrSX9fmcNuqMMMzzzRzR3Hls4kG0nBT/Cqc88XkvHbuWf74kkHXd7flWxos/k+IfsolH2dVMSqf48c/4VkSaTqGqzare2caJY2spYRjO5hnoK2UknrsKT7bnqHgOO306G1dy93ajZLLaADDSZ65P1rvL2ybVPtM+IbTb80UcQWQhT6D+dcF4a8uCOWKzEtwbgJ5aNwF4/xrp9HjisdTvpZd0A+zZghEnOe/P+etcdWN5cy3/r+tg5jJ8WL9p8P3MbX37soCioPlbt275rmNNS58O6dDeiOaexkb5vIGSPw/GtHxBOL/AECxtxcSI9xMUwcKxO7r6ccV2ml289tDa26rE9usXmTMepapq1vYR+b0/pHXhcN9ZbT+85w3CXdx55trm2j3CU7+rFV+8cdBXHeL9Tmj0Gznu5klncuVY5J55GD+NeqyajDNeNZLGqzMhZUI6p0Jrz3xHDqN7MYIbKOOJXAi5HXOO/HeuWliuatHmVl5nq1MB7LDTUHd+X6nFeHkivYghlaG7lkDMsa4B+vtSTt83liOMJGwxCvzkEGq+mXA07WbpXuHjRJHgaXg59PzrY0bRbrxFqEbaTHGURv3pGe46/T3r3HJR957Hz0HeKUdzqPhf4Zm8Qa3D9sby4o5RhGG8k4z9MCvXdNXR7S8Gn6goupIJXMcbReUm8c9h/OvJfBtpd6T4ol0e8nMUKSrKpibjrjg/wCcYr1e9t5jLqx0lUaR9ky3Eo3sxL4YH0GOfwrirWcrt6W9DaN3EzvEs1vb6hcLDp9vp7ZDwCXO7ByGIA4x9a4Dx2Y7kaMm23Fz5kiRtFiPP94nHTmuvto4o7Ka6lMc90FZmXOSBnGAfTiuD8SyQL4ztnCqIhFG20rkcnJ/mfyrWlHlaS6E+vU7zw9puva34Ue0v9Lku7WNVNpcMNhyDyTjr7VyMel6npNzqM+nxyK8AKT2+3YHj6nH0PNfU+kPDJpVo9tjyGiUpjpjFedfGmaOws7aSLastwWUjHXA6muJV5Sm4pbkQqKUrNbHm1p410r+yoYZiyEbSLduOfVCeopdfin1VGuYJ99yzARM8YyBvzV/xb4PFjolpcmyhnkuFjZUJ/1cvc8/n+FYF1Jd6TNp7RagJC5w9u4+96kH19BXPOrFu0N7npUMNzL2kvh2v2Zzlgbi0uLy71GIJY2MY8mDZtUZ9Ae/NRNeXniqWGzsLOb7MJzPcuikKuccfQCug+Jl7/aPhbTo7dDb/bJArsVwRx3/ACrrvhTBfDwyYYrBXtyRGu0hNwzjJ59K0hWk6ftWle9jOtSVCoqSeiX9foYPjXXotX/sfRNPt4I4NPXfNjGcDr+dacXhx7XVLa2a0dzMpkd9wCxRHoBznI9q4vW7eLw58TJ7CUS7pkSIsgztLnk47jFet2CXOs6ZdXWoI0djbQmKK+WQBZE+hHWt0lTguX4f8/8AgnP7S8rHBa5FfeENe0nVre9M+kNInmG6ypjYHOAeuDXbaZcx6l4fupmh+0O28xrJh/4s8evHSsTVrax1jw5PoaA3kTRebE7ZBUjJGav+CrNrDw7YAeXIkqggAdOg/kTmpxTUaact0/wO3Bx55SXdHPzwJpuo6FN4ouX+zNhZFkGAecEnHHSt67t1sNSaNG/0YudjA8Fe1WvFOq2dxoei2l3ZKs9zdRxyQuP9VGWweak+JmnJBqn2SGNHUFJ442baOMcV5+Khzxg3pdv0PRwNf2dWUPLb06+pkR29/JIv2yaHyY93mxqM8H7pFSK7NbvC8ch8pj+927c9xjFWM21jFchkmLyYBLHfh3Jwp9s5AqsTHbhtNRbh7iSMzOw+ZRu/hz7da5ZQdm0ehCpeyf8AWhxfwx09tY1zUXv5nnYOXKliVUEnBwfcV6LP4U8NarpmoWV8Io5YJSBOq7GhbHGD7VwvhPUU0TXPLurU280SiOTDYMkeSFI9a7HxZq/2mGZI0MtrbSbXKAAhumfQj/CvcmnJqV7Ky17bHysYyV4JXZ5pbWniuz1e/wDD73cmoadaRlW80hiVPIwTyARg1Fd+Ery1tH060s45xeGPYYxloumQf8a2m8P3mq+ObWScTWtveqFjYtgLGi9+/IHWu9tNKttSsSLTU7jS9uU82KMtHKMgkkk+nQjpWdXEyg1KDVnvodNGhT9nKFRarZHL6eZtFtFiv5xJJBHgqg/eYzjp6fSs7VrPVbbSFS02vbykytyXZRnOc54613K6fZpaZtBDcTW4ZBcmLEgTrtzk5/3jXILBd2sdo2oXzWkV3MYmA/egEg7cH8O9ckXKcuZavz6/JHoSlGFNRd4ry3/pmj4f0i+W1jv9Nu0t4Gb95HcMOndgvXNZ2rW1vO0lvcvdXN0reYt1LgW4BPde+MfWqV7YXNkz/YnkAtyI3uWuspOxxn5c/Lio2lP21NIuovtVzMDGhJBzlCSeDxSbn7S0df6v/V/mhKnSdFyk7X+X9aitc+G45Ybi1gEJjJEQSPIYZxk+2ec1I2rWGrXcsemzwrPtw+0fKpHqKit9DWHBjgMUzfIsa/Mkij1NZk3h14L98ac9vdXSkxvDkAkdN/41o4SXvXf4GUZUXaNlb5/mdZsLWJUT2z35IKPcHA49KzdcQQm6urdEmnEbRkkjyt/Tp3qrf3ko0ayjlt2jubJxIG3Z84EY+fA+tTRahYXjGW5l2KX5DKYycc4OazheLU5ar0LrU1UUqcEo9lcZ8KrgWR1OK7MXmDyyIgcDfznmr3jLRotSv7YoTHOMSFQMqD3574zXP3Xh+4mklex1CJbe4O8/3Tk5xxXUWlkDoSwtMXd3QeahOSw6Ad66pYmi5e0g7y7WOFZbXTtUjaK6tmR9tePUJLS0migdsyOE6ls4Jb8Bx9amvvF1nFd29laWXmzafbiA3DLxEnOAT+OKq22k39zd3lrcym3aMpunRRvl71Jc3VnplzBJdrDaZEjC2bkzHOPMPrxUSrQk7NbdF6b/ANbdTopYJ04KUd31ey8jKsptTRmEl19ptpnIt4oRwc8nn/PStbwjFq9pJqs06KgkThI5iFHqB6ZFavgiC31b7V5hVSf3gDLhe+NoPTv0rP1nxHcLK2nxlfs0ROGVfLL/AI/hWsW6snHl1/r+vMiolSirvQlvvE1zKlxaywQwRyp5O8FSYR/cJ96xZ7ZrGPzNTaOeSFAkQdMZQjt9PY1LraWIsY3ubKP7M6MocTb5fNPr04B9a4/WdRtLKwiSEEbItg3vvJPc+1dUopwdl/VjhhdSvJ6HsninR7Gzv3tLISvbRsxm8o5JweBiuf8AiBLBFo9tBMjxWcYidld9zNg8kA88BjU9xqH9najJNHex3ERj5kMRDFs8den0rK8YajJquhyTSp+9nJjBdQNzHjA9KcYS927ukcl+25mXHhOJtQmuLC3lkgiUSQv9RncD6VJf6JfWeh/Z9InzNtJkTdzz611XhC3eHR4bBId9wieXA8hJ3cZx7CtaAW8Nw0Zuolck5i25LEYzz9c1wVcVNStDXl79T2aGDp8vLV3l2OL8OSTXlha6ZNMILy1bHXDOOxFdDeajFZW1vBEnnYYRiX+JmB6VLfabbapN5tvFGJ7d8xs4IBI+naqVtBYHW3KgJfoOYuw+gNOONjNXkn6CnlM4ySjJWZQ0vSn1LxDLqWpOhS3kIggiHyxbe2e9drYTtZzv50QGnlclySSWPYCqU8sNtBwY489s96htdabSI0FztmuJQXUoeQucA4rkVWeJqbaJbHoPDQwOHtfVvcuTW8enxXYijYyvc7IZZ5h9xsZC9x9KyJbRdIkFtNIEDvsjDkncT25pz373EOofYYyt+lx56Jdn5WzjkHsMVPJrMjraReItKZJ0beJ8ZiBzgHNVWoSna/567Bg8TGhdb38jgNZ8Iu2sJNFGn2d33bQmCv49+/51qeEJD4Q8RXOoypHHGYjGOy4PWu3ttf0vULe4iaPEtuwBQAKzg909aozabJcRSjzLO6gM2NhjOVjyf1FaRxmIpq1VXW3mTPL8LXv7K6l96MzWLCDXEuNV06IG5KG5jZOSHQdfSuh8E+IQmnTy3JjS/lhxCW+eNuOC/wCPWqMNreaZLF/ZgElkcIYYsIsY9ar3dubC5uptO06KV8h7i3RC+fcr1H4VvDGwn7rTs9vLyZy1ssnCN4tXW/S/obd3Pa2tnbS28dqt9ImJIAf3TEnJIrI8ZaNbW3ibSLxkEEU0R3owGVPlkYweOMj860Vs7F7e31CHw1NPfGVU2C6JRHPYp1Xt1qx4ggXxDp87eI5rW3ure5dBJDNna+ff6DitXVV1JXtrfbr5XOSFFu8Ha/Q1NB8Sav4e0eJ7JYdQscBjCzjzEz6Y/wA8Vm6ZcXvjz4lCx12IwQ2qGYxp0aMfdX8zzVLS/D99dmOCKSzttpDh0fbh+5Psa73SLfRfBgnuorj+0tcuECO4bP4D0XNOdWnG8otNswlhqilyqNpGL8cL+5kvtI0TR/kud29pB92NQOhH0/nXDWEdg72SK7/2ha3IjSK4XHmOR/8Aqrf8SWlzq/iLTbma6jgtt7SySCTDSsP4AOtctatumtm81JNXgnlumlwJIwkfG8j0xjp3FcNKCmk/X9f0PQknh6XsV8/Xy+ZY8U6a66HpqkG6K4lMhztJ4zz6da6TR9YGi6ZDb2AjSa5QEp1EWenGenWoI5Luy8ORpe2Ml6GBDxQrz6jbisLQooLHxCLgaHem6xviuGyVEbkDaR0BGfyFOnKykmrpN9v6sViKHPKLvq0rlLQbRNR+Jl5c61FiOCJdkh7NvAU12FnpWravavFLctaQRASLbx/6svknp61R8UWWoJ4iM+mgRR3tusLkHYI3Vs8EdM9M1rWel61dalPb6bDdRvOwkkaZcRrxzzXXSq8yU00nb7jhrUXTk1JaFrM//CSaclqsRurrCyxLjhfXHXFbPjG7s9O1UWqlYwFSBQi4+Yj0FaWmaVpngiIXN44vdcmUrGQMtj0Udl9TXDareJPPfXV1JieRCWljGWTJwCB7E1y4qpGTjCOp15bTlJyrP4UvvY/m41KGCRvMtluCixvHjc4AwQfQEHmqfjWW6vPEF1c3si3diXEQjtx8/Y4H0wcn0qpYXd5ZaJqMpIlc2otraXBDsEBBYqc4OfTrWTZ6qNG0WMX4F1qVxG8rsW42PwQnvtquS8lThry/18vNm/M4wdaejktP6/Q0vDdvOLqW0h86X7S5kgjnf96RnJ5zjjpXTWUk8EUkklopklfyDESFMPfPPUdM4rD8IaVqc+tafPf5tN8REcqfwxg5b8Dx+YrR8Z3Zhvr+5sYpZWmO+KOHBJbvsHXNctSmr8z3f/DHVCtztUo/ClqyS4sbCWEi80+3k3EiNFiJc+/HQdetVI7K1tdzzRyoZIjFbW8T8qxz85GScj8K39N8OwXtpZ6ukupW1ltkWcvKYiAP9j68CtTSPB9pYwS6nquoXVtHIN6QNLyq9QGJ5Y+1JU2pJfgYzx1JRlr1t/wP6/U5aTSrXw0sFvrU1zeajtwTbkAQ7uilicnNchrcmu6ZavHZWCtZbzthDmPByeMDrWl4osNd0zVLvUtsc8l24uYoZ2DhkA6kggg4rOvfGmqaPbRtqOhJEl5L5gclirL32E9/SvTWHjJKW7831/q55sMXUirX+5HeeDhpr+H59Q1NkNlDCJDbg48wnoD+PFc60Gs+Mbq40/T/AA7ZW1nbP+6ZB5SRehJ7n6VzOmwabqgu7az1FoFUbrdZLgKyrjd06Nz29q9H+GnjWLSbeTTNakG4u0i3LkAt0zuqY4f2UXyq8vPoTicROrN1I/dfQ8s8rUtA8Vf2Z4phLRs8cwHBHGPmyOxr0HVIV1PUYrrTLeYzEPGSFCiHI7H9Ky/jXfeGtTupdR0+7W41GGILuRiwA+npXI2etXenaThGBuANwbds4x2zW0aXPFTatIj2s5JKT0sd7YeJ9KtfDs0t9iG9jYW5hU52nIySfWua07UtTuNXh1Ozilv4YkMYknjwEJ9egwK4qFpr6Kby5EZmmEjrJMTE8hPJI6flXoXiyXVNG0WzkuruzkN4VAjgB2nHXkHpROmouy3l/l/w/UyjJ7voXLUXl1o8QiuHhUlZlGAVmHfNc54v8QR2+bB7ZHjC4LsnDE8YzXYX2k6rbw6e0U1rNBhf9FVAqgZHQDsKt6v8PotYZN1xBbSIFMpZ93Q545xXkunCMlzP3ddt/wDM9v60uVziveffY8d8F+Jxra3FnaWYt5Y/uHaSuPeuruo73TLAX+lyNBDuAkMmfLA7gD+Gu3i0LR9GhkeytjPIw2LIqYDkd8Dkiuevbi3n0+Sws47yX50a4EgOD0wAD0AqYqLqe4rR6nR7Wo6K53eXe1vwMyK21G/1u2M03lGCIzyRMcKcj5cnvW5ZaNopulkvLVb3V9g33O7KQcA4GfrWLeTSb2t7t3ughLLcAbWhAPCkHHbjNdFJ4lt9N002dlBbiSeMMfNwCZPTPTPet/q7m0o/1+pyVMVaLc9db/MS/sNE0eW2ubrVRBNODxFEWzx0z0zXC+KoFjuSNPuYhbiMuZFI8wtxgYPpmutsPGGlfZxDrsdvPLGmUEUfIcdQe3pyK4TX76LUbiSWCGK3tlyUSL09zXoUKTpvW/r0/I4KlaVbfb0Me9nEVuZbu4SV5hlI1XGPTNche20lwJnuY9iAfKmMsan8RakRJshBEzOAhccjb/F9K1/CWr2tpLGdR2PNzjfzzjg/1rHHVpRj7OG7/I0wkIVZOVRaR29T1mC4sxBc2140Vv5su4mfkRDvzWb4d0mTVNenl3iTRoifIDHA69ce9b0nh60ubuebU7WQQEhUTzgQ341oa3q1lpOmPp8FkljNgCJuZDzxu2j39axqYvn9yktWaUcCqTVStsv61ItXEEaXTAylIxuAQfe7cf57VV1/whdT6Lb32lbYZ7WYvcxStySRyfcEdqZd2F9NpFpqMs1xdS2Y+aO3TYJsnpjFaI8UyTtLZPbmzhMQKA8SM3/1uK5oJUlzLVrc7qqqYlxprRI5jQNLvdMuLprYXk0fm+UI5iPkH94H05qxq0LeZ9pFyiOvyklRg9uvb60661lLWxlgvJZo1PymfdliT34qHUVuPISOzn2xoQTcHB3eox2rCVRympP7+/8AX3noQw6jTcHr2XY4zUZ7qELo1uXEwcuXOTzngAn+da9po7WLT29/dvd3VwoWJI8hgCc4GffP5V0F9qeljSrXU2t457iQDaW4249T271heKNfiHiWzfTvNhijVDcYONzjJHueCMV61Grzq8Y23v6o+fxFFwmoTlfa3kv+GPQrrRrK3ttSngcPerYcW7xnzfk4z71kpqlhfab4bs72KZ7O4AzICC8cqNkAnuDyCKtQeJby8iskjEsDFHLO6N5oHGcAc9Cf0qz4JhntddaV2hn0yZ3OJ1CMhB4cD396yVROHNLf19UTUozhUcFt/T+4ZBB4c1A3TagtpBcMwljkSLywYwOMf3iO+K7fwha6DY6X59vB54JLl5ByTnnOa5Hxx4U0OxuptWukuTMHM6iKfYJAePLA6D8Oa5ux1G6tpoptE0TxBa386qVd5ZJokz6o+RIPyojSVRaX/C35/wBfcZTrTUVG2j7M9YtND0p4b++0HS4XuZmw3lkEsM8gZOBXNRanYXXiO8xYwtHa2uWvbeZoyrJw0Tg9yR+VOt/FOuWmpaPdazaQW9narIs4aLa5J4Mg28dK811yC6sob9ddshZQTMZbfULCaRopQSCN0eSen05rWlRTer1/r0+7t3MKtScNHotzpItRhGqC/tNTkmuliOyEE43vwQTjt2A44zS+DrS+0CCa/hXT7+xuMy3lpdTgyrGHx5qnuSarWcCaLpV/YXdsZ7xIY7nT4YVLmYuPv+Z6c9O1demnaW+lWMt1aJpDrBm4shbNJMuB5gTpyOCa1qz5YtJaP56fn/weooOEmtbfeVr/AF9rXQE1J9Ktopgd0izN5Y2E8dM+3WqjanoligJcNqVy5kBJ8w5I6A9hjtUouYdTBubWGcwXMYVGukI3KOQdh4WufurGG5vI7Zo4meBdzFG5jPb65ryJTUbpqz12/r/hz6XD4ZS5ZN9v6+41dUnu/wCykGkW9uZ3bmWXkxZHJArz/wAF60dG1qS81uOV5Y4WjhQx+UhR26/mTmtrS9ai0qzvje6ZcwXEbeUGJ3vMMnH86yzdQahq32bVNSlS3a43wpOMH/dP+zXRRm4RcGrrv1/C/cxxNGNWSnt6/wDBsdhaXF5e65Je6PHcHyV8qYoxwXx8r7PbnoeeagfxnZW1vdWlxdtPfoP3sgtzw+c4xnqMetauqWFlpt5DoNpdx28F1tMsscBDQSj5gwfqc/iOO1XJdL0630qPXbK9h16QGSKSNjhrhiMbSTjonr161fJCUFzLov6baa1PPWLkqto63f8AXYkstVtY9LSW726lJdRJJDBAnMGf75zWjpUcjaZ/aEl5Pp9uMbIjK6MxwDgDjI5615/oGswWGoXs2nwJZ2rxoGS5bY0JySQoxngHI+tb+o39y13HDqOqwziVVFrHKoD5x1OKzqQjD3YLX8fTTQ6KKqVXecrR67W+RovdwwEyRIz3GTt5z17n1Ncl4XtF1nU5ry7aW2ktXEjR4wGiBwEOe+ea6d7sadcRW9xp8kLRhC8xUlCTyOayrqOzS2uG0po4wGaR5Ebd3yRn61hTn7JOUt+h6Eqftmowdlu+voV9fnCXj3EqB/KBMK79gIPBz271L4G8MDX53t74I81v5ZSOIOirHknJbt+HJpfBOka14td5LtRZW0zssU4QOwTr+uK9juLvQPA+jF7m4itLdepdsvI382NaYZuCaW5w5riorlhDWXRf5nLeLYrHwx4dbSdJBm1WdFYmRt0joCM8noPQdK5y0spoPD1zq8l5BDfGQxqWzthGBkjjJOTwO9Yd7rkut69qGpTSiW3lZfJRTnYgHC8fXNSW/iRIYUedCJlG5oowc468jPHaplK9Ta9rG9DCSp4W3NZy3PSLrVojLp9ixkezsrdbmZnTaZmAO0EduVrlPD9gPH+t32p6o1zaOVeG1CSghRjrjsRT9F12zkieAvHExBlMeQOoPt7+tcC9z4psrjV10GB914wKdPNC+obOPyrsw8leWvK31eh5eIwsoJcutr7a69zpPGemS6RrVkss8V99kt0aZ5XwxjJK/L06A1uR+DrrWfDtxYOkbaa2ZvOvZS8m/qCB/Bx6V5ppPi+y0DWWm8V2s0mpCEQiG452ZOS5zn610rfE7R/7FjC6hfX11iVRFbHy42z03nHbFdtSFRxSjr5/icUZWb7nnuvaDcaPc29is5mjkBwEUg5Bzt47jI/OqlrHb299ENdt7p3Q+YR523JPYE5rcm1291/XrS/RIreSEFIUkwFL9cn1Jr0ubwPZHwsmtawI72/iUNKr/u1A9F9SPeqnWdJJS/4JvGEd2eP28Vu5uZomMZEmREDkj2q/pljqOqT3S6fZvcEZExMvyp7c8VX0u4gXUZGKbIcF15w2RyK07W+18W13eaPHKYkHmOQuefU5706nMv8Aglprfsc/Jby21wbJrQNPGm8PHjMR9MDFdz4Psb/xBpaWeoaik9pEcBEhAI56Hjg4qv4U8M6Vr+b2+mu7XUrjGZRJ95sdMDpXTeHPD6+GNT+z2+pi8SVSQM/OGzjpWOIrcsXHqvL+v0Hh6SnNM3LTTroOLOKKaORo1iS+uYQfN54XrnHrWPq2sNpN5LY3dhcK0QOZFA2E9zknA4/nWhbalb6R510ongW2kJ8u4YuHftg8nnsKx9WSbXra4tZre6nacFpW3AMCR159v0rz5WnLXX+v8jupRqUlfRL+rFm3/tDVbB3s0dbfgxrE6qWB7+h/GrGo+d4Tlhvnne4sVhKyRlAGQtjnPrxVSz8SaP4VtVtZ9QkiIO0W1zA+6MAfwkAjpXB+MvGcetWYhsGnuWVRFJLKu3OCSDgfUit6eD95NR0OKvjpyTi38j1K0vbW/lkN7bJ5n2XzYecswwc5ry/xfbNqMDyJDDBwQNx6eorN0S81C10e2EWuXER34ECIQAmfXrirOs6bd6NbLPcqkgnXcs4bPJ9feuqNONOV18tzGm5SjZ7GKk1tp/yXLb8L84xnPFcfrOtm4hnisE2xyfJuf60/xDcahcbl8ssq/wCs2jbhfX61zl5aXSK5SC62GLzH/d9P9r2rpuo69TmrVJfClsXbS0v7VWm1CEnzgSpPYGt3w5oEl9q9tKilt4bC59OuK5nRNTuJ3FtNOzIqhFDdRXo/gXTrq+16JNPDFYYZJAwPAGOv6V87iW/rEm+z/I93BxpvCxcej6+p7he2W93Ns/794jErSDKqSRkgdjjNUbnQsNIblVdmSMDyRs6c/U5IzWrZyKTLJe3PnyA/KFGzbWT4kvNRnsnhsMu6yAhQ+0sPc1KqNLlTO1UG58zV7d/0Nd77ahiU4VUHydAuP61yPiqK2bTftV1cC1fPyTfxDnOKRtSjhljtWkL3kzBPKU5+f0rPuTqlzon27UrKP7DloxbqeQP+ehY/jwPWnQpTnJSasv6/rsViq9HDxcYu8vIwtQv5bstHa2bRFv3VrctwzHrz7H+tV9Ni17XLiCMTPBay5P7oA55xjP510UlpqKaRqFzNBDMWMRghB37Y+MkY5xwOfarvw4trZrbU9XuoUtvsUTJvVm2yZ5JweeuPzrunRhCm3BbfPf1/q549PHVZVV7Vu276fkZGqWD2UJ0aQwmfBkSB+MoPTmpdF0lZtN1DWtNmuXuLBE/cuQRMCMcY/u9M0niDTTq8ia0r3KsdoUOuzYgPLHHIGOav+DYU0jUdXvLJ5LrTLpwi3Up2RqMZYJnk/TFZwi4wa+/16r+vMvE1+eopdV+S2IPDeoajLdySTSyW/lQySKs7AbwTyc+3Sp4p11m3t9XtYchfME6Skgyew545ApfE2jXMV7oVz4eEN1pExI2SSb9xbeW4444PU4qRtHt7/WtT0y3aSDSxgr5RKES45KD0yAampCMPfhp+mu1u+qNsPiXWbpzV9/6v2N+50PVPFz6fp1w9rbw7s7pJ8SMMA7kHfuCK6jWvElz4bM1neSi8tbVEQSQKq7RtOc89QQOOK5yK4l0y9sZ0t2uktSQzFPMZTjr9aNT067heS48PXFkZr+TzRFdLh8/Q9xx+FCrOokmtP6+ZjVwapylzO9ttP62MLxtr1vo2h2Uravcag925uvtEMGyNXT/lljIx1GQa39StraXT/DWsqyS294s8UsMieW670/docHgJjqfTNTo8Oo6Xp2iM2h2kkyC6WJbMSRTSKD5rsmOOh/KsCfxh4ftJDH4Vc32pXlyN326ErD0PIAPAye9ehG7Vktdfu27Ky/y2R4bbcveZ1/jCZofBEn/CPWCPdWFgsVyHjyXt33BlDeuV3/8A66w/CMB/tLT9Tu7kR69PvuHt4ZfNia3D8K2O/pS+BW+y+Kry+167W2F9byQSM8kaRM55wR39s1N4I8Pa9pviXUta1pLYWs1r9mheD5QwO3aFHXAx1rKUlCMldd/V9vM2p05Rmrr+ma/izTor+/8At8moTi1ZAYoEXaEX72Co7jGKxrMadqMEl1ZIyxzLtaTlGx057itmytYftl0/m3rTLLuzIMJn0Q+lc94ws5dNE9xBcTPdyp5FvZDhS568Z5NedJcz5fuPoqDjRio32KXjKCyk0htSS4VIIAWD4z8w4BrhPCr22p3GnyTH7ZKzkxbBwrc5JI7fyqxDomvXlotqTvghTzHg+0tg4IBXkcnmvQdK0SLTI4U8qGCVoUlGF2/e9PfiqqUlSjp1ZvRxHtZavRI2rOTU7fRkttQurd/NLSq8iCQxALyEJ/r1BNYOs3McOnWeiXrgGAyXMbR4iSZCflBA549vpUviG/WGBBNBcXMEOS6WxEm3dwu9ev0qgPDtlNMZb+bzZbuOJw0vE0KjkgD26VVOV1eWi9F/WxxzoqMuaCu7vb0IfCWkaVLqEd7dO7arPBI8UmMpGp4Dp2GwDp71v2UGgz20cslmjSxYRpSSZCyOcjJ7Zz9c1mWcosbi7h2xxafE5eF5GDHHqxxx7AVBqd3rUk6w6Xp6ySSj5JLg7FY8dPwOaVSs5StS/Pb+uxVLCRhHmr6eRsa/cXHiSSb+0rd7fTogAgzt8wDoAB2p2m6Pb3SR2CWu1rrKsix4UL3rQW2lWJRcSjdbRguwGVJ7gD60hgilnkkleXcmQGichgMjgYrk1bs3odkXGFPlpq39aGxBe6L4Ws7qS+uR9msyIbdWJQSP7V5Db3Nx4o1eXVdSkIga58zyVYSLHFnJIHY44rrfEljbanLY2zW8l5P5wAQuThjnk+wH8qx76x/4R6wjjhRrtkjBlMUeHkkzzx6Yx+VbKpanZLVmFLDL2/NOTd1r/X4kvhTTLjW/EcEEUUlnbNHsigfkxRj+N/8AaNeqanp3hPwlpzS6ksJncYBc5llPoBXnx8QN4X8Qrq/kvIrQMGt1x8zsM4z7f0rjdZstSvvF9r4g1FSGaQXHlkhiwzxgZ4xXRhKKqXqVHv8A1b/gnBmVeopRo021FJfebHiW/WXUTHYaa+mRHJENwpLHPGPYGsLw7qKazbmO2updPksHMawvLgZ9663xZrsWuamnnXdnZs2I43MoBPY8Vzt5YDTrq6lsRp15ZXMm39+wQ8Y+cE4weK7FTi4p25X/AF30e5zxxc0uWT5lbr/nuXNV0eyv7Nf7cEd95JHJcKznOcZ7CuX1mO2XWJkh0UadE6jMPn+bjI6jjgVn+I7pJNQdsvK4PzfZv3ZGMjkjrVSK6nR7eYzsYnb70o+8PY9zW9Kk4q7d/wCv63RnOopy0VkXy8kM8ccEO8ICNyvjGOhrUk1ma4skgmkumlb+F7g7B+FYJvUZVjMbpEwJUJyQQfUcU+OPylL3GWSWQGEmP5o/YenWtuhopX1Ru6ChvLy3gfygjtyH6bs4Gfzrc0S31u2v7xPsMXneeIrlCcKucZkxn8RXHWN/PBqkaWu1JmfaCfzBr0vQPA9tqNxJq3iW+1CZ3AePZIEVuxBx09uaio+Rcz2f9f18iZNOWhSukb+ydYka8lumtZQu5Btdzz93GOlEulatplhZXcdtJ9qm427djICR154J681s3dpY+FZ7oWljLdQyYKucfJ7ZJzkdfWucvPE73NzN53mvFBscOrEqM9CT/SuVRqTfu6x/rp6nRCdNRunZ+hs2fhi58OTyXGr6gpsywa3tzNvLNgscj2rJt/G8tvfXQa1jMLvuW5yQDnHI9sVm3ep3MmpXFpcm2W6WLel1J820HPYcZ5wKyNPKW8sTafPHNqCjy5vOj/d7BgAgkY/nW1OhHWU1duxzTqzklG+h2dzf6dJZyzXktnd3Es5mVD+9YsVUDaOw46VzmvaxDf8Ak+RakzpujZ/lXf6jA6AYPWnaxpEun2LS3kTCSRgTdwcZdzgDPWqWmaTJdXCiG4is7u3zIsrEBl+pz3qoxp25iLSTsT6Fp9o6D7fND9oP+s3uFKR5zkY69elUdRna8tYYJZn+zwgDa/OTjtgVLdW730o+wyFGU/OxIyT37dKrS3Ej6iwvRFHtjwwhwOfp61S35rl8tvdaMbVIElWRVXEY+4R14rOuLOGMB7i6k+yzDDqGIyPT6VuX7wSyieKPG3P7tWzx6msvVEgltz5kRKRfOqg9eOapWQTTauzlJLK1fxNJNZEmMDgbMBRXrfwYjjjutQu7hM2lvasGy2AXwMD36ivKEim/tVpIoDCkoCBCckZ7V718NtJFr4RnDMANr3nHG9FOMc+4/SvExKSrTt2t+B6OHS+qrS12y1d3Kaf4su9FdpIbuRfP+0TYKs5PQZrq/CmkNqF7Ok8csaiQ4aU53f7vtXNtfWMyxHxJLb3GpK3mK0kWMDORxzjFe0eEYQNEtmkkt5ZGTJMAwnPoO1OVOK0tr37+aIxGNq0KV779uh4d4us7LTL7WToEkr3qx/aLqS2wWgjyE2DI5zyTj0qr4btV1vOjLJcrbTwi8gZypmUoMYIH3wR29q7/AMfeGdG0MWV2qvBp251mtoSVaUk5ADfi3B61zclvpto7a/pq3sd5DPHEIYBiViR/GnuMZHtXbGa5LK/r59P66HkpOo/aJnKaFM99qlvb3fnLESLEKxMWACTlyOh46Ctmy8R3y3WqeG7m0t7eG1TDXka74JQR3JHPFa1pazjxNBczSiK4uoi7rIMLvBwc5H38EUnh24XWPEmp6e5gxazGPywoG1Rxv465rOtJST0vp+pvRhaabfc5rRisNjdwf2gRNP5m2SQER8HPuACPWtPwbrSX+oSf2taxGO1c28MWMbQeQRjgcd+9aHiXwbbrqWpzWNpe3LloiAWjWOQZ6D2HeobDSTJfW1vq+lK8zx4a7g4UFclQQDnisZVYuPm/Tt/S/I2hT55cz2ItU0fTrL/SNTmv7yxErpGsbFfLEhwqFfTtn3rT8P20X2w315YyWc0WYgsvXafpWrqV5eQsNPtrNgY8ZlOCoyOo9asR2wbUGLzM0iIBwOvesJVpSjaW/wDXQ7KNGMG5Lb+tbi2OxpWCxx+aCDkE8/WqerXDWUb31/aSW9tG5Anc4X0yKCNSfWY5LWBIokbE6BOZPTFaPiTX767vraytbRDayKI4Y5FGPNzjLE+n0qYQ53Zf1/SNK1Z0ZKSV099dvuOOttb0hYbi5sbuB7K5UxSouCAOMgE8r9BS+F/Dngi3uHikjjuL0oQIGbC7Tkqcdc7DjOaXWV1bTJZ7aDw8y3RVvLntYfknPH5EA9faqHhqDWJNahdZnutRgXy2guYkhZ+Bkc84B5rqpxmr2lp6/wCS/OxzVfq9SMWo69TTv9Gs7O9uLq1S3/s8Dd9lk+RQSflJySAevOKujbqVjcNo01xG88m0zXBJx0+6CehB4xXa3KzWlo0eqtaziYDNuYRheP7wOTXBRWV1oNyRpmn+ZpUeXW1iYyPuPpntUSd9G7vS3b8SqEuazjFKKv8AM1Y5V0e5sdL1Bx9plAEYZiAPTcT3NX9Ut5mkhmtp4GktZwZliIf5T1XI6HFUPFlit00UYiMMjIPLlwGaJyPTvW20o0zQUtFcfaQMPJtxk+uKyjJR3WqNqnNJRkt5f13JbGwg0+Bo7ZVjhuJPOcuBuJx6dq4H4m6vGuoR2Gj3U1xcbhvGQJJATwEOMcV0Ul/DIrPHuklUHJLYCcdcVi6bq2g6fZyXmuX1rMQ/mW4A3vg9Onv0qqc/aTva4vYOhFzvZm54e1yzFm8T2kUV8ybRaSWuJotnGDjrnqM+tJqrxs8JuIkF043Mo4ZRWZqHie7tzB5MUdrdXp2W6lC/HYnjjiqWmWjS63qj6zGg1nYuzaxIaM8gE9Bk8mpqR5k2lb+vyLow9lJOW77FUwaXrn9pW2qRz+bG/wDo0OcJONv3j69fw4ra0U30X2aExNNP5QLAcomBjg9v/rVq6Vpu+2eaZhEkS/ORz+FSaW93eJMtgv2ezXJaVh6dPzrHmajyLRGs+TmlN6tdXsvIq3iXkkcdmGRsryYh19s/Wny6edK0Zlmx9omfDc4xx6fnVG2S9mvksLWJhcJ+8yeAAe5pmuwmytFs7i8mnM7meQyHPUAFay01kze0ueNKLWuv/BMfQPEK6U13cam26WV5BaRxR7tsIGN5I9e1YqS6jqepQsPOtLVk8xtyjLE9ee2MfrWyvlqI4YLURW8UYWJl6DnpUaae+pPNZx3f2bNuzlgOQevH4UOam0kv69DpjT9ipVG9ev8AXYyfE3iGM3S6Tp9sl9MVDSDzFCEdMEnivP8Axbf6hHqMGk6jpCwXBULEk74Kc9Qc85FbfhPTYGnNoROzbifOMWMg+p9sn869R8deErKDw5bXmqTB72ONTFcz9VI6DNe7FQwtorX+tz5OvVniW3LQ8H1W21LSZGSa0SGSU7EUxZII5G3A5HvRbyXurxiGOWSYwq4YR8gH6Y5rvktdQvbm4ZmEzz2oC/MBNDC3O5M9+BnFUfCVtJby6g/ksZJ5JHkeAbWPPy7D2FaxrNLXcw5G3ZbHGRtqNvqljb3Fq4ilAM5K48s9xn6V6LBLpNl4eNnciWa4EREA8omKI4yMOfT+lV7yVtRv4tLmeUSyRbpmlJLLg4HOO4Fb/iH7DMy6fa2mLG1hdzJIvRFGM/Uk8VlWqW5Yy/rzOjD0XJOavp/Vjzu50S70y43/AGzcHhyqEcSPzjnsKgaeY/upC/mLKPMBXGB3P4V0GpRx6joUbiSRBAsYhckYZsAjj8eTWALuDRtfa41BhPBIXBYMHzkdBjtwDXRCbt726M5SUJWhsbr+HoZ9M+3i72XuxnRS4EZC4Jz6HH51e0z4iaynhw21pP5EkBwlzCq4PoCCP5VlzT6fq2kC9tLARkOWnAbyy2OhxnnPHT0rO8R6Lpdpb2kdozNIzEuQ2SHbkkjt7U1OMvdl38tP68yZTdrvb5msPEt1eu0lzey6iZEEkzygZWTGCRjoOgFM0O6urKyuokFrLEwMrW8uR5g7DqCT3rAsX1NbS4SNbr+xgRvMY4zn19a6Gy1KxsJTe2nmLsXYJJIhKADwQcdO3Sr9p0RKSjHYt+F9Qtm8SZ1e0jijmT5k+6oc9PXjk/pWj4zLfbtMXRRaDUGuRHAsLEq8Z5+asJdLk1y1kaBrRzuCFpiQy4Gdw9FweprLuHlkv7D+wZ/31hJII9qAOx9c+/vT5YSldaNfd5BzStynQ+L7vVZtOI1eB1nDBTHCWPlYBzj1zx61zTasZdJunmF0JzMkcIkl2EeuRj6V6JpurahexrFeXSW18Wz5ir5hWMZz+uOlY+oaTb+J9SmNxE11MwG9ol53dAB07cmohNR0dtO36G8oyjqjG0C01XU9POraXbGdYZxFgHftIGSSnHFQ7bi112+Or2ypOyHEqJ0zyvH0zzXRWl/qHg+SfSbSyQQXGZXi3ZKk/LyR7AVjeKE16PUZpNXt0tIJAhhEZ+RlAwBn05oUrvW1nt3I1v5mQi28UcjlB5sgBeQHgD0rmvEN+guGWeRohyIwDk4qLXNTktYDE8ok2/Mdny5HpWDZC4upXuHUiZiPLU9ADU1qyoR52zRf7RJUoo19BZvt1rKIpJBG2YoupmkzwMflX0P4O0C4e3XT9UuZ4haWbTXskRwvzkkQg/zrz/4YeFp7eQ6zK6hIUIhP8RJOCQO3evUdUsb+30+5SykwhiMXOR9WrxJuXLKpJ6u56sY81qUHYs22m3sHiWysrgwyM4H2gS2+7zcDnkDFdVe6PY6PfwW+lvNDLMTIAjHjvge3tWLa6/cNp95a3N9cRXWcxXAhUmMemM81a0rXdTsRZNbwf2np7fu2niAD2x9XU84PrWyqRn11/r+v6Rx1KWIpO8lpt5O5x+t/FC9e9fw/f6dcys1wI4rjythJ579OK2L2xu/Dtzb3t3KzS+ZFMwjBklkKZGDnqMGumgi0W2N1dw2sUd1NJ5rxOx5f1GeK52+c3806WtzcyzzvuRt4LW/+7kdKqVaKtbT9f8hUMNKTd46en9aEHiy0l1i6OqXMMl1BvSaKyj+V1ONnLdhjk1zGs+ITpkTWGkRvb30YGJIYxJI0ZIzz9e5rr9S02ebyPtF3e28sX3micASf72KJYGVuLaPe3IfOSPxrCVbRdkdtDDU46IyvC2pXlxeXN1dXzJZkjC4AaJsYIJHf2ravLwM8bwRbFGcTHlmzWQmiiFchAtxPIXMSLyT61o61o+p/2H5UU4hdcbXzynv+FYSnzPTY6VCnTs29f6/rsCXFyl5FHFNnjJb+77VDrGqi1hnuXld9hEfyfOzMe3Fa/hm0h020iVp2nnjXBldvv8fzrL1qE3moWEthcpCscpe6hEYKyLnn8eKIxV7NidVOekdjX0JZpFEpc7QoO48Ek/4VZuInMN0mmwSOXBM0hAJfjvmtqG9gtLCMQWxSWfmPA3fpXm934+mtPElxHf6Rc2ULyGElwQsnuOK3hTk43Rwe1dWo2427X2Okt9c8TWcam8MQtOiuyHp9RTbG2tNa1MapdLbQyx/fuQH3fTmr/hLUrLxDPY/OJLeO3yEI4BBrK8S31retMbGFYLLcVyowZX9ay5nFXubxgp1HSVPll1aWi/4Jcvb7T4LzZAZ7ibOBmEc/TNZ+r6pbzyx2K3n2G4D7mhikG9sdj7U3SY2/tC1VQu8Lud2GSB/9apFXTI7i5vtE0sQXe4mWd1DNJnqfrRGfV/I0lSUJKKV7dS9JYXCGK+kGI8BYpCP88VV1K9SGznuZUkmlVM+Wo5c+ntWmdSmnkhScjy2GRE3Vc98e9VL9pb3fZC08uOPkyKRkEMDg/WrSTZnFyuudfd2OU0lIv7Jht9QtzFcXk3SNid0eMnns3rn0rntd1zw5oOp29ra2qTPbcRzFdyq3oW7n+Vdt461CSw8NXUenokIV/IGAAEkIO415PDY3TWkVw3lzw7Gz5qCPDd69ChQjVjzPRf1/wxhUxc4Sva73110PXdN1uDVpLdtSsopoinno5Tpj0PrWvPpv9r6otza7re22jc4OCw9PpXnfw+ja50+9Mm5JFkRUQ9gwOce2a9pi2aJoAup4VS5aIBkz8qnHSuSpRdOTpyd0h1cRGMY1KKtKWljntOtrR9Xgs451SyQf8e/QPj/69Y3jfXJEuIo7eWOzhaXy4gR8uRyeO/ANCeI0nZV0OztbxiWa5uc8xBuAB+NWJ9Kh8RWlrBcMlrfQvtgd494B9xWfLaSUi7OH71rRK3f52Rf8P38Oh+FZ764kka+v3eSGO4++q9FHsO/415hcayNZ117SU7LlcOcnjvXQ3tvrup+MrnQ4bcTPaQCQzSttQ9sCuI8TeHltNQgWaF7i4V3mJtmxjYuce9YVFOtVUXomd2CVLCwlUjJSnu/Q2LnVLfTbbyNRu4pJI8uxhU7Rz9360lrrej321bPUYnuXB8uMHaW9qr6v4a0m4/4l+hwvBe3cMU2Zy7L52N/Ppxmuo0Ow07RtWsG1K2ifUMeVHLHHhWOM/hW0sPTg9U7v5dP8/PoTHGVZxfLbT8TjT4XnhuRHPf3emedkJ5o3ljx8gweRV/4karqMulWluI2+xwMsSrOSc8cuO9et3N+iX9gJdGmuIi6hbhVDLGfX61xz6NZX9/dxnzkvbwyu0SSFzBydrDPHPpXZCpPRz1S1PHkoSb5Y2ZwH/CKeffaiTbK8SqBA7TcE9yTnIzmsuXzPCutNsmuZdPKiNmkTPkv/AHM9x6Gug0DTvFWqM0Wn2TNHkp5v/LKUg4Jb0/Gum1Hwsmi6SR4iT7VqEsnCxyfu0QDOcdfauirOMY2nK/kc9BP2qUNzj9V0zU2tdPudOjnntp0JIRPJbeDnOT2/Sr0aandahcxXU7IstuRGiqNmT0BI6kEfrXW26SyGNrmCRdKNuQWkGVznhQvvk89Kx9cltrTT3eNvJLMEVl2gJ6deK82Va9opa/5nq06UlzSbukeczw3mkWk0b2lxqEsMsc8qv+72gDjHqBU09tBrclpdy6bbWkSy7xEuQSMenrnFb9xI894rz3Ql2/J5S9G+vp3pt29nJj/Rof3JyCueDiqq4yTV7a99fQ41hFCXNe/3GBfXNxZw3cMBjMJAAIICIMj5P061gwal4eu4lbXJib2R9xKqd6YPIGDjkfL+NT3GmnUpWjiIhiibzSfV/f1rLuJ7CwuLq3vkRVJVw0C/fP8AhTp1LJLr5Hn4id5s0/D73WrXM2nRSXEOnmYPsjyQV52KfwpurxXGkSfYgXAk/dm2jxvbnI6dM1W8G3OpI8qaSyrIkfmMGOOB/eqXVrm/1K8s7u5hYShGZLiNgwVu3Su2nVafkZpOWh6FrfhIjSLW4nubsvDGm5ODGoIHBT0FS6RopNhJq1jaRQxohEmWwr4PO3bz2rmLLxXqiQsNQtrqO9dcJKDsQ4PIwR7H866vw9quqCw8iC9tLKCYMzK8eduTxz071oo1FFJv+up006ivexHZ6hK8t4ryWVuFHmQK6/K/PMZbr71J4NkuYpjf2aiQyTEvKgBOMYKgehrm9Ujhsry6E8qSoJh5bo5LM+MElPxpLPVLSMNDdXt5DZbSAsQBJbv16ZrdUkldfl/TNOeU9Hsd/YrbXuo39xql+kUtrLGyylF2+WOo/PPvXmnj/wASW1xql4kN+01kX/diZslV7AZ7Vy2ra1boBZieV0Y8D+WawxbPP5klyu+QnMYxkmsatWlh3zSevRF0aM6ztFfPsVL++trq8EcISSFV3HC/x+ldP4S0KXWbiFLQCTkA84GT0qPSvD89yiTtaJgcZPANe4/DPwetrp7TQSlbzGEAwmOhL/59K4JydeaqTVkuh1wh9Vg4pp36nUaHpcvhvTjpcumA3LIuJUYEAc8e3JNSalezLp+oWs0exiudxGT06CtTQJbW8t4/7S1Gf7akx3gAfMQenuPpXR6tZQ3FlOzeUsToxQgDjjkc1Nd2i7roYwr+yklJdTzrxJ4au9UW2W7hkhKN53k78Bj2z9K5bUrbW7DWN0N9CsIcK4icq6j3I4NeyeIbjSNTiUXu9Gjy+d5UceuK5C5aG3tp7ZpYntJ1zggHI9a56icXf/hj0sFiZVY2lGz6/wDD6/cUWn06604Wk4a4n24YvnJ/HvVHw3oT6NlrKe9bexYySSCXyh6LRcW8+mQ2kzJ9qt0BCsPvgfTuK7Tw5rOnOvlPZG1lcAsGOQR9Kzg5SvF6HTiLUo89OPN/X9dClp8V9dOwjUXEsgyxlBcgev8A9arOt6Nd6ZpouECzxkgOQPmX8O1ZniIXUNvLrOlTqkluAWWPgMR3xXY6N4ottT8Ew6lc5ZnURThVwRJjnirSjdx6nBXqVafJVppOLdmut+3+RxGnCSFTeyyGNQNozyQPWtKwnsb2LzpbxhG3XKEFvpWZDrcUzOJrBoS8hAVmwGHr+WKt28Ul3q0ccTW9uJOLdTnJ/PikklojqqqT96a5fuNaTSjeapbCOXybYNmVMcsMcD2rz/xXo2qapr/2TSZI7WwLmFxG5+bOR8x/Lj3r0bVrq/sb+wtrKzN7u3C5nchBBjpz0OTVGTTrC2O5HQX8lytyQWLRhgcjntW8OWGrPMjUqT2enb+uhoeCpnm1i5tVjY2+kRi0DSD5vM7n6YxzW94utNL1TQbq31hB5AUyZ25Kkcgr71z8WlGO8n1CDxC1hJdEmYBFbzD2PYcfSrk1zYQLbTNcPql3GdsaY2hmPHTpWl42TX9f0zglSlUqc2t/JfrsYPhDQodF8KTeXzqF3A7hlGNi4PB9D04qrJov9mNo+nXrtJNJEXeUjnJJ7ewrrdbu0iFsNQtQrL87LasCy+xrlbnUrDUNXung1CY3S4IMsbb1X0GePyrGcU72PTwtSrJ87vZ38/Jbdi7JNHpzzQ21uZ7dcEzKc7Rjp7VHa6lZfZQulW5nnbk3E3CxD6Gsm7uYUgFt51wWLZZd2D6DI7ist/Liu4rszNGi5Ah3Z8xvXA61kpdEd8cMnG8/+H9f6sXNU8Vw2r+S0scUsriETuvz/wCAFVPCa+JbTW9Om1aSG707UA8wlVh5iRjByR0H3hxipJL46hY2kOm2UU9wd5mini2SKB6A/wBat2sZLSpLcTRxQ8ZjX7pPb2rdy9irSWr/AK+Rn7NVb8jsl97Of8WW99qMV/psE6zRfaWYtGwB3DI4Pv0xWboOia1b/Z4f7IVRJwTNLvWPHTmu6trfRft7LFdXsPyeazeSNrN35z1q7dalax28H2aQyheGZuAtXQxMqMOTp5/8BkVqEas1KCd+uljNkhtrD7LHOC/nSjz2j4IwOf5YFWfiFeXPiuCGx0h5LaMkES5I6elVorKbW3mh0+AyxoDuuCSi4+vYV02maRrFtFaS2j2M1pkPMEO4uM9vfHNYe0lN3Q6yo0eVya5leybta/5Pscf4XfVdAMVhPcs2oGdDgRBo2j5ySQOuB+GRW/da5b6JdvrF3eRC28zypImX16fU1jajZi78YJf24vrXTrOaWGeQK7GQdOgz8nBO7pWhFpltd2Mw8walC7mRPOUYGDxj6ZrpqJOza062OWnyzvzbv8maGuXcl1b3N5aStB53CsnBzj/9dc5oXh2Sa4v2ubs7/J226t8xwR8+71zWmxeeKLJK+UAW4xh89PyFUri1ub3UItTgvwtrbMyyW6rksxGP5CsIu7d9jsUOSHJHT+tE+5f8PQPo9h9hnXdGgO1iMkKSe/Xilgt4LsOZJQm18HnoR9OemKXUI5nsraa2YL8sgI6EHGBmq+jXsu2CNrWKW+zmSSIbd56Zx68Cm2pO8gUWouUPw6WOo0qFEEg+3vDz1U7xTL+K8sld7bUomkI7xAZH1x+lZ11cTwRBpLYXG1SxwvJxzj61Auop9giuXs7iOeRVJiY4MZOeo9BV2ujj9lJyvvfyTJoIri/kkaK2uJmjOHlSYKM9efSqU0tvpc7PKI3mLbj+8aZs+hzwo+lGkTSayzR2F9FAif6wpJuAPocVZstH0trq5klu/tcMSmObynwVf6Y4H41Cg2bznCm7TfyV/wA9vuOR1/VDq80f9o3kUdiHIeIsQ+QOAAOn41h38Onaq8QRpbu2bG07wyqOvPPp7V1w0eyh1ua7nIumkOYBMCPKUDGAM88jqa4to5dN1Ke9mglhQIVcGTcJSTxj0x6Vfs4/Zeq+RKqT2cbRYmpWVi0l1caa8qHZ5TRoQOfX61zOo2XnSKbeQqMmR5RJkNGT0/Oup8P+HZxZXFxb5iu5ZS7CVcK3p+lZerxWkVxcWoljMyskcyZI2Dr/ADrOSak43vY8+oo6OKszi5rKQ6kWhvmt5CMtC6/J6da5jUrKeMJ52x0csvnJzja33aseIdQuft+0ho1R2bZnfuVW4qODWb5nNqsEOJDwAPu1pGnJJM8+VnN2LPg+5ng1OSG3mNvI42JJjO7+Jfl79K07J1vvFkwllwrNt2JuCbtvLf3a5gu9rqKNE8qyRt177v8AZrodM1OG10yRnDS3k25JZGwdvzfKR6H3rqpxe6W44w7noGq6xc22qWlhqVpZmOUfugwzgZHXNLqFo9g9wzXU8+mzy5bZsVEOM4U8nAzjPtXnF1rdxfzxSahLGwhRhlB/6Cap/wBuKYdkUs5UcmPJbNdtKjayWhupRWrZ2M15BZG9uEXCMfkOclhjGfauPN891O0NuxSJPmkY89ap/ar28ufKgjd42OcN0H19qvWiiwjRiFJkb5AO7djWeMxKoR5Y6yZ3YOg8Q+Z6QW/mSaZ4dub+8jtdPtDJcOcbe4+teveBvhagd21CBr2VR83lv+6T2JJG4/pV74PeG4gJb+RjJcneq++evHrj+de0+HdPlt/DcSGYrMyF1VFHy+gNeZ7Pl95vXqaYrFqnpBWXQwPh/wCE005DcTW1tHb8+Wki72Hofarmr63p+na20c0UUtxt2oQgwue4FbXh20mjsRBcvLkhsFh71gT7NNuzd2lr5s0bAlDyW6960snI4Yy9pOblr5FO7El9bn7PF5aA7gzrtJx6VVGqCTwntN2Y5g5UO+fmx1/pW9ea6mu6FO8Wy2jbKqFcNKcdfpXD6iUt9Gme7jISCI/Zi3Vn9AP61FVWhKJ2YZ+0alNWs/Uu6n4VsvG0pM8sttcqmx2hkJDjoePx9KzovBj6bFLY2mpB4YSRGjnG0envVjTfEEumQNLZuxuRgBAPlI9+Kzb/AF3UNWe4eKGT7QykkngZx2rjlXUoqLZ61HB1qNWU4WUSOzims7wCF0aTDbd/AX61qy3k8v2SUqj3ECYkd8qrn29Ky9Ch+36av9q22yZ0KyRsc7jnrWhPost5+4t5GWLBAlUdD2C1KjyrlXc66k4Snzz7EGp3bhvKTCwzKVnAOQM8g/nVbw/e3Vjpr2LW7SxtIW/dDPbH6dauaja29mXj8tmmhO1ie/4Vp3+mRKbO8gt5YGdAs5ViFA46rWaptzcr7BKpTUIwtdP9Opo2s9zq+n2cFqYxOAqSedFuKoOu33NaEP8AY+mahPZz3PmqXE543eS/91PSuZ1uz1ez067XTHe33c/bfL3bR7Z7VQ8CaHP/AGDeTXWqm7Ny26GZkwfwxXStUl1R5U6MNZc1oPtbf89PT1Om8XeIFnxbWMomtz8ohCncx/CsWZZ7S1P2tDbKSDtkJJBpt3os+lWNzcSC6cxgFmjUlDWxpUkt7poiliUKT8xLfOO4P0qLSlL3tDpj7KhSSo2cU9e5zkFrZG6t7jUJLsr0hmY/uwfXH9a25dZjsL6GZgLiK2BMSpyGb1p9xpaNA32q5ZbaPIAYg4PsMVm20UEOpyQWVoZzEMlph9wepHQVLdSNl0L/AHVW8nrvft9503gM/wBuXt5dXNhI0YAInuPulz1VR7etZD/DfXW1e4vp9TtbjcSkUWGVY485x9a77RZNI0m22R6jEA+CTLIqjPt0reVgyhlIIPORXb7O8bM+bq5jVo15TpaLpdHiuvaZ/wAI7Mxutkl1JGMyqODgfdPeqvhjxWY9SnWKKOJ1k8sRyMG8zjOQD04Ndxq1xbXPiAyI8JjBG/zFLkkDoB0FYWu6LaxXjXNrZ3DzXkm52hj746L2FYzpqC5rnt0sT7aMadeOrWv/AAxfbxPqN7cC0hgsoMkh4+5Hoaq6nZfYtIMVuIx9quN0m1/MYYHAHHAHNS/2XFDokMt3A1vLG3+qYbWlB7ufwrStbvTQInkhEirgLCrAjJ6mlGLkveMXKFJp0I6J626tfP8AruYlhay3oNvpthcXAHymac4jBrpdJ8CW0e2TVZPtEg/5ZRDZGP6mifVrjy2t7TS7ixmjOYvNJCtxn6Vxur3+va3cC3l1OayTbgiEmPnv8w9qcYU0/fZEni8Qn7JqC663f3q/4WOj8c+J4bUf8IzoUam+nXy2YDEVtH3JI9u1cyl3f6VqMFppt8VVVWGNfuiTAwOO/FacF7YeGtNknmCtfv8AJCpOS749+tJ4H1UeJrdrzXbB01hJfLt4/KIKEAZfPTnk/StpR9pFJOyX3k0VHCJ+5zLu+r0/D5i6bo7Q2FzfSo32y+8wTrIwBVM4HTscVj3GoyQwCOxilnaSQW4CcbecZ57cV0ms2y2niK5MU8t00jbyu7IjBA+U/jn86Y0Jm1MedC0CwReaBtzg9jipqTb0NsNKMY87W+pymoajfW95a6Vawy3d/cPtEUAzsPHzOewFdbPptt4S0e3tnmEuoSfvJX6Bmz1qTwhYpoUV5dWpMslwxlm3D97KfU+g+lUYrI3939r11y0zKWCn+EZ4XHrxS0hG0d+5LqSq1G5u0I9Fu2V7/wA7U7Wwt7UKpSbzn8s4MmM8H/Zyf0rV0OzMUTwBI2ll5lkkPyjB4HrzzWxFowfT5msdltMepY4wvYVwHijxFD4buhb3l0oklIEaQ5YvzgYA96uMXdaXFGrGupU6bt6noD6jaaVahJFjll3gFFf5Bk84J9j+lcr4r2xazDM92kNgn+tBHJx2rA8J293rkmpXviH5dJsLlysMkZQSEY259cetaz6oh1KS41iZrG3kYBCE3OxIyODwAfX+VdDjdqKV3/X4mFJRoylO+3Xz9DofD+kfYrqbOxbeSMsYljHlg56kj+VVvEuv6VomjtdXFzaySglWaBdqtg9MZPNZOt+KVsHXT5py1pMoHmPGYXQnjkdD17V5LqDXRv5tOtxE0au0iyoD84JzvPvx1+ta0cPdpS/ruZybk/at/L/M7TxXq9peLb3ULySSTOUjVOSgAJ5FcqdVEiu2ogzwq2x7Zlwxzg5Az0qtZ3qxX8MyHdbyx+WjOc8nqAB0+tN0ieOz1I37oiBAYgIm3hhjAPsa6/q8Yx1X9diXVqN2jsWNa8VX/nNaxQGABA8K4KbRjBB/SudnS4vIri9E5VmOWfy/vc859c/St+/1BdRvJ59QkZk8oeSoGWJA7n61y8i3F7FgJJG+PMx2+lZqlZWirHPKEn8T1MvU4JnkKPbph+S6N0/3q5zUcw3Uc6ypHOP467HUYWReZ0MZHADbT+NcBqEUkl8HUI4c7I0b73WpjSS1ZFWDVlFaiXeqSsoTy2yrfKy/earOlQT6jAzRDy4j69q3YI4Io1WK1RJD8rdzQofG1cR+iDtXmzzBq8aMfmevRyhJqVeV/IqppYjuA83lbFXiMN8pb/aq1JHYyQTReQsc2eH2jCey1IljI7/OrFfUtVldMlm2Q264bG87j/n0rCeJxM7JyPRpYLD00+WH3mWsiwySSQA8pj5K1dDIkmCyROHxsUsP4z0NJbac8rb7ZoUKkcL6g+hrq7/wwug2tjf6r9oa0vmMiRpyzAdvbNVQw8vac9TcVavGMOSO3ket/CnUrOwtAJFeObyhETtJJYE54+teg6nLcWOkC40hlZJSCxbJ5PU1876d4vls7m01KK0NvZbiSjHLD3r2jRNXg1xLWaSJrK3kH2hZVk3I598dq9GrTa95nz9WCcrpG5bwazftZGaQxQBR5yrwGHpWveWa2lq5tUkLngADdiob7VJrC3VoY4p4wMlhMMn2AJ/rWUPHNvvWOSCOBnGU8+4WMfjmsFFzWhyN1ZWcVp/W5jaJ4Wks5HvtWQvAm6QR4AwPf39qoa/e6ffoiXOg3eTkR7J9pAx1IHNbEuvSatA9tD5suoM3mRLtxGuCPu/3h7muX8ceJLCy8NajKbt4tT2FWkzt+YD7oA4I9T70VINxd9X/AF2OuFSTleej8mY+mW+q3GiyGwmjgbGwSIvI9cDsau3sN/Z6fHPd8+bkA5+9+NSaBdz3EGNIt0muZfvHyj+6/pUklnqaIItVtJ/s8JJdzkgAnPGR9K8lfAkj6qUuWs27LXbrb/h/vMq1t4Qi3mp3qwWync21gTj3rRg1KW21Y/Y32L9+E5+XZjrj6VjfFbw5NeeGbOPSryGC2ZhNLHJDgygdmYZxUmlyLBpsS2gIm8hItjZLLxyAcdK1lBQppqXvX2MqdWWJqSvH3bWV9t/63NmGL7VrAmuLvI4b5Rt3fnXpd4y2Gg+cltHJEEBZJe/pzXmWjaoNFPmXENtLKRk5BLD25FHiTX7zxLd26vcS2+nwjcYIDsaR/wDaPp7VdKpCKd3Zs5cbg62IqQUV7kepZ8Q+Nb7UGgsobGBrRjtnUyY2Rkdfc1TuPEFpFbWyX1xHp9jGNkEUIwMDp61u6RpNmujzak9sqoT80rHIX8qllto7qz87TLeO5liIJWEbhj/aQ801zNrm/AS+r0240o2s7Xeyf9fMdomr6jfwg2Fre3FnLneZEIyP+BUiPYaa5gG/7WcArMCMc9K1tD8UTPr39nNYw28B4XC+WV+oqh40hMOthLk+ZJdwkQsBjaemCfrirduXmicsHL23sqkeW6vo9/Uw9b12efU0trooZIWQqF4QcjGR9K0dds3sEvZNJIlsjhpmU7iT6msDU4JZ7E6hIo3BhC+ByDXU+E9VtY9KOnxuomlU8AEk/X0rmheUmpfI7q0fY04zpK9tGunS7+XQ5nS2ge+kZpX/AHsO4zSRhxGc8qozn3rqNG1IXsvkPdsbaJem513D8KzZtQs9NsWjsYds0n3ucZ/TpXP3mrQ2sW+eVbeMnPzSc/QDvW3tZJqLd2J4dVVJ2sul7feen6TY6FcLJc2TvmNiGZgRtI64yOaqS+Iz/aBj0lbm5Lnbgrxn8a8wudXv9Ts45vtBs9MibaJrgtG8jZyAFU559xXRyXcCaIjzzyWsxvFDNHwyx9eK2lUildaHFHAXk3Ubn0XX/gnWXy6hdsRquniSMqRgN0/+vXNz2uiS2xW1tZ4rhTggyEkn2GK6228UyalMkWiWn2kd3lbYAMevr1rF1q817UtYlhj0+3s47Ng5uPM+Y49H4z9KifLLV6meFlWhLlklC2vxW+9DLbw34hubCGKa4CwB9yrKx8xRV/UYLfTdYhgkzFZC384y9ZMg8jmtDXTK+ny39qs81xLCoNr5o2p05Arzy3k1PVtcXTT5stw0W91J/hzx8x4A4o5VD3VcvDueKTqVJJRV7pWXz36dyn4i2ahPCuj2zzRwHCCQ8qOmcgelbXhbTdV1i6a2SaW2sYlw85Pf+6o7/WvQPDekSaPobQpFGLs5Y4IOT25q5Le2Omwq1w8cZxg/w/pTjRu+aZnXzZuLo4eN7aJ7/O1ilpXhnTdG3T4eVxyZJm3YrE1S9gs7SS6vWKxTO1xcdiVH3UFYXiTxdNeXbRQttt1PCr3rFEl1qFvLJeyrJbrwPl5PbaPX61DrQXuxNqGXV5fvcTLV/wBWN7SNXjuYpdcvAbKLyjNEj8bV9PpWfDqgv7u3SBzHGymaabbyU6/rwPxqzBY+ZbIzwxqjYWFZfmC46cepNcva2lneySxXFx5WnJdvDcTxTL5z8ZyST0yenpVxUqnwo2bpU27+i+X9fed/DctJdeSq2EdpNH5UjtMfNwRnIHvXHaroMWma/Z2mn6eL+28vHkbwgjweDvPOcn+dZlh4K0+e9WLQ7u8S5sJ/LkaXCnZ1G4jqMYrqtXH2CcwQzboto+Y9SQetbus6RhSoRqStF6sra07a/r2n+Hm822sI5N14FyNyKu7aPrwKm0lbXXZftN5PNPYpcyLHbyjjL/KB744xWXNNd2N3LqSXhku7iEqsT42hRnpnuciuM0HxzDo0TWGqsXRHEkIjb51fOe3p9a6MInUg+Xp+u/6HNjKapTTe1ja8bzfbLaS1s45dRh0lSspkICqSehA6ex9q5CCI2lnGYGaSRVwNp9+ma2dZ8apdofsUk5kuY0g1ByoERdP40zyc4H51i6Uzww3dxLcSRsGEsB2YOc56HpivRinGNmY07PUW7+x2MUJg8xGkGZWkI4f/AGarfb4TauU8ox54G37hrC8QyzancQIqm4mZXkyJxGE68v8AgM1ykU1zBM8c8piMcTSvHnKP/un0q4uF+VvUJVZR6aHcS6hBYzsz7P34H3B096cZGlmNvb7kjA35Hc1z8V/FcPBsddhHyIRt+b0rQa8ihRsFhP8ANnB6e9aci7agp366FDUX8pnM/wB1DufA6VnWUcT6h5wgyq7sODuXc1XdTuhGGmc4GM7z91/VaNJtoh5lxECkcm0BFPH/AHzXBmdRUsNLz0OnLaHtsXHy1Zo2tkv2dJEQqSO4qSDR3MySuuRn/drds4o2EZm4RRjAFTeZtlRY3Hl5wwHavn6D5Yn1dSgnLUgubHyYFfOQP0rKjuHFw8lvsjRVOWIzwR3ropopL+QWyrhANzY7iqDabbfvBFMA0Zw2O+PrxVqfvXJq0rxsjuvhg3g06cG1phJelDGrscLGnpjt9ea1dKn07Vbi2F/debZW7nb8p+UDgHOMYxXlJhawgK7uH6YxkfjWnpmt6paWZt0vzFajH7sPhfxx1rq+sQlc8uWXVIttS3/D0O88Z+FdBldbyyupzZv/AMsmUgMewjIFc1P/AGp4R0mO2il8mwkOF82dSYvYqM4rA1LV7yeWUfaZH8zg7XKA1kGC4CsghQxgcKRnNOOKSXKtiHls73lK50UfiBbdGWaS0dM8yzhosn0BB5+uKrP4rmW+E+maasJQY85NzecO/wB7r+GKx4dMjvbiNJSzvjOGHCioZtODSIJB5irx7CtI4pX1X9ehnPL5SWj/ADNS58fz2c5dIksRt2bYAzsfbk8Vg3+uanrFvPMID5BRsTSDrx90ZwOPYdTTZ7pLWD7LKqBM5A7D+tU9R1mR7BV0213RgvEJRGAAe/8AOnLE+0TjTRyywaotOrK39fefTzzqlrdTaFOywRsMbE/eKPf1FWNAl1TU38u4v2FoVxKtwVH04PNc49wLi9luWAWMj5lLAflW5dxQXukWc+m3iJdQgGVyOqdNp9a8un7zsehXp+zhZrV9bXa0/rU1rXRD50dpNqFpNbMxEY27jz6Vjy3rNqMlrZ3bBLVijSC3GFwemRVTT/ttnq9jdX8nkQw5MLD5lcd8fnUluy3xaDSreCNBliskwBOerGq5k+hCpSjK85KStvpZPUg1d01K8iXzt0IG0ykcn8K6nwr4Tto4fteoPbTW55hC5A/HNc3YQTpbTk258xZARMvbrxXV+F/EbXNheWl1EsL26gIF+UkGnTjFyvIzx8q0aPJQei0ex0xs7SOwuIS4Fpc/KqjoNwxxWRo8uneHZv7LlfEuM+cy43DtUKXFtfw/2fBK8B3ZyWBIPtmrt3LpOl3ESXtwZJXGUVyCOuK6nbdHiKEop0p3fNrZb6bMztfF3dTHUdIthKIOSCoy5Hp3p1rq1ybSebUCt7HMFQW6qB5ee5z9efpXWWwjCfuVVY85BXoaivrC3vYJIpl4fqV4IPqKbjrcyWMhyqnOOi69bf12seZm8it7S7je1BtjyyDIAf8Ahzn8aq2m6HR2eIW8LTEsNvBVFPf1zmuh0vQLrwvfX0+oag2qWV620CcANGOuCO4FY1/svdfmsrKAlXiJW5RBsUnjAJ/iHXpXPOm76Hu0cTCfwrTR3/T7zP1KS3uIEmkt1abGDsyA361y40ZNbvdHnmQW0m8yLHKgfzee/PHbpXqmgeCz9m36hJNG/QKSCxx3Jrorjw5ZXL2klyGkktuI3+6QMYxx+H5U4U5J8y0ZFbNcPD90tV/VrGRpvgXTGv21LVIjd3bgBUkYmKIDoFTp2q/J4bsb3UPPuIkaFD+7UHr35q1qf2XS9IHnFpFhUKi7iCfTpXLp45sI782k8FyrA/LMRz9PetZckUlI8yjHF4jmqUW36fpqdTf6Gl0kSxXl3beSP3fkOFCn1IxzXPXGsS2mpWdhqMf2i/SAuxijJUc8Fvc8fmava54g228SwefbB2G53TDFf9n0+pri7vV7/SNYZovNaKf5pJN2fwPvScow1RvgsLWqxtU87L89TobjWL+6glgs7QiXaVkuduBHnrWjo1xbaJo5uJIcLtCiT+OYj+dY+laos4na7Vls0G8wg9frVKW5l1y/lvpSFsrUARqBx7Io9al1DeWFUr05R5Yrfz7L1/BGzaeKNScubmzKrIwKIF5VfT8fWsTxZYX18Z7jU7byEkIOS3THQcUt3dagbiGPTJS+pSOMySLuVQOSAKn1a6QW8trq8ZmvI24mD8A9cY71Lb5NWbUaao1VKlBK/be3lqctJbwwxEx5JJIDEYz649q1LqKCxS2BZvP8kTFRwqDsg9TUdq8UdqqyRjzJJd2W/uDon59arRX9zc6zLLNCjwzwMN54EbA9BWEIXeh6NWct3svx/rUfqVxL/ZAkn1CS3d082EkAgE9CSazfD7xtLCmo6XbCFcmMhRII3I5YD2NLbajZ6LdxystrHe+S6yWcavIJo2cnHz9ztNWrWDTbK2udTSeexhkbzhA/zbc9R7V2TpOmrpnFSqqo3GcdPIh168uoIt3lC633ccdvOWMaxnHV8HLc9jXEzQ3cF3qNx4knvE2MvlmLKqwH9zn866KE6hNrcdjummuIm+1QtEAkbIc7VeofEl1Jc3EVhfwLLMRI5ty33QQBgkccc1tTd7Ra/r+lqRJezvKEr9l+BxtxqltqtxaWt+86lIiY5g/QE8E49wK0NYsNP1DQxdwwub8MYgGI28fxqe/rzXKw6PAmuTWEU8MQkbyhKzYVscjnsa1r2ZmnSz1O4MsClxEY/wCA9/w969FUouyi3pqcHtZ6uSWpWTw6+nxxW09y8wdgZVI5U9c/TGKl1m5MUF7ESZHcfuGPBA4xj8qVr+F23pez3FukQKjuBnGKkZmmcTXLpJFtAgU8FFx0Nbpyvr/X9fkEYR5bI4nQ5btNZn+0CMFkAVJMqKi1fSr+7MnkW6tKp2bQMgDPrWh4i1GQXsJspPLmT5BIOPlH8NOh8fw2mjTafJbeTekbS8Y+Y/j+NcmIwdR1o1qfz1NqOLorDyw9Z+nmYg0+80uGK2urdXZHDLt/hNbun2SXzedcM8FwEO8YzkGqLl7mdNS0u7WSHeEZJ+CPlHOP+BU7UfEht5JLGFMXFuMeZH8wcc769TdWvqeZFxjZtaEOuwK9t+7liEartjDNk/j/AN81d8LSlrOISRgAv29e9YKyvi8iiMU8f+t3kcturpfCyiSBP4eropNeFnU701HzPfyCP75y8jq4Rst3c8bazkDzO3lgj0x0rpdHsnvUe3WIvNMQEVRyec01baSwnlgmTY6kqY26rXmRhywUj6CU1Ko49irZN5MF2Q7AiPBA78jjNZBMklyyITjHQdK27yPy3AY7I3UPtH+feqsEH+nSSFdqHGAKzqc1tNzWEU3rsJbxIUWO5i3KOjDrWzb6dYyWmGQg/wAIFRw24aIjCbOufSq0UJRuHK89e1JzaWpaoq+hm3sf2eaRWhAiz8uB0FQ2er2qXhiaTyIsfe8rqf8ACurbTo72EIXJce3SuK16x+xzvD5RJHoa5nOVN83RjnFSVlujfvba2nWO4t3xxghe/vVVo4rKFghcbuea5TTdcnsxixkO3OCrHIz7VXv/ABJNe3csP35V67DwK6lWk1ZJ3OGUqUUnKRnTtNq2qz/P5UMcnljeMKX9M1sW9jb2FvIfLyQDgIOpxUWgsJPDSW0wjin+0GV2YHcxzwBXRW2nWd/DLFdXDQXi82+zJ3Hv0719FSpRo0bW6HyM6jrVHUf9eR3su4XBSYqrMAcscAVu2utCy0d7SJsjPLxoMAc/nVC28PTLdeVJMHlJALSAgZ9Kj1qO8szDafY42m3BSbd/lkX3HY18pCM07n2NWVKtaD16nqPhe60XXNEW1jkhE8YJ2k4ZSfr2rh9VaW21mdE01YnQlfLQ8t7/AENTWPhK7ngF7pFzGk6gCVN2CtR6ffxXF7s1C4F1qVq+zco4Kj+E+/eu27atJWZ49GlTp1Jyoz5k76dUylousXdvYR3esTS3KvmNbJP3bnJ46dhV7SG8NXmjapd3NhqGn3FogJnExd2PTjtnPatWPRjrl9Pqulfu70LscLjIPXIJ6Gp73w3f6hp9nbSGRDbnJWQKFc9ydveiXtXJuOxnKpQsoTlyyVr62a+XW/c8hubrVYNXuptKvbq9tVQlDKp+Y4yCe/tVDUvE3iGS1iuRa306xkKXMW4J6/8A6q9ZtPhtqEOrW11bTujRJtYk4jf8K1PGukeILqxnK3ll5mwRRw2qOmOcnPJyeKuabitFfruVHG0lUUIy0fnt+H/DHE6b8b/sFpZwsqz+WNjgxlePp1rtvDPxj0bXIhJCpKg4cJklay9T0jR/iF4Rs57S3iiuYgUmuPKXdGV4OVznBrj7K1024u7XT/BGjMms6dMIjfQHy4355Mg6EEUoOrzcj0f4foclSGErLndPvezs7/fb8D2TWNRsfEWju9i9w0kDb12Ic5rF8LtLbaoz31uwg+8ZgMjj1rvrWBLO2IiSCJurhRgE1J5EjwzJLIp8wEDCdOP1rbkcmpN6nmQx0KdOVGMfdfd6r8DkNQ+JOkWdx5YjnlX+8ox+hq1Z+ONK1CMLHdLZSk/8vC9vbB6/WuX1XwA9rdyXc6i/tOWZY/3Tg/TpVfTtH0bULOaSzjMNzE2DDLL+vSuVVcRzWaR6n1LLZU1Knd7arX70/wDI6jXG1TWL97HT4dlsoVzcyALuOOCM8/pV628N6TD5CXcKyXUQzvJI3n2rI/s66uBHaagPIMpCxbWOeOAc1t27JpuniG6mnvZixXM/VfbNdKSk7tHFVcoQjTpSt6dfO5y+vW01ze/uFO6bIXcScD2qtHoqWseHCTXgbBM0vyAfjUmuawkeufaRJPshAWNF7Ef/AF6Zpeq213KZLuHzz0xMMAH8+aylyOVup6sFXjRTS0t/SI9SkmtLC4S4W1XzsBAjhmx/nmo0na20aUI6g8H5uCZD2A9hVvxJPYXn2eC0tRDKkoaYLycc8/Sm6boC6jcf2hqUrtb2RDRW5TaDIMkPn29KfLeVhOqoUVOa67fh5mBqeoXOk6RLc2sjSak2dgxgD3NZEWsXUmkw3V/h79l8x1HHJ9j0q145jeWW2FheCJvP2KNuRLnr/WuDvGMN5PPqsspjc4SEthUQHHB7seDikqM5x5V/wTrhVpQftJXv8jTh8exahbC2RJI7oAhIpFJzzjg/Wn67PrkVtbLp11HGpBVgw+8xI/QVnaVfeHlvZriGOGHUOVMpUhiB9447Dp+tTQ3er6/LaXegQXUlpAziVlhypAHX2rWNGUaytHRd9tf60E8RD6s3OSu30333/wAzXubjS9F0qW91FYwCf3u/L4Y8cZ6d/wA6jfXGex8zUIWsYHhzbtMPldMcHjkD3NYEVzHqU9qmoWTS2ss/75wuInHON31xXZeKJk1mGW4NtHFN5S2tvZSL8igcAj867o4S+tTV+u39eeyPLr45wfLRSSt2MewRvEhS1s76a3vrqMG2lbdiXCnjk+2Pxqj4LntJprq1v2ntb9ZGQozHc7DJC03wc00kiaSjyyKijd/yzZMDAaJvwrL8UKieI21RbArHd5FwHfcBKO2fU8H867VBJuC2f9fj+fqedzylqyv4geJNXkmay8uRlEmFyeQOv1z/AJ5oEedPguLq2RlPzm65/d8cCpXnuABNbLGW8oGaOXJIJ6Zq5HKfskam2/cyx7WOMBvnzzWqVkaKL2KVzpaWxtHs7lZg3H7nOVAAJ38euaLr97maBBgk59FpqN5MxkcHzH+TYp6D1q7cQgW7JamQmQ/hHxzTWhqlZWRyl68dtfQLHsMikHJHT8PSuZ15bK81GacosVsWVXCyfOzf3q0fFKyrqMBiAIhRgXT1/wAtWDHp7Q29h5DW7yXBLGWb7q4U/JVyklZdThqK7dloh+jLZJP++hmmtvLdljg3M7N/tbfu1QimLMLd7hdrbnWUDBVmXo1P1OxltpQAJLUyxq4VfunI+7Re2RheCRpGIwplCjds+pqfba6amXspehLYSfYfKkA8lU+V5Pvbt1dZpiNAIWj4QnKfQ1z0d7HafLbokiyow/ejhen+H/j1bkd5EJolU4jAXp2r5/NZucYs+pyWMaUpRvtb8T1PwVrjaXdWF8X3G3bnC5OzBFTeJLiLWtcnvbcHzGJbG3G3PU+1cjGp2g2zHkcEd6sQ3LyReQLySMjkrjrWFKspRSvqerUwyhU9pbXY0LuRby6dicFUCBR7VatbRjajafmByTmqaiFIkMm9pj/CB0HqasWV/tkCtEY1B44rCpUjzcqO6nTajdmiun/OqCXaMZz0yfSs7WNXbSbLzLyEm3VgDhc4PvV2V2NsXUnzAeR3HvTnntr6G1h1OzE8cB3rGsmFlPbcO9aU4RlJcy0OfE1KkKb9m9SaOJEliaPJW4RZI8HqCMj+dcR43kntfNkmBEjHjnkmu/g23lz5lxlSec4wAfavPvH6S32pxwAeYgjMkgPZAOTS+qqVSMe7Mq2McMPKb3S/E85lhlnnSJvNgjkOPMx8q+tbOnaEbZNyrIZPurJjYT9fWtCzs/MQxxoWgb5eOCPz6VP5U2mXH7mMzoJPM+X0xzg54NfQvDqFPlp7+Z8dTq81VVKu3kTw+G/EEYhmg0S/ksMZWWEHb9frWj4Ze0fUhb6rL5LDfHluCDg9T2q0lvPLpt5NoWrz37TsD9iJfzoY+425wCD7Gr+u2yajHHqc1vFDcNGIz5bZ5AwCenOMZpXapOM30fk9v61FF89RuCt+W57rrK2Euqvq6CSWG3G3ZHwM9ic1xJ0xby7vJY4Y0s7gGSYQ7t5P+8OlQeJPHa6ikOnLBHapG++62LjcRxtNejeD9LhvdGhvrlmSF1ysZOFArxrN+9E9RyWEpXq7rRa30+RwmivcaqsZ0VZLWIkKkjHAlA4B9a7DVNC0w6fcbIIG1VYxLIttgFj0LL71TiuZINdaDRxHLFgoFReMVi3mjF9VtpZWktopXO5g2MDPPFZza1t1OhRlOUXKXLZX0Wr8n1KFva3bahbyW91JAfMxIgzlvQgjoRW3qPiK5W6ngMn2hej7lBD49avHSppb2KCwjRIiflfnJHrmp/EGk2zR/wCj2mbn7o2Hg4HLmotNR93QuWIo1Ki9or39NC9YRXes6hbanGJo9PFt9yFsYcccCuZn+1CbWpZ/tP2eHCwyZODKfU+39a6Lw5qK6Ho0uVMk3cHhVPYZzXK29reXOohn1CWKOcs5VEJiA6kEdPzq5N8qtqznoJwqTvZQVkvNXv8Af5nOeCrmeb4kxvABD5AZZ+eJcjPQen+Fem+B9Pl0q5vEjiQC4nkcE8lh1/CuD+H80tjrev3l7Cn2VpSlt5Y5YevNer+G7yN186dDDu4XcOBXQpKyh5I48cpLnny6MS3t9Ttw897qEQaUkiDZgKvoKqxz6lbThrS6Fxakch5OY/zra1q/jsEF4jK4X93IFOSB649q5C1vrvWNam+1zQrpCgGN+FZj3z+lEmr7nLh1KpFzlFcvp/WvzLOr6XDqsSyvLdSTy8gqx+X8OlVvCd3Z6fdtaPZAXBIDO5/Wuh1G+0+J7QLIrJMBiQEbWXIOQR7fzrK8T6LBqX/Ex0PYb0sI3WEghx/eqJU0nzLc6KNb2kPY1rqEtn0X/ALkuoy6deXc1+xcxnbawA56+9c14h1HUdTWwRiY9+/5kHeq/iC1nsobOzZbie7MvQ9QD2zV/eLi5jike2gWAYUGUAk49DWcpuV4s66NGnS5aySb118kraLz3MS2njsryN0tDOsIOWKk+Ye5B9qk026TVNVigsozEDLklwAVHcmpZtJN3fmxXWorSdlZlVW3Nt6kgVJo1qdH1e6uY4C9lF/qy6k5AH6nvWahJNXOuValKMnHWViOd5oPFd6G8ozhSqsQBgdQM1FreqLpOkSBZmklKbZGA4J6nAqBCkks8ojPnXMrSNNIx4zziql0mnXWqW8NxcbGDFoUIPzADDH8c1cdXy3/AOGHKCilKS1SWnRv/hzkrO8udbMlx5skNtEVjhUMRg936cnn6Vz3i26huL60jER/s22ucTtGOd3U/rXbeJL5LKKR7a22xwARwQxriuPvb/TbjWvKv1Bs7dRJJHAwD7+vHbNdWGk61X3VaK2/r8vUjFpUKDcvilZvz/4GmpXa/wBGv4Ln+zYxCzRkGU9yen4cd66vT/Hmt6TZabb6LDFaadaqsLK6jbLJtydzfXNeYa88cWrSQWtv/Z9i8eSJcGTb2yfrnpTDNqBmtYtMnmM7hECzbNpyPXpgevWvZp4aMbNq689T5/EYj20bSWq7f5HpWvRsNQ1XV9K8l7F5PNNjMvy9B5mB0IDZ4rorD4i+GLPSbTS/F2mxQ200PmQS2keV9xjO4VwPgO8tNI1eG38TXEz2tuJJfLwXEp5IXI46nvXn0bQyvPG4UsG3Wyy4IA39vyq44eMnZ6pW/r8mYTqc0VHZn094U8f+GJ9SstD8NaB5sUMvkxSKU+QZyG557k1H49+H1pPrdxd22q2kMckbSyafIesuflkAzxxxXzvp1k8U9tLHO8EsjmQ7mMbc8Y4robLV3sJpIJVaSJ+Glc75JMjHU8mlLCpO9N2/G/3sVKDUkzSgZrOS7CWwEgkwenzepp1zqv2+4h0y5jkULCQvoM85quLZ5oobvmeNmeLcPuj1H1qdeYpYGhmQR4EbHvVcqfqeheVvIZ9kjtQXjUvMmAWPPFVL+4dYJYrdShByxHGDWiu8ypCXKogGXYfeqj4jsbySxTzY8Kx3mRR8pFVF2krjqfA7GDf2zR3om/dyQyJtkXfwc965yZbWxaNJLdLhpJWmkBj3eQa6Ka3VSkKnzEKhVY/wn+tU9VSYX9pbInmnfhwO2erHFaSSe5xy8jm9TtZbyzu9Vu/OeYTLHbyJ9zb06Va0bR7stKiO8crxN5oZPvr0O2ukaxb7XEgEe9nXOwkjC9CfetG2s2u5zHIhWKPlR5YTB7E4qGl0FGk+bU4XUba5kmSOe22cY8wcYb+GtSy02e4t4pbvELRgqZM8yfLxge1dHdeH7V7MGdMScqJASapae0Gm6hBAI7WYheYnLbWGCM+1RKjCcXFq5rGVSnLmTschaS+JAqm2ViqthSTxXoWkTeJH0ppUt7aSSL523xgke9XLKzg8qNraN7fcxkjZWKeWO4Q/0rVsZPsXnXvmTRyk4G3Cb0Oeqn3xzXmVMugpXirHo0cfVjBqcm7/AHI4fVdc8SR6iPtEMbTjptAGfbArUsvHmnTwRw6ja+VeRH/WJ0Psa3JRJIbqa4tmLr/qhJgb+cccYrtk8C+G7i3Ka5YsEji8wPC2CGbs36YxWNXL6Sje2vkawzatCW+nmcZZeJ/DUjhH1COzJGC0nQH3xmr63GmGUSWWoWkpH8SzDBqj4i+FFhLYudDmEsLPuaEN8+cH8c4zXmkvg6Cz1D7MpkO3kuoIb8fSqo4L+9qKtm9Rv4U0+zPWrnWrK2RpJZY3JGAolBI/CvPNauP7a143iqY7NWKKxOBn09+9Un8PTEGOGWYpyQfMNaum6UsLW9uYzKSeNxBKj0GPX1962oYWcavPN7GWKx3tqXsoxav3Lei2Upf/AEhtiH5wFJ+groNR0+BWCRg5VMlwuB7j3qC4tNQ0+M77ZI4hlGz29OnSmTXxlns4ZmTCrvJV+fpiu9Sc7NHDpFWKqaejbUt4kE033XPWtRPDusR6dcBYWkig+aXa+doI4J/xqxEYGkm8udZJMA+WFAKD6dat6Vrtzp8Ups5zIkm+GSHPmb15zgAZAB4zWdbm5GkTzcskz0exiuby7ic6JA92eV8xPu+57Ums6hq2szXNq9tJBbWg2thggJH866jVbrUNPnkXTohNYEYZk/1kR/GuUWe6k1G4tJZC1knzfarhjiJsd+eee1fNyTjpc9rDz9o/bckdFpq7r/g+RgNdvHK0Vsz28RwNqtg/XNSaCbzUvF9smny+RLEMDeMg+ua6vStGH2fN5eWl1flziaIKYyvHB46/41cjtBokjXGmwNJqBBM5CblA9Ae1QqUnZ30Oqpj6dpQgveasu3q79PU2PFj28NgNpfztuyKKJPvH2rmtQuNXuLZIb62t7OyI+UOuHAHHHeiXxBeRpPf2lrkqvJCkgY68GqOp+Jre81CS5nnQ2GAwVv8AD1racrvexw4XC1aaS5U7dd2npov+CbKeGYv7GS7lu1EO0k7uM81wni7Wrhbaey8NMFAGGkbkIfQ/Wm+M9W1XX7EzRXjWmmgo0aRZ6ZGB+VZHh/wpq1tJNHqU0ULXC/eib5wD3OenH86uCjdSexvGNSKaqyvJ7bWX/BR3PhXw7qF/FHvZYpUUM5OQpPtXo1ho9tp9oY7l/ML8Eniufl8Tw6FpcaJEsSRptXedxOB7dTXn+qeJdX8Sql7L51hbQSHMRkMRZB346596qPJBXZxVIYvHTs/diaXiKUf8JUljpMrSW+4PcSP0Rc9Ae+a19V0DQtTtorZ2W4uLQl4zET+orlvB2oQzJqMqW7maXdDGzgbmIPX6VtXl5LYLLcWiA7AYtw7n+tZ86jqtDunQm2qae3pr6mDqQnN2kVrL5Sx4jRVGAtejfDeSWO2ktpQWlHJYJwfq1YujaZZTxLJqIKTqodmJwA55Ax34ra0rXPsE8kbKVtgB8pXO0+vFTRhafO2ZZjV9vRdCnG9v607lnW7gWGqi9urJml2gK5l3Rx++Mda5CWS2N8btEnYHJZmx8p7DBHOatXV1a+Ib/Vhr95OlraoBDHby7N+QcjHcisrQrOCJz9lspWaYbpI5G+ZR0+b8q2nZrmMsJD2acZKzSV+1u2pdEkbyM0NvFbNPje/8b+3TgDitTVLsWVjDDMpdWXCqOA1R27IWAWMS7Vx8uf1qK3gOo3kjQfKIV/iGVA7nnpUtvc1ahe8lZLU5m5hupdQE8sxihEAjW2xwq5yW+tZviaeaw0i71VYI5pVuQluM7TGj8A1o3cks2lans82a6lQgGL7yr04/nWH4kke4vY7m6uVj0uNEgSzIwHbHBPvmlQjzSUpf15fPY7KzlFOEdPPt95xev3t9f35MDRzyhRHNcRxEICDgnHrggZ9qytX8PW1hBb3emPLITIVukuBjb7oe4rptS1G/0zV/It7K0tLW5UZckOrD2I71ydxdXk0EwaUrPuPlIzZGzPp0r6DDU7RVtP66+h83iZ80tdUiO8h+1RW7MhLs+VmJ4Ax6f0p2iySWN6qXLl4Jo8IFwTA/0PrWok4uLaMyrGoB3nBzzgD+lZzSC2nMiRRKM5LBuDXYlf3WYOFkmzT8O38TXNsdRtZLuBJ38xYuNiewqDXNBtLXU7e7tJkImCztEpyEzn92fcVNZasvmSzJbho3GxhGetR3VxArAxINkjHhTxGae0rgoXVuhp6ZLGt5ci9aCQwfvUCjcC/UIR3xT9es9NvjDf6fetG8o+eFoDGUlzzjtj/CsiWa3tJdtsc3Lce1acs7S29skqGSQHoF6E0mtU1oaxpp6M6y41K0u/CWiWJhiM1g0ouDF+6Dlujcd+ma5xr+cLHaFo4n35LMM7kHYe9RWoiZpAm7O/PyDritMraXFsm20ZrxGGHzxg1lycuy/r/hzaK5Y2RmX18l45FlDIxJGcHoe2PWte61J5dL8nytyICGx/LH41kN9ottQgNvsD27+Y7sgIUjp14zUsE0c10InkAvUBk2jofem1oktgT9673J9Ns7CTSmW/iZXUGaKZVyCc8Kw9eetZc2nulwuoLbBQOq+zdf51tMbq1P7pFIuUxtBz82cAgf1qXULOaGzD3XmeY+AcDg+tSt79xvt2MOWNt0knkIEVsHsVFaWkolxqNrBe3UaKzbt6g4UepxUPMUscUsKrEpJDr09s0tuzRzpJIwiAz8u3mnJdgTurXHakB9suY7J4ZbTzCItvysQD1x2z1rIfS4vtLARkyYyJCPu1raglvDdC+M8UykZVY4sPn0461FqLOyxi3yEOC27gikntYXR33HWFq8gQxkwEfLJsXhj69avW1qm5i8ZVAM7n4GfYelOtXuGVokhTaANrFh8xqG/E9k0T3y7Pkyjpzg/wD16htt2D3YJFTVreX7PH9lunEmc8k9PeuwsLvUNQt7W9tJlkkKCF4WBKIwxndjscfrXHfabq7vIl2HMic/Nwox1H6VHoHiZtAvChG6xuMw3UE3BKnjP1pSjKUbdTKajuerX0k9mBf6eEFzPiQFCNyEDH3T06n8K4TWkuLh5r+4kikmf96VjwD6c10Nvp9vp9tHm+ja2uOYp84lVsdG/Sp9M0fRrfTJ5NVvWmuZD9lIVsg45J45GMfSsVywXf5GSlaS6HBKnG9FjTsORkmpSn2HEtrgSZDkHotQ+NbF9H1wwTSpc2g2ywFR8zIQCPx5pLd7aWF42nltY43BeRhzJ9fat42cUzZzW50V7pGm6y0V0dUuvtTgedaEjbIR3rn/ABF4cuvD26WWyjS2ljLneefbBrNuI7myK3qvMskh/d/P8pGeCK6XxBb6rqWg2qai4ukZPMWAt84UdwOuKSvBpJ6Ee602lqZugRF7L+0ZJcxm3x5WMt+dR6VrEmh211dRxS3cVxBIkJkt/mBJ5AI9D/Kua0e4vl8S2VgqyRwA8KcjIOeD2616jq2kagul3VsqLdWsCF7SEyLEImIJJ9WPJrLFSjBNSe6HCLmk4rZnsGjYj8IQPrACzyR/OUB6+tcbqt1YGSexjF1PblN80mQB2wf1rdfWbmTRL22Nu52/dLYwoPQZrzS8uJIg+/zHc/L5ar29zXzteqt0e7lmClebm+vf8SppVsdP1O5gR1+yku1tK87FVyehHQNXSaO+sTzqtpK8ioeQM7CO+T6Vh6bfGNRHMSsDMC1vAMsa9FgTV/ENmbaMLpNmqjahGTIPc1ipuo9WehiEsLG1lZ7t/nbdv0+8wp9d1aytbiHTrV7xVRlkuET92MDnnufeuDg0i21nQpPEGpaiq2TR/LZ7MBWyRzjk16NqmuXWjWjaZcTwzoAQFVQP5VhaLNY69GbAyJauW2rtGMGtqc1GSu9fyOd0pum5qKUfLr5vb7rHF+GY9WvXithJcm12yRRRRR7TjoGHpivY9M+y6HbLfa1BIrgBVM7bRn/PrXV6JpFj4dtQzKrXG3DMB0HtXP3upweKNafTmgWa0iIAVhwx7mt3e95PTseY8T9Y5o0o+4lrK+5yeqPP4g1GO4vNpW2kLpFbj5cds1nanb6rfTwwpHHLDMxSS2K79p4wx9O9dZ8Rtb0/wroz2Ph+GBNVnZQm5TtGTjJNYPhe/wBZj0qE6tqUNxK128M0kS/Ip9ieeKU6bs5tnTh8UppRhCy6X8hsvh3V7TESSjYuBiEDv7VoweGJTbRxz3mJTgrGB3rU8T6vd6C63C2U95PcssbRWq525/jBzwDisfXB4otLK81Z20vT7a2AkRWDvKF77jzz9KinhlvfcJZnUcVdpeiLreGtWjklurokxJlss3+sPFWdTuNUvNF06209EjE7MWlTAaMjpnOeDzyKteFtdufF3hO5eN5o8ExLdSx4+bH3gD1H1rM0+S4n820lmW5ubU4EqgduvQYHNbQh7GTfY5XWni1y1Gvd7div9nu7rVphqFvZNdwPmK5jXaTwMgr9c8/StaxaaA3cETGYyKBPIABtHeorVZrTeSVM033ick47ZNRTulqGjcFjj5ivQ4GcCocr6nRGCS5Fqv6/Loa0d1b2FnKyr8rcKpPzH/61ZOual5NusOn3EZmkINwg6DPfjkYA6V59JrOp65DJc6bEYbYSeUBN8shwwztyfSo7HRYoGvbDVHkUXE4I8t8NcjOTnn061vGlL7WgoxpqSlF8z/qxq6Vqone9gs5grrAzF1OSB04ri7LSm1i+GkXerTubUC43Hhs9cH6f1re8U6xZ6LEbTRbWNbqVcRpHhOB6mvM3juIbhb83MyTocTAE7j9fUV0YGg3rHRdO9wzGsno/ie/kv8zZku1u7b+yJYQPIfzAzsXJHrk9KqxR21lbBbkKWjJIPcVLBGEjdpXJTbklqzY4LfULsRXOoRafBIreXLOC2XHOMAZOa9hO9+x48kqST6mdqms77e6hth5SRp95eSPwrkZ7yeyedL6dt+Q6LCwKE1Nd2n+ls97GRIwwQuR0747VnDSZXUTh9zk4AFc9bHRpe7EyeFrVfet/XoWbLVdSucqm8QruZvJwpI/lVrTdQu4oZA8smwHfG+Ny/jVU209mq7lYZ4HHINGlC2XUZ/tqkqylTn+Fv71Y08yS0mjT6jNNJPXzOus9RjW1hcsxLnmQj/Vv/drqdNuhKpWBX8xuHJ7fjXmj6vd6Zduhkt/3vQ7cgf59a6/w5q9xd2/lhY1lbPKdOOo9q9JVI1I80diKcuWfs5uzXkdfG00eY4CFjTgyf1plvqUN5cyxLOoWPB3Rt2Fadrp0c2jvGmJJQgPLc8jisPTLFYrmH7RCIpwxQvnhxwAgTtjn86iMk2dVVSjbzOrl0eeXSmvYpx5RlVW/i+9wOOw96zZ5JrbzoWWKOXeqxtjqnfNaFvqTafZXFot1LBDIcZB4B9KNQtpksrS6jjimjmVZDJnllPQ47dKzTd/e2KlZPQqXkaxeRJbsYrvODhMqVHqe1aN5quoOkkN46eTFMVYKnyqV4H556isCKWQSvLv8nzF5WT5wvJAwenNVrTV0jm+z3EMrWLSH5wc8n2+tVyaa6mbqXd0aM0gu3khhJYxyhGyDzxniluLedBG8f3x1PUH1FN0u01mfS7y90S2a6t4ZBtlz95e4+opsN5HMJPLjKd5SzEY47VL3snt/WpSkuW5Fc2lvLbD7E+yWOTLfNyPw9KsOJmjDwpvKjOyo7dZ5Xihit45JLnAwvXp+tdn4c0VYtRNretsumj2ozr8qOfp1x3qKkuXzBONrs5exi+0alBHHuNy2ZBGOM4FdKLOw/s6a2v8ATbXylGHTzCLiFuzYzyCfas/x7ar4Uu7S4s54r1pYY5ZAv3JUzzj24NbOlSxahbaVLYwxBzMgDx5kdh6SEjI61lKTlFSWxjOd37rPP/EmkzeHb64inuJBLc20cyAdQCASo+nNOuvD8UNr9phmhli+z7wipktgZyT64FXvjHpl/p+r6Xp8Ub3L/ZQgeU5DqSTjPryaZpF4f+EPWCyEkLyERys65c9uP0/Kr9pempXM43ctFsb9tc6BqOj6RfSmdTG3PlRh93ABB9Oa6nSvBF9qAh1OyubeK34ltknQ7mPdXxxtP514PDe32hmRIruUWrEkEDkjn9etdV/wlWp2OmWtzb6pdxxwr5kaFMtv9Tkn1qalOSS5JfqZv3rtG743tQNL8Spq0P2a+ju4jaeU2VX5AvBPrsPH0ridBEbTWtrNEJrq4b7PFGH/AIiDjv8AWpIkvvEl5Y2F68t5d3Tl2L8Kz9ck+vAp2kaHeRyXc6LEl/b3ChXhP+rZSMU4tQi1J/1sUoyei3O41r4cpcaJbW02oWdpeKv722E5dg1cOt9cyzTWutQ+ZeaVuW2GW3Be5yP4cVpza/p0Wp3N9rsU8mqSz7JnQFIl7Bjnpx6Zqzp8FhLrqXj3aSboMIuOXGSeR2AzSU3BXm7/AOfl1HSg6rUUanhvQ8yp4o/0dtL8gwxqRyWz79xiukluJ5rWeGxt1kEeVn84EBeM5B6dcVYvGt9SitW1aeL7FDIjx2NkhQSPnIHvzzVaXxJbRaHOupSNDeTTPEqImwJyQF9zxjNeViZufM/LY9jDRlCKjvrq/wCuxLpskjs1u0rsjHovGfrVI7X1S5gt4zshJUHHMhx2/Emuh0S2jsdCk1CHJuGO0luRj6Uyx2tLJdbFE+WO8DB4Fecvh1PWda1STjsvxZzkUjWt4d+nKHGMFxkL9atS+KbiFLkXUwGCcELzj0x2rL0WR7jxVcmRj90tx64zWpqNrCLMXZQNK5G7PIP4VlCbs2jsqQg5JVFd2X9amDcpJfiyvJoXjifkrIcFvQ1PJ4fljuzqtosSQRCPHltnc/H5Hit7wxYQX95FBcKfK7KpIC/Suz0Wyt7S4CRRgqxyQ3PI6H61UaanLmWhzYnG/V48u7X5DtV8QXE/hckRhbmU/ZyuOQSKwLC5t9H0yUadOp1IqTJuHJPoK6HWo1Op3gxgJIHXHY7BzXE6nbotwqKWAj+ZSDzmtqkuXVnnYGlTqU+RKyetv09DhrXVfC6apcXPiqfV768i2yD/AJ5I2eDjPXp2r02aeTUrfTEtbCKC3eQNPHOwX5CPUdTzXBXttHe6xBHIAqTuGkCKvzHBPcHvXUpdT6lr0WgTzOlmy+YzxHbIxAHU9P0rshU9vFP8zCvRWHqWT+7oEl9f6DrbwWly0lpanf5bHeZRnG0fga1fEVvqcmr2EmmPNNpt5KFmtZ4cwomOQSOfXGe9cf4d0e3f4oI8kk8gjV9qO+VHTtXrPhS4lEl6DIzBr90w3QAAAAflSj+6St2/M58bPmbl1X4mffTtZusGjWkn2KIHzY1TbHljzx1JqtZSkQCJlUEyF3WBPL47A/Su1v5C8zREDaPQc1xWtXUtlaN9nIXg1zyk1uxYRxqpRUbP1/MoaxqIiuIo7WQgEEtnmsYzpqd/EjtOAnLFDhVGM4fPrms7VJWWG3cH5iM1bNjb26fukx56+ZJz1O3FZ06lm5Poe7PDKMYQj1vdnLeI7+6txFpv2OxtbSZ2VPIUlo/m5cHucVhahPa2tzDFo94GmwT9qxlVj/unn9a0PGF1PplvH9jldPtcwjkyc4XB4HpXG6KxmmeKX5ljIwT1Oeua9nDr2sE3t+Z5GIf1epyR379i7ptipadrqZJQT8s3Oeeo+hq5cxeV02ELH0/u+/vT5UWK+gjjG1GHIHerkFukVsVyz/JnLnJ65ru50kmcsVq4/ic5qtxFY2BaZ3cHOdhBPGOMfjXJWOqI8z31xCokhz5O7uW6fgK0dcmee/jgLbEYPnZwaZ4asoJtb+zSJmG3tmdF98d/WoxVf2cNN2KhTdWr5Iq/Yry9tk1G6hIinJAbG0GtCxuWsInjMEZgb5GKp86HtV4ReXp7QCSQw7N+wtxnca6KCYxYMaxqjIMoEGP8f1rCjQTWp11Krpu6K3hfQbS9RpZG8xZGEcvmDdsPrXO+KPCIsNTiEkLhJJPLG3vzXo+l63eabfbbUxKLmMQy5QHcBuwf97nrUGtMXsy7feguhsPp8prLE011OvDWmmmtjyrxd4TbStVtra6WURugaMsMEg/w1k2MBsb5ooLxTbjduCH549uDur2j4/n7VofhLU5ubye0Bd/U4rxh4UtWd7cbOBkDo2W71nl1aVOp7NvQ8/MIQnBV4xs76nrXhe/sFvoLq+SZoABG23+L2yK6bUYtOe+j8iZkjDmVGxnIPb8+9ecaaiRWzJGoVCPujp92ux05itqgY7xt6PzXsTaumrnNTm5KzNS80lY4Fllz+/8AnUy/wehxUF/eRrpaW9/ffahDtjjZFC4A4xjHqa6+xs7afwnq1/cQRy3EUaBN4yB82On0rynVL2WG+JG1tkgRQwyAN9ZU5qbt2KqSSex6f4W06Gz8OmeEwmZYBK/OJBu5Hl9hjIz+NZnxJ8PrqHh23vDbxQ6hHtxcodvnBuCJIx0OSBml8M6lNJFbWEixtC5VGJX5iAT3rt/GWl2v/CNyQhGCsrMSGOcgbh+oFZynyyUutzK3NozmfBNwmj6dDPFbyJHBF5R8mT5d2MZaP+tcRZxy+KNelNnphuIkdprraGjiz/eyOnGeK9Dg0y1XwW98se258vZkHjB6jHSuC8EyMfC04U7NrTSjbx8yomM/99GlQqqblK2v/DmmJpKm7L+tjQuRL4c1fSvtapbxsgnW5BMh8skkdO/GBWh4P1qe8ilEIhiKuyyyEHbHIeh56Cuuh0u01DwHY3d7EJriR4bZ3YDLR7vun/vo1438P765j8R65pAlJslYoAQCQOO9VFqqpJrb/Mwc7PXqdr4x0CdbdWmf7TdT2vnZI4+Q4IGOOlYPg3UhpxjeyG2WO5X94hzsU5JJ9Rxj8a7jUtRmvILO2kEahi0LSIuHK85Ge2cc4xXnHgW3hj10SJEok+3QRb+c7Tvz/IfkKmFS8XzdCJaJWO1+I+qHXbua1lgh1a2zHsSFcMoxyVI6VysmnTaZPN/ZV9vsY0Be2uZ1Se36ZJHeuj8azSabrLJaNtSS2yy4GCd9c0LdZJNTkd5C0J2DDYDD/ax1rNJOml0KhJwqK25p3/h5b200uW5UW1wpMiNxh8Hk4/z1rlfFtjqN5rKt9kkESARQSQdAOMuR3r2vStPtZdLsTNCspgj3x7+dpY8msvW7a3sS3lW8Tbem9c1wxxkqb01PTnhqdVtPRrt1PIdE0HWrfUJJo5RBFN97zDuZQT1GOhx/Ou/0K0sNCt5I181vtkgDtJJuJb+8fSrOpFbfQrm8jjQTRoCuRwOa2odPs4tQ06Y20UssgRw0gyYyV52+lE8VOrF82i8vISoUsM043b8/6ZzGtaR9okjEBjVpX3tuUuCoHPA7+ma6DSdEkSwdUtLaKN/+Xi5IRmj/AKHFYPxe1q+0vWvD1vp8wt1mY73RQGOX29fpXo+m6RHe6heR3txdXEcMKKiyOCBu6np1pSjLkTZMMVDmaSsc/oNnF58yaFpsoeMbRdXsoIQeq81m3ujvZWc1vapHGgjMs11NmSSQnJOyuusbaCSOH9zGslwgSSRVAYqD93PpVrUgHEsGAIo4zhV4z9awqtcrOijVlzL+tD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extramammary Paget disease of the vulva-2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5834=[""].join("\n");
var outline_f5_44_5834=null;
var title_f5_44_5835="Risks platelet stim factors";
var content_f5_44_5835=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F74625&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F74625&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potential adverse consequences of thrombopoietic growth factor treatment",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Thrombocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stimulation of tumor cell growth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stimulation of leukemia cell growth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interactions with other cytokines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoantibody formation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stem cell depletion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction in threshold for platelet activation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased bone marrow reticulin (positive reticulin stain)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased bone marrow collagen (positive trichrome stain)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rebound worsening of thrombocytopenia upon stopping treatment",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5835=[""].join("\n");
var outline_f5_44_5835=null;
var title_f5_44_5836="Causes of stroke in pregnancy";
var content_f5_44_5836=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F60303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F60303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of stroke in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hematologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sickle cell disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polycythemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombophilias, inherited or acquired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombotic thrombocytopenic purpura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiac",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valvular abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arrhythmias, especially atrial fibrillation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiomyopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infective&nbsp;endocarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patent foramen ovale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial septal defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Vascular",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aneurysms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arteriovenous malformations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasculopathy (eg, moyamoya disease or syndrome, Takayasu arteritis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebral venous thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical artery dissection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atherosclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postpartum angiopathy (Reversible cerebral vasoconstriction syndromes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pregnancy related disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preeclampsia, eclampsia, and HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amniotic fluid embolism",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5836=[""].join("\n");
var outline_f5_44_5836=null;
var title_f5_44_5837="Resident attitude questionnaire";
var content_f5_44_5837=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53532&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Analysis of resident attitude questionnaires",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Posttest means*",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        P value",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Untrained (n = 26)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Trained (n = 31)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Self-efficacy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psychological sensitivity",
"       </td>",
"       <td>",
"        4.9",
"       </td>",
"       <td>",
"        5.5",
"       </td>",
"       <td>",
"        0.0001",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Emotional sensitivity",
"       </td>",
"       <td>",
"        5.3",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        0.0005",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Directive facilitation",
"       </td>",
"       <td>",
"        5.1",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        0.0001",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nondirected facilitation",
"       </td>",
"       <td>",
"        5.1",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"       <td>",
"        0.003",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Somatization management",
"       </td>",
"       <td>",
"        4.6",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"       <td>",
"        0.0002",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Outcome expectation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psychological sensitivity",
"       </td>",
"       <td>",
"        6.0",
"       </td>",
"       <td>",
"        6.1",
"       </td>",
"       <td>",
"        &gt;0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Emotional sensitivity",
"       </td>",
"       <td>",
"        5.5",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        0.075",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Directive facilitation",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        5.8",
"       </td>",
"       <td>",
"        &gt;0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nondirected facilitation",
"       </td>",
"       <td>",
"        5.3",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        0.055",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Somatization management",
"       </td>",
"       <td>",
"        5.8",
"       </td>",
"       <td>",
"        6.2",
"       </td>",
"       <td>",
"        0.024",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\" rowspan=\"1\">",
"        Commitment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psychological sensitivity",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        6.1",
"       </td>",
"       <td>",
"        0.195",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Emotional sensitivity",
"       </td>",
"       <td>",
"        5.5",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        0.022",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Directive facilitation",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        &gt;0.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nondirected facilitation",
"       </td>",
"       <td>",
"        5.5",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        0.045",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Somatization management",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"       <td>",
"        6.2",
"       </td>",
"       <td>",
"        0.008",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Posttest means on a seven point scale adjusted for pretest scores. Due to missing data, outcome expectation and commitment means are based on n = 56.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Smith, RC, Lyles, JS, Mettler, J, et al, Ann Intern Med 1998; 128:139.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_44_5837=[""].join("\n");
var outline_f5_44_5837=null;
var title_f5_44_5838="Contents: Primary care ENT";
var content_f5_44_5838=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care ENT",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care ENT",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Laryngology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/40/16009\">",
"           Hoarseness in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/10/33960\">",
"           Laryngopharyngeal reflux",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/17/30999\">",
"           An overview of rhinitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/30/13801\">",
"           Anatomy and etiology of taste and smell disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/41/1690\">",
"           Approach to the adult with epistaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/32/43527\">",
"           Bad breath",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/49/34584\">",
"           Clinical presentation, diagnosis, and treatment of nasal obstruction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/21/11608\">",
"           Differential diagnosis of a neck mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/16/8458\">",
"           Eustachian tube dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/1/18455\">",
"           Evaluation and treatment of taste and smell disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/24/7558\">",
"           Evaluation of a neck mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/21/18777\">",
"           Gingivitis and periodontitis in adults: Classification and dental treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/24/18824\">",
"           Motion sickness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/10/11431\">",
"           Overview of craniofacial pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/2/22568\">",
"           Salivary gland stones",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/22/35176\">",
"           Tonsillectomy in adults: Indications",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Otology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/33/12823\">",
"           Cerumen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/36/35397\">",
"           Ear barotrauma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/6/26727\">",
"           Etiology and diagnosis of tinnitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/15/10490\">",
"           Etiology of hearing loss in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/32/39429\">",
"           Evaluation of hearing loss in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/24/39300\">",
"           Hearing amplification in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/61/32729\">",
"           Meniere disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/42/18082\">",
"           Patient information: Tinnitus (ringing in the ears) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/58/41896\">",
"           Presbycusis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/25/38296\">",
"           Sudden sensorineural hearing loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/57/25495\">",
"           Treatment of tinnitus",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-5A6DA3E46C-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f5_44_5838=[""].join("\n");
var outline_f5_44_5838=null;
var title_f5_44_5839="Contents: Other topics in rheumatology";
var content_f5_44_5839=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?3/39/3710\">",
"       Rheumatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Other topics in rheumatology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Other topics in rheumatology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acute rheumatic fever",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/20/23879\">",
"           Clinical manifestations and diagnosis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/8/8327\">",
"           Epidemiology and pathogenesis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/2/44070\">",
"           Treatment and prevention of acute rheumatic fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Adult Still's disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/3/11320\">",
"           Clinical manifestations and diagnosis of adult Still's disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/22/35174\">",
"           Treatment of adult Still's disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Amyloidoses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/31/1530\">",
"           An overview of amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/14/33000\">",
"           Causes and diagnosis of secondary (AA) amyloidosis and relation to rheumatic diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/15/7418\">",
"           Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/10/42153\">",
"           Genetic factors in the amyloid diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/22/11623\">",
"           Musculoskeletal manifestations of amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/62/35815\">",
"           Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/24/30086\">",
"           Pathogenesis of secondary (AA) amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/9/35994\">",
"           Prognosis and treatment of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/29/13784\">",
"           Renal amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/53/23383\">",
"           Treatment of secondary (AA) amyloidosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Autoimmunity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/38/5735\">",
"           Apoptosis and autoimmune disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/57/3992\">",
"           Overview of autoimmunity",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Autoinflammatory diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/31/25078\">",
"           Clinical manifestations and diagnosis of familial Mediterranean fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/58/24487\">",
"           Cryopyrin-associated periodic syndromes and related disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/43/3768\">",
"           Hyperimmunoglobulin-D syndrome: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/7/23670\">",
"           Hyperimmunoglobulin-D syndrome: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/31/9720\">",
"           Hyperimmunoglobulin-D syndrome: Pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/3/8247\">",
"           Management of familial Mediterranean fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/32/32261\">",
"           Pathophysiology of familial Mediterranean fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/8/15494\">",
"           Periodic fever syndromes and other autoinflammatory diseases: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/56/28551\">",
"           Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic diseases of connective tissue",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/56/2953\">",
"           Clinical manifestations and treatment of the hypermobility syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/3/20538\">",
"           Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/51/5945\">",
"           Management of Marfan syndrome and related disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/50/20262\">",
"           Pregnancy and Marfan syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hemarthrosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/42/5800\">",
"           Hemarthrosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         IgG4 syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/55/13178\">",
"           Overview of IgG4-related disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Inflammatory eye diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/32/22023\">",
"           Clinical manifestations and diagnosis of scleritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/5/80\">",
"           Episcleritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/15/11511\">",
"           Treatment of scleritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/16/23817\">",
"           Uveitis: Etiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/10/10407\">",
"           Uveitis: Treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuropathic arthropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/38/39527\">",
"           Diabetic neuropathic arthropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neutrophilic dermatoses",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/43/30393\">",
"           Neutrophilic dermatoses",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Osteonecrosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/43/28346\">",
"           Osteonecrosis (avascular necrosis of bone)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Paget disease of bone",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/50/7978\">",
"           Clinical manifestations and diagnosis of Paget disease of bone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/22/10602\">",
"           Treatment of Paget disease of bone",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Panniculitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/52/13130\">",
"           Erythema nodosum",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Relapsing polychondritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/63/26616\">",
"           Clinical manifestations of relapsing polychondritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/47/4856\">",
"           Diagnostic evaluation of relapsing polychondritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/59/42935\">",
"           Etiology and pathogenesis of relapsing polychondritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/32/29187\">",
"           Pathology of relapsing polychondritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15673\">",
"           Treatment of relapsing polychondritis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rheumatic manifestations of other diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/42/35496\">",
"           Malignancy and rheumatic disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/22/11623\">",
"           Musculoskeletal manifestations of amyloidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/54/7015\">",
"           Rheumatic and bone disorders associated with acromegaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/13/2265\">",
"           Rheumatic manifestations of hereditary hemochromatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/12/11463\">",
"           Sarcoid arthropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/9/25752\">",
"           Sarcoid: Muscle, bone, and vascular disease manifestations",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sj&ouml;gren's syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/22/18794\">",
"           Classification and diagnosis of Sj������gren's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/1/11287\">",
"           Clinical manifestations of Sj������gren's syndrome: Exocrine gland disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/42/27306\">",
"           Clinical manifestations of Sj������gren's syndrome: Extraglandular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/36/25162\">",
"           Pathogenesis of Sj������gren's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/11/44212\">",
"           Patient information: Sj������gren���������s syndrome (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/12/26826\">",
"           Treatment of dry eyes in Sj������gren's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/57/36762\">",
"           Treatment of dry mouth and other non-ocular sicca symptoms in Sj������gren's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/14/2282\">",
"           Treatment of systemic and extraglandular manifestations of Sj������gren���������s syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Viral arthritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/33/1558\">",
"           Pathogenesis and diagnosis of viral arthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/51/23354\">",
"           Specific viruses that cause arthritis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-58FB29FBB7-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f5_44_5839=[""].join("\n");
var outline_f5_44_5839=null;
